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ABSTRACT 
THE ROLE OF THE VAGINAL MICROBIOME IN HPV INFECTION AND 
CARCINOGENESIS by Alessandra Christina Gill 
Cervical cancer is one of the most common cancers affecting women worldwide and 
is caused by persistent infection with high-risk types of human papillomavirus (HR-
HPV). Cervical cancer rates are particularly high in developing regions, including 
South Africa, which currently also has the highest HIV prevalence anywhere in the 
world. The immunosuppression associated with HIV infection results in an increased 
likelihood of persistent HR-HPV infection in HIV-positive women, resulting in an 
increased risk of progression to cervical cancer, a risk that increases as HIV 
infection progresses. 
Another risk factor for HR-HPV infection is a condition called bacterial vaginosis 
(BV) which is typified by a vaginal microbiome (VMB) made up of a diverse array of 
anaerobic bacteria with low numbers of lactobacilli. However, little detail is known 
about the bacterial species that are involved and the mechanisms that underlie this 
association. Using samples collected by the HARP (HPV in Africa Research 
Partnership) study, which was coordinated by the London School of Hygiene and 
Tropical Medicine, this study aimed to determine the association between the type 
of VMB and high-risk HPV infection and the presence of precancerous lesions of the 
cervix in HIV-infected South African women. This was achieved by characterising 
the VMB with the help of 16S rRNA gene sequencing of the V3-V4 region on the 
Illumina HiSeq platform, allowing identification of the bacterial taxa present in each 
vaginal sample. Laboratory and computational methods were optimised prior to 
sequencing of clinical samples to optimise the information gained.  
We were able to determine that samples collected during the HARP study in the 
fixative medium BoonFix® and stored at room temperature were suitable for 
microbiome analysis. Furthermore, when using the Qiagen Blood and Tissue Kit, 
the inclusion of the collected vaginal swab in the proteinase K digestion step 
significantly increased DNA yield, which was correlated with lower levels of 
contaminant reads in the sequencing results. In order to further refine the 
sequencing results, we tested two newer OTU clustering methods (DADA2 and 
Swarm) against USEARCH and were able to show that newer methods allow better 
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species separation than those (such as USEARCH) that rely on a similarity 
threshold. 
We found that this population of HIV-positive South African women had VMB 
profiles typical for women with black ethnic background and HIV infection: the 
majority had a Lactobacillus iners-dominated community, had a microbiome 
consisting of a diverse mixture of anaerobes typically associated with BV, or lay 
somewhere between these two extremes having lower levels of L. iners together 
with BV-associated anaerobes. In contrast, community types dominated by L. 
crispatus, L. jensenii, Gardnerella vaginalis, Atopobium vaginae or Bifidobacterium 
spp., or containing a relatively high abundance of pathobionts such as streptococci, 
staphylococci or Enterobacteriaceae, were uncommon or rare. Our results provide 
evidence for an association between HR-HPV infection and a high diversity vaginal 
microbiota typical of BV with a paucity of lactobacilli in general but especially L. 
crispatus. However, the effect sizes were relatively small in comparison to other 
studies, which may be due to the fact that our entire study population was HIV-
positive: these women had a high baseline prevalence of non-lactobacilli-dominated 
VMBs (43% had a Nugent score of 7-10) and were more vulnerable to acquisition 
and persistence of pathogens (due to a median CD4 count of only 428 cells/μl) than 
HIV-negative women in the general population. 
In multivariable models, we found no evidence of an association between the VMB 
and histological precancerous changes of the cervix in this cohort, beyond that 
related to persistent HR-HPV infection. The results of this study suggest that a high 
diversity vaginal microbiome with a paucity of lactobacilli is associated with HR-HPV 
infection in HIV-positive women and highlight the importance of taking HIV status 
into account when researching the VMB in HR-HPV infection and associated 
precancerous changes. A better understanding of how the vaginal microbiome 
impacts on the natural history of HPV infection and cervical cancer in women living 
with HIV could ultimately lead to improved management and treatment of these 
conditions in this high-risk group.  
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CHAPTER 1: General Introduction 
1.1 What is a Microbiome? 
Although the term "microbiome" is often attributed to Nobel laureate Joshua 
Lederberg, the term (in its current context) was already in use much earlier (Whipps 
et al 1988). Lederberg defined the human microbiome as "the microbes that share 
our body space and that inhabit our skin, our mucous membranes, and our gut" 
(Lederberg 2001), though earlier definitions also included the environment inhabited 
by these microbes. Today, the precise definition of the word is a topic of debate 
(Schaechter 2013). Some researchers have used "microbiome" to describe the sum 
total of genomes associated with that microbiota  (Ma et al 2012), and may include 
in that definition the surrounding environment (Cho and Blaser 2012). In that case, a 
"microbiome" can be thought of as the microbiological equivalent of a "biome", an 
ecological concept that describes a major type of ecosystem. However, in this text, I 
have elected to use the definition given by Lederberg, which can be viewed as an 
amalgamation of the word "microbe" with the suffix -ome (Lederberg and McCray 
2001) and as such can be considered synonymous with "microbiota". 
Although the human microbiome comprises viruses and eukaryotes as well as 
bacteria, the latter have been studied most extensively. Bacteria make up the 
largest portion of the microbiome in terms of biomass and there are well established 
methods available to study them. The majority of these bacteria reside in the large 
intestine where a single gram of dry faecal matter contains approximately 1011 
bacterial cells (Franks et al 1998). This is an almost inconceivably large number, 
whose magnitude can be better appreciated when considering that this single gram 
of faeces contains more bacterial cells than there are human beings on earth. In 
terms of genetic content, it has been estimated that the intestinal microbiome 
contains roughly 2-4 million different genes, outnumbering their human host's genes 
by a factor of 50-100 (Hooper and Gordon 2001). Thus the metabolically active 
microbiome provides the host with access to gene products that are not within the 
repertoire of the human genome - thereby having huge potential to affect the health 
of the host. Although the intestinal microbiome is the largest population of 
microorganisms associated with the human body (Feeney and Sleator 2012), other 
regions of the body harbour sizable bacterial populations of their own. This includes 
other parts of the gastrointestinal tract, upper respiratory tract, skin, hair and vagina. 
The microbiome composition is different at each of these anatomical sites and, 
within the same individual, variation is greater between sites than temporal variation 
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at the same site (Cho and Blaser 2012). Microbiome composition is affected by the 
local environment, which is in turn affected by the life-stage and life-style of the 
human host. This study will focus on the vaginal microbiome (VMB), for which 
certain bacterial communities have been implicated as risk factors for the acquisition 
of sexually transmitted infections, the onward transmission of HIV (Cone 2014) and 
other reproductive health outcomes (van de Wijgert et al 2014). Hence, a better 
understanding of the VMB has great potential for the development of interventions 
that could lead to improvements in women's health. 
According to Lederberg and McCray (2001), the term "microbiome" invites the 
consideration of the microbiota occupying a particular niche as a single entity, rather 
than separate units that function independently of one another. Until relatively 
recently, accurately describing the microbiome as a whole was impossible to 
achieve, due to the fact that a large proportion of microbes cannot be grown in the 
laboratory, making them impossible to identify by conventional microbiology 
techniques. As a result, organisms that are fastidious have perhaps not received the 
attention they deserve, while others that are easily cultured have dominated 
microbiological research. Good examples of this are Escherichia coli, the 
archetypical intestinal bacterium which, despite its prominence in the literature, 
actually only represents a small fraction of the gut microbiome (Arumugam et al 
2011) and the discovery that Lactobacillus iners is the major constituent of the VMB 
in many women, but was missed in earlier studies as it fails to grown on standard 
culture media (Burton et al 2003). The advent of DNA sequencing in the 1970s 
opened the door for the development of new methods to identify microbes based on 
their genetic material, without the need for in vitro cultivation. However, early 
sequencing methods were costly and labour-intensive and lacked sensitivity, 
making them unsuitable for comprehensive analyses of the microbiome. Ambitious 
sequencing projects such as the Human Genome Project have driven the 
development of more efficient technologies which, shortly after the turn of the 
century, gave rise to modern high-throughput sequencing technologies that are 
capable of reading several billion bases in no more than a few days. As is described 
in detail later, the work that follows was completed using the next generation 
Illumina MiSeq sequencing platform to characterise the composition of the VMB and 
its association with human papillomavirus infection and cervical cancer in women 
infected with HIV. 
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1.2 The Vaginal Microbiome 
1.2.1 Early work on the vaginal microbiome 
Interest in the potentially beneficial nature of the normal vaginal microbiota was 
kindled by the pioneering work of Albert Döderlein in the late 19th and early 20th 
centuries (Döderlein 1897). He examined the vaginal microbiota of postpartum 
women microscopically and found that the microbiota in most healthy women 
contained significant numbers of a 'vaginal bacillus' (later named Döderlein's 
bacillus and now known as Lactobacillus). By contrast, other types of bacteria 
dominated the microbiota of women who developed puerperal fever. Döderlein was 
the first to suggest a link between the production of lactic acid by lactobacilli and 
protection from infection. He also warned against prophylactic disinfection of the 
vagina in the peripartum period, suggesting that it may lead to disruption of the 
normal flora which could allow pathogens to flourish (Schultz 1961). 
In the decades that followed this work, studies to determine the association between 
the VMB and health and disease were hampered by the fact that the majority of 
bacteria could not be cultured, making it difficult to accurately describe the microbial 
population as a whole. Furthermore, methods to define what constitutes a normal or 
abnormal microflora were highly subjective leading to conflicting results (Amsel et al 
1983, Martin 2012). Nonetheless, the existence of a clinical syndrome characterised 
by a thin homogenous vaginal discharge and associated with a loss of lactobacilli 
was soon recognised. This has been given a variety of names, initially being called 
"white discharge syndrome", later "nonspecific vaginitis" and finally "bacterial 
vaginitis", which was later changed to "bacterial vaginosis" in recognition of the fact 
that most cases are not accompanied by significant inflammation (Martin 2012). 
Standardised criteria for the diagnosis of bacterial vaginosis (BV) were first 
published in the 1980s by Amsel and co-workers (Amsel et al 1983), who aimed to 
create a method that could easily be used by medical practitioners. The "Amsel 
criteria" for the diagnosis of BV are satisfied by the presence of three out of the 
following four conditions: (1) a vaginal pH above 4.5, (2) the presence of a thin 
homogenous vaginal discharge, (3) the production of a fishy odour on application of 
potassium hydroxide (which is indicative of the presence of a significant amount of 
amines, mainly putrescine and cadaverine, produced by certain bacteria) and (4) 
the presence of clue cells (vaginal epithelial cells covered with adherent bacteria) 
under the microscope (Amsel et al 1983). The Amsel criteria provide an indirect 
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measure of the vaginal microbiota and are simple to assess in a clinical setting. 
However, although they have contributed to the study of the vaginal microbiota, they 
suffer from significant limitations. First, recent studies have shown that, with the 
exception of pH, they do not correspond well with bacterial profiles as determined 
by molecular methods (van de Wijgert et al 2014). Second, all but the measurement 
of vaginal pH are highly subjective causing concern that they could introduce a high 
degree of observer bias to clinical research studies, particularly for larger multi-
centre projects. There was therefore a need for a standardised laboratory-based 
test. 
In 1991, Nugent and co-workers published revised criteria (now known as the 
Nugent score) for the evaluation of vaginal smears by Gram staining (Nugent et al 
1991). This built on earlier work by Spiegel and others, who had developed a binary 
test for BV that was based on the assessment of gram-stained vaginal smears, and 
which was developed by using the Amsel criteria as a gold standard (Spiegel et al 
1983). Rather than being a binary test, the Nugent score ranges from 0-10 (see 
Table 1.1), with a lower score for the presence of large gram-positive rods 
(Lactobacillus morphotype), and a higher score for the presence of small gram-
variable rods, gram-negative rods and curved gram-variable rods (representing 
Gardnerella, Bacteriodes and Mobiluncus morphotypes, respectively) (Nugent et al 
1991). These morphotypes were chosen due to their high intra- and inter-centre 
repeatability, and the resulting score was weighted according to expert opinion at 
the time (Nugent et al 1991). As expected, the Nugent score has been shown to 
have high inter-observer reliability (Forsum et al 2002, Zarakolu et al 2004). It has 
been extensively used for the diagnosis of BV in clinical research studies, which has 
allowed the identification of a clear relationship between the VMB and various 
adverse health outcomes including pelvic inflammatory disease (Haggerty et al 
2004), preterm birth (Hillier et al 1995) and infection with sexually transmitted 
diseases such as HIV (Martin et al 1999). 
 
Although BV is considered a clinical condition in its own right that may present with 
a malodorous vaginal discharge and pruritus, it should be noted that the majority of 
women with BV diagnosed by either Nugent score or Amsel criteria do not report 
any vaginal symptoms at all. Furthermore, vaginal symptoms are only marginally 
less frequently reported by women classified as having normal microflora by these 
methods (Amsel et al 1983, Klebanoff et al 2004, Koumans et al 2007). This may at 
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least in part be due to a lack of consensus amongst both patients and clinicians as 
to what constitutes an ordinary amount, consistency and odour of vaginal secretions 
(Anderson et al 2004). When assessed by a healthcare practitioner, malodour is 
fairly specific for BV by Nugent score, but a large proportion of women with BV are 
not classified as having any malodour, even after the addition of potassium 
hydroxide to vaginal secretions (Beverly et al 2005, Simoes et al 2006). In contrast, 
when using the Nugent score as the gold standard, the sensitivity and specificity of 
a ‘characteristic’ vaginal discharge are greatly variable between studies (Beverly et 
al 2005, Simoes et al 2006), which may reflect the highly subjective nature of this 
assessment. 
Table 1.1 Calculation of the Nugent score. Gram-stained vaginal smears are examined under oil 
immersion and three bacterial morphotypes are quantified per high-power field: Lactobacillus 
morphotypes (large gram-positive rods), Gardnerella and Bacteriodes morphotypes (small gram-
variable rods and gram-negative rods respectively) and Mobiluncus morphotypes (curved gram-
variable rods). Numbers of each morphotype are converted to a numerical score (see left-hand 
column) and added to give the final Nugent score. A score of 0-3 is considered normal, a score of 4-6 
is considered intermediate and a score of 7-10 is considered consistent with bacterial vaginosis. 
Adapted from Nugent et al (1991). 
Score Lactobacillus 
morphotype 
Gardnerella/Bacteriodes 
morphotype 
Mobiluncus 
morphotype 
0 >30 none none 
1 5-30 <1 ≤4 
2 1-4 1-4 ≥5 
3 <1 5-30 - 
4 none >30 - 
1.2.2 Modern methods to study the vaginal microbiome 
The advent of DNA sequencing technologies has revolutionised the study of 
microbial populations as it makes it possible to identify bacteria without the need to 
first culture them in the laboratory. These "molecular methods" were first used to 
study the VMB at the beginning of this century (Burton and Reid 2002). Although a 
number of different methods have been used they are all based on the same 
principle and involve extraction of genomic DNA from samples, usually followed by 
PCR-based amplification and sequencing of a universal bacterial gene, i.e. a gene 
that is invariably present in all bacterial species. The most commonly used gene is 
that encoding 16S ribosomal RNA, which is particularly suited to this work since it is 
not only universal, but has evolved at a relatively slow rate. This means that it 
contains regions that are highly conserved between distantly related organisms, 
allowing binding of universal primers and comprehensive PCR amplification even 
from populations with high species diversity. Bacterial taxa can then be identified 
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based on the more variable intervening regions of the gene known as hypervariable 
regions (Case et al 2007). 
The first molecular techniques involved the use of Sanger sequencing, which relies 
on being able to generate a large amount of amplicon from a single species. To 
achieve this, amplicons were initially separated by denaturing gradient gel 
electrophoresis (DGGE), allowing identification of species that were numerically 
abundant enough to produce bands on a gel (Burton and Reid 2002). Better 
resolution could be achieved by amplifying genes in a bacterial vector prior to 
sequencing (Burton et al 2004). Other approaches such as terminal restriction 
fragment length polymorphism analysis (T-RFLP) or microarray analysis have also 
been used instead of sequencing, but researchers are then limited to known 
bacterial species (Borgdorff et al 2014, Coolen et al 2005). The use of Sanger 
sequencing provided the first opportunity to identify unculturable vaginal bacteria, 
but still lacked the resolution to identify minority species. 
Over the last decade, the increasing affordability of high-throughput sequencing 
technologies has made it possible to produce a vast amount of sequencing data to 
describe the VMB. Initial studies utilised 454 FLX pyrosequencing technology 
(Spear et al 2008), as other methods were not able to produce long enough DNA 
sequences, or "reads". However, continued technological improvements have now 
made it possible to accurately describe the VMB at a relatively lower cost with the 
use of Illumina technology (Fadrosh et al 2014), which has been used in this study. 
These next-generation sequencing technologies are for the first time allowing 
detailed description of vaginal communities, with great potential to improve our 
understanding of the health implications of distinct VMB structures. 
1.2.3 The composition of the vaginal microbiome 
Despite the current view that a vaginal bacterial community dominated by 
Lactobacillus spp is optimal, recent work has shown that a substantial proportion of 
apparently healthy women possess a VMB made up of a diverse community of 
other facultative anaerobes and strict anaerobes. In some ethnic groups, this 
diverse VMB-type can have a prevalence as high as 40% (Ravel et al 2011). It 
follows that although in some cases a diverse VMB can be described as "normal", it 
may not provide optimal protection from negative health outcomes. 
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There are now a number of studies that have used culture-independent techniques 
to characterise the VMB in healthy women of reproductive age and those with 
bacterial vaginosis. Most of these have identified groups of women whose VMB is 
dominated by a single taxon. Often this taxon is Lactobacillus crispatus or L. iners, 
but VMB communities dominated by other taxa, including Lactobacillus gasseri, 
Lactobacillus jensenii and Gardnerella vaginalis have also been identified (van de 
Wijgert et al 2014). Furthermore, VMB types that are not dominated by a single 
taxon are also prevalent. These communities are variable and consist of a diverse 
assortment of facultative and strict anaerobes that commonly include Atopobium, 
Dialister, Gardnerella, Megasphaera, Prevotella and Sneathia species. A more 
extensive list of taxa that have been identified in vaginal samples is presented in 
Table 1.2. 
Unsurprisingly, women with BV by Nugent score have a distinct VMB profile 
compared to women without BV. The vast majority of women without BV have VMB 
communities dominated by Lactobacillus species (Srinivasan et al 2012). 
Interestingly, while L. crispatus is mainly found in women without BV, L. iners is also 
common in subjects with BV, but may be more abundant in women without the 
condition (Srinivasan et al 2012). In contrast, women with BV by Nugent score tend 
to have VMB communities with higher overall bacterial diversity (van de Wijgert et al 
2014), which in turn correlates positively with an increase in vaginal pH (Drell et al 
2013, Human Microbiome Project Consortium 2012). Several bacterial species have 
been associated with a high Nugent score, including G. vaginalis, Atopobium 
vaginae, Leptotrichia/Sneathia spp, Megasphaera spp. and Prevotella spp. Often 
not only the presence, but also an increased abundance of these species is 
predictive of BV (Datcu et al 2013, Ling et al 2010, Ling et al 2013, Yeoman et al 
2013). Considering that the Nugent score is based on the semi-quantitative 
assessment of selected bacterial morphotypes (see Table 1.1), it should be no 
surprise that there are strong associations between the Nugent score and bacterial 
community composition profiles as determined by molecular techniques. 
Interestingly, two studies that defined BV based on the Amsel score, did not identify 
a significant association of Lactobacillus spp. with BV (Mitchell et al 2009, Yeoman 
et al 2013), while two other studies did find an association (Haggerty et al 2009, 
Shipitsyna et al 2013). These differences may be due to the small sample sizes or 
the subjective nature of the Amsel score, but it is interesting to note that one of the 
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Table 1.2 Taxonomy and selected characteristics of bacteria commonly reported in vaginal samples (Aagaard et al 2012, Chaban et al 2014, Datcu et al 2013, Dols et al 
2011, Drell et al 2013, El Aila et al 2009, Fettweis et al 2014, Forney et al 2010, Frank et al 2012, Gajer et al 2012, Hernández-Rodríguez et al 2011, Hickey et al 2013, Huang 
et al 2015, Hummelen et al 2010, Kim et al 2009, Lee et al 2013, Ling et al 2010, Martin et al 2012, Oakley et al 2008, Pépin et al 2011, Ravel et al 2011, Shipitsyna et al 
2013, Smith et al 2012, Spear et al 2008, Srinivasan et al 2012, Wertz et al 2009, Yamamoto et al 2009, Zhou et al 2010). Bacterial classification for Mageeibacillus indolicus 
(formerly "BVAB3") as described by Austin et al (2015) and for the remaining BVAB species as described by Fredricks et al (2005). Remaining information is taken from 
Bergey's Manual of Systematic Bacteriology (Brenner et al 2005, DeVos et al 2009, Krieg et al 2010).  
 
BACTERIA WITH GRAM POSITIVE PHYLOGENY COMMONLY REPORTED AS PART OF THE VAGINAL MICROBIOME (continued on next page) 
Phylum Class Order Family Genus/species Gram stain1 Anaerobe/aerobe Morphology 
Firmicutes 
(cont.) 
Negativicutes Selenomonadales Veillonellaceae Dialister - obligate anaerobe or 
microaerophile 
coccobacillus 
    Megasphaera - obligate anaerobe coccus 
    Veillonella - obligate anaerobe coccus 
Tenericutes Mollicutes Mycoplasmatales Mycoplasmataceae Mycoplasma - facultative anaerobe pleomorphic 
    Ureaplasma  - facultative anaerobe coccus/coccobacillus 
 
BACTERIA WITH GRAM NEGATIVE PHYLOGENY COMMONLY REPORTED AS PART OF THE VAGINAL MICROBIOME 
Phylum Class Order Family Genus/species Gram stain1 Anaerobe/aerobe Morphology 
Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides  - obligate anaerobe rod 
   Porphyromonadaceae Porphyromonas  - obligate anaerobe coccobacillus 
   Prevotellaceae Prevotella - obligate anaerobe short rod 
Fusobacteria Fusobacteriia Fusobacteriales Leptotrichiaceae Leptotrichia  - anaerobe rod 
    Sneathia - anaerobe, moderately 
aerotolerant 
long rod 
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia - facultative anaerobe  rod 
1Gram staining characteristics given as negative (-), positive (+), variable (+/-) or unknown (?). 
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BACTERIA WITH GRAM POSITIVE PHYLOGENY COMMONLY REPORTED AS PART OF THE VAGINAL MICROBIOME (continued from previous page) 
Phylum Class Order Family Genus/species Gram stain1 Anaerobe/aerobe Morphology 
Actinobacteria Actinobacteria Actinomycetales Actinomycetaceae Mobiluncus - or +/- obligate anaerobe curved rod 
  Bifidobacteriales Bifidobacteriaceae Bifidobacterium + anaerobe (some 
facultative or 
aerotolerant) 
rod 
    Gardnerella vaginalis - or +/- facultative anaerobe 
(some strains obligate) 
small pleomorphic 
rod 
  Coriobacteriales Coriobacteriaceae Atopobium vaginae + facultative anaerobe coccobacillus 
    Eggerthella + obligate anaerobe rod 
Firmicutes Bacilli Bacillales Staphylococcaceae Staphylococcus + facultative anaerobe coccus 
   unassigned Gemella  + facultative anaerobe coccobacillus 
  Lactobacillales Aerococcaceae Aerococcus + facultative anaerobe coccus 
   Lactobacillaceae Lactobacillus + facultative (or 
obligate) anaerobe 
large rod 
   Streptococcaceae Streptococcus + facultative anaerobe coccus 
 Clostridia Clostridiales ?Lachnospiraceae "BVAB1"2 ? anaerobe curved rod 
    "BVAB2"3 ? anaerobe short rod 
   Peptostreptococcaceae Peptostreptococcus + obligate anaerobe coccus 
   Ruminococcaceae Mageeibacillus 
indolicus 
- obligate anaerobe rod 
   unassigned Anaerococcus + obligate anaerobe coccus 
    Finegoldia + obligate anaerobe coccus 
    Parvimonas + obligate anaerobe coccus 
    Peptoniphilus + obligate anaerobe coccus 
1Gram staining characteristics given as negative (-), positive (+), variable (+/-) or unknown (?). 
2Bacterial vaginosis associated bacterium 1 
3Bacterial vaginosis associated bacterium 2 
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studies also found that the metabolomic profiles were much more closely related to 
the Amsel criteria than to the Nugent score, indicating that the Amsel score may 
better reflect community function (Yeoman et al 2013). The wealth of information 
offered by next-generation sequencing studies may in future refine our 
understanding of the VMB community profile and function that most accurately 
reflects symptomatic BV. 
Data on the stability of VMB composition within the same subject over time is still 
relatively sparse. However, a comprehensive longitudinal study of 32 healthy women of 
reproductive age was carried out by Gajer et al (2012). Samples were collected at weekly 
intervals over a period of 16 weeks and were analysed using pyrosequencing. The results 
showed that some women have relatively stable community profiles, which was 
particularly true for communities dominated by L. crispatus and L. gasseri, but the study 
also identified four individuals with a high diversity VMB and persistent asymptomatic BV 
by Nugent score that also had very stable community profiles. In women with stable VMB 
profiles, the most significant fluctuations in community structure usually coincided with 
menses, with sexual activity having a lesser negative impact on stability. In contrast, other 
communities showed marked shifts in composition over short periods of time and the 
authors hypothesised that these communities might exist in a limited number of alternative 
equilibrium states. Shifts in community structure were dependent on the type of vaginal 
microbiome. Communities dominated by L. crispatus most often switched to either an L. 
iners-dominated community or a community with moderate numbers of lactobacilli in 
combination with various species of strict anaerobes. Conversely, L. iners-dominated 
communities also switched to the latter, but were twice as likely to switch to a high 
diversity state typical of BV. Additionally, most conversions from this high diversity state 
usually resulted in an L. iners-dominated VMB. Another host factor that is associated with a 
particular VMB composition is pregnancy, in which the VMB is generally more stable and of 
lower diversity and species richness - with higher levels of Lactobacillus spp and lower 
levels of BV-associated bacteria - when compared with non-pregnant women (Aagaard et 
al 2012, Jespers et al 2015, Romero et al 2014, Walther-António et al 2014). 
1.3 Human Papillomavirus - a Public Health Problem 
1.3.1 HPV and its effects on human health 
Human papillomaviruses (HPVs) are small double-stranded DNA viruses that lack 
an envelope. More than 200 different genotypes are formally distinguished and are 
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separated on the basis of having less than 90% similarity in DNA sequence of the 
L1 gene (the gene encoding the major capsid protein) when compared with any 
other HPV type. Viruses that differ by less than that are referred to as subtypes or 
variants (Burk et al 2013, Bzhalava et al 2015). 
HPVs infect and replicate in keratinocytes, the epithelial cells of the skin (for 
cutaneotropic HPV types) and mucosal sites such as the cervix (for mucosotropic 
HPV types). The virions require access to the basal layer of epithelial cells in order 
to establish infection, probably gaining entry through microabrasions in the skin or 
mucosal surface (Schiller et al 2010). HPVs are currently grouped into five major 
genera, such that members of each genus differ in their L1 open reading frame by 
more than 60% from members of other genera. These are further divided into 
species which share 60-70% sequence similarity (Bzhalava et al 2015). The 
sexually-transmitted genital HPV types are mucosotropic and belong to the 
alphapapillomavirus genus, of which they make up the majority. Genital HPVs are 
further divided into low-risk and high-risk types according to their carcinogenic 
potential. In the general population, infection with low-risk HPV (LR-HPV) types 
(which also include the cutaneotropic alphapapillomaviruses) is usually either 
asymptomatic or characterised by the appearance of benign papillomas. They are 
only rarely associated with cancer (Doorbar et al 2012). 
By contrast, high-risk HPV (HR-HPV) can be identified in virtually all carcinomas of 
the cervix, and they are therefore considered a necessary instigating factor for the 
development of cervical cancer (Doorbar et al 2012, Walboomers et al 1999). The 
most commonly encountered histological type of cervical cancer is squamous cell 
carcinoma, which arises from the squamous epithelium of the ectocervix and 
represents 75-90% of cases. The largest proportion of remaining cases are 
adenocarcinomas, which arise from the glandular epithelium of the endocervix 
(Mathew and George 2009, Tjalma et al 2005). HR-HPV infection has also been 
associated, albeit less strongly, with other anogenital cancers (Wakeham and 
Kavanagh 2014) and a number of head and neck tumours (Leemans et al 2011). 
However, most HR-HPV infections are eventually cleared within 6-12 months of 
infection and do not result in cancer (Zur Hausen 2002). In fact, infection with HPV 
is extremely common worldwide, with an average prevalence of 11.7% in women 
with normal vaginal cytology. There is regional variation in infection prevalence, with 
sub-Saharan Africa having the highest HPV prevalence at 24.0%
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commonly encountered HPVs are the high-risk types 16 and 18, (Bruni et al 2010), 
which also have the strongest association with cervical cancer (IARC 2012). 
Table 1.3 Human alphapapillomaviruses types currently recognised by the HPV Reference Centre 
(see http://www.hpvcenter.se/html/refclones) and their corresponding IARC category: group 1 
(carcinogenic to humans), group 2A (probably carcinogenic to humans) and group 2B (possibly 
carcinogenic to humans). The remainder are designated as group 3 - not classifiable (IARC 2012). 
Alpha-1 HPV32   Alpha-7 HPV18 Group 1 
 HPV42    HPV39 Group 1 
Alpha-2 HPV3    HPV45 Group 1 
 HPV10    HPV59 Group 1 
 HPV28    HPV68 Group 2A 
 HPV29    HPV70 Group 2B 
 HPV77    HPV85 Group 2B 
 HPV78    HPV97 Group 2B 
 HPV94   Alpha-8 HPV7  
 HPV117    HPV40  
 HPV125    HPV43  
 HPV160    HPV91  
Alpha-9 HPV16 Group 1 
Alpha-3 HPV61    HPV31 Group 1 
 HPV62    HPV33 Group 1 
 HPV72    HPV35 Group 1 
 HPV81    HPV52 Group 1 
 HPV83    HPV58 Group 1 
 HPV84    HPV67 Group 2B 
 HPV86   Alpha-10 HPV6  
 HPV87    HPV11  
 HPV89    HPV13  
 HPV102    HPV44  
 HPV114    HPV74  
Alpha-4 HPV2   Alpha-11 HPV34 Group 2B 
 HPV27    HPV73 Group 2B 
 HPV57    HPV177  
Alpha-5 HPV26 Group 2B  Alpha-13 HPV54  
 HPV51 Group 1  Alpha-14 HPV71  
 HPV69 Group 2B   HPV90  
 HPV82 Group 2B   HPV106  
Alpha-6 HPV30 Group 2B     
 HPV53 Group 2B     
 HPV56 Group 1     
 HPV66 Group 2B     
       
 
HPV 16 has by far the strongest association with cervical cancer, with one meta-
analysis finding this type in 54.4% of cases of invasive cervical cancer, compared 
with only 2.6% of women with normal cervical cytology. There is also strong 
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evidence that HPV 18 is associated with cervical cancer, with 15.9% of cases of 
invasive cervical cancer being positive for this type, compared with 0.9% of controls 
(IARC 2012). Both HPV 16 and 18 are associated with squamous cell carcinoma 
and adenocarcinoma of the cervix, the predominant types of cancer at this site. 
However, HPV 18 is relatively more important as a cause of adenocarcinoma, 
causing similar numbers of cases as HPV 16 (Clifford et al 2003). In addition, there 
is convincing epidemiological and experimental evidence that other HPV types also 
cause cervical cancer, although they are less carcinogenic than HPV 16 and 18. 
Currently 12 human alphapapillomaviruses are classified as carcinogenic by the 
International Agency for Research on Cancer (IARC): 16, 18, 31, 33, 35, 39, 45, 51, 
52, 56, 58 and 59 (IARC 2012). Of these 16, 18, 31, 33, 35, 45, 52 and 58 are most 
often identified in cases of cervical cancer (Smith et al 2007). A further 13 HPV 
types are classed as probably or possibly carcinogenic by the IARC (see Table 1.3), 
based on weak evidence from epidemiological studies, limited in vitro experimental 
evidence, or a close phylogenetic relationship with known carcinogenic types (IARC 
2012). 
1.3.2 How does HPV cause cervical cancer? 
As a causative agent of cervical cancer, HPV has the strongest association with 
cancer ever identified for any cancer-causing agent (Scheurer et al 2005). It is 
therefore not surprising that cervical cancer has been the best studied of the HPV-
related cancers. Significantly, cervical cancer is also one of the most common 
cancers in women worldwide with an estimated 528,000 new cases every year and 
over 260,000 deaths annually. The majority of this burden falls on developing 
regions, including Sub-Saharan Africa, where cervical cancer is the most common 
cause of cancer-related death in women (Ferlay et al 2013). In this region, the age-
standardised death rate for cervical cancer is 22.5 per 100,000 women. In the 
Republic of South Africa this rate is typical for the region at 18.0, much higher than 
that observed in Western Europe and the United States, where rates are below 3.0 
(Ferlay et al 2013). These differences can be partly explained by a lack of 
awareness, insufficient access to suitable preventative cervical cancer screening 
programmes leading to later presentation of cancer cases, and inadequate access 
to treatment in developing countries (Denny et al 2014). 
The mechanism by which HPV causes malignant transformation relates in part to its 
molecular biology, a brief summary of which is provided below. After infection of a 
basal keratinocyte, the HPV life cycle is closely related to differentiation of the host 
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cell. Normally, epithelial cells undergo terminal differentiation as they progress 
towards the superficial layers of the epithelium, i.e. they no longer multiply. HPV is 
dependent on the host cell's replication machinery to produce new viral DNA and 
proteins and has therefore evolved mechanisms to maintain the cell in a dividing 
state. This is achieved through the induction of host cell expression of various viral 
proteins. The HPV genome is approximately 8000 base pairs in size and encodes 8 
well-defined open reading frames: E1, E2, E4, E5, E6 and E7, which are first 
expressed at an early stage of infection and L1 and L2, which encode capsid 
proteins that are expressed later (Lehoux et al 2008). In HR-HPV types, proteins E6 
and E7 in particular have been found to have an important role in the progression of 
infection to cancer. These proteins have been most extensively studied in HPV 16 
and 18. In these viruses, a major function of E7 is to inactivate the tumour 
suppressor protein pRb, thereby maintaining the cell in a proliferative state (Lehoux 
et al 2008). E6 acts synergistically with E7 to cause cancer by ensuring cell survival. 
This is achieved by E6-mediated inactivation of the tumour-suppressing regulatory 
protein p53, thus preventing programmed cell death that would otherwise be 
triggered by the abnormal cellular growth caused by E7 (Hiller et al 2006). 
Additionally, E6 activates telomerase which extends the reproductive lifespan of the 
cell, favouring the development of cancer (Xu et al 2008). 
During the normal HPV infection cycle, viral DNA is maintained within the nucleus 
separate from host genomic DNA in episomal form. However, in rare cases the viral 
genome becomes integrated into the host's chromosomal DNA. This may facilitate 
progression to cancer if it disrupts the E2 open reading frame, leading to the loss of 
suppression of viral oncoproteins by E2. In the majority of cervical cancers, HPV is 
found integrated into the host genome, but this is not an essential event for the 
development of cancer (Pett and Coleman 2007). 
Consistent with the observation that only a small fraction of HR-HPV infections 
progress to cervical cancer, the overexpression of E6 and E7 alone is insufficient to 
cause malignant transformation. The mechanisms that ultimately result in cancer 
are complex and involve the accumulation of several genetic alterations. Although 
mutations are rare in normal cells, HPV infection encourages the process by 
causing genomic instability, at least in part through disruption of DNA repair 
processes and by preventing apoptosis of abnormal cells (Tommasino 2014). These 
changes usually occur over the course of several years, explaining why persistent 
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infection with a HR-HPV type, permitted by effective immune evasion, is a 
prerequisite for cervical carcinogenesis (Lehoux et al 2008). 
 Table 1.4 Summary of the most commonly reported cytology results according to the 2001 
Bethesda system. Other findings, such as infection and the presence of endometrial cells, may also 
be included (Solomon et al 2002). 
BETHESDA CYTOLOGY CLASSIFICATION DESCRIPTION 
Negative for intraepithelial lesion or malignancy 
Abnormal squamous epithelial cells 
Atypical squamous cells of 
undetermined significance 
(ASC-US) 
Cells appear abnormal which may reflect HR-HPV 
infection, but may also have other causes. A small 
proportion of women with ASC-US have CIN grades 2 
or 3.  
Atypical squamous cells (ASC-H) Cells appear abnormal and a high-grade squamous 
intraepithelial lesion cannot be ruled out. May be 
more likely to have CIN grades 2 or 3 compared to 
women with ASC-US. 
Low grade squamous intraepithelial 
lesion (LSIL) 
Low grade changes which are most likely to reflect 
transient HR-HPV infection; thought to reflect CIN 
grade 1 
High grade squamous intraepithelial 
lesion (HSIL) 
High grade changes which are most likely to reflect 
persistent HR-HPV infection; thought to reflect CIN 
grades 2 or 3 
Squamous cell carcinoma Highly abnormal cells that likely represent invasive 
cancer 
Abnormal glandular (endocervical or endometrial) cells 
Atypical glandular cells (AGC) Cells appear abnormal which may reflect HR-HPV 
infection. Tends to be more often associated with high 
grade lesions than ASC-US.  
Atypical endocervical cells, favour 
neoplastic 
Cells appear abnormal with some changes that are 
suggestive of a high grade lesion. 
Endocervical adenocarcinoma in situ 
(AIS) 
High grade changes which are most likely to reflect 
adenocarcinoma in situ, but a proportion of cases will 
have invasive disease. 
Adenocarcinoma Highly abnormal cells that likely represent invasive 
cancer. 
 
1.3.3 Grading of cervical changes caused by HR-HPV infection 
Persistent HR-HPV infection may lead to changes in the cervical epithelium which 
start in the lower epithelial layers and progress until they involve the superficial 
epithelium. Over time, these pre-cancerous lesions can progress to invasive cancer. 
Staging of these changes is most accurately achieved by examination of histological 
specimens, but is often carried out less invasively by cytological examination of 
exfoliated cervical cells. However, the correlation between cytology results and 
histology of cervical biopsies (which is considered the gold standard) is far from 
perfect (Lonky et al 1999). The most common system used for reporting cytology 
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results is called the Bethesda System, which was updated in 2001 (Solomon et al 
2002). Broadly speaking, women are classified into those who are negative for 
intraepithelial lesion or malignancy and those who have abnormalities of squamous 
epithelial or glandular cells, with the main purpose being to assess squamous 
epithelial cells (see Table 1.4). However, a definitive diagnosis of cervical neoplasia 
requires a subsequent histopathological examination of a cervical biopsy. There are 
currently three grades of histopathological abnormalities of the squamous 
epithelium: cervical intraepithelial neoplasia (CIN) grades 1, 2 and 3, developed 
from the system proposed by Richart and Barron (1969). This grading system 
Table 1.5 Histopathological grading of cervical intraepithelial neoplasia (CIN). 
HISTOPATHOLOGY CLASSIFICATION DESCRIPTION 
CIN1 Nuclear abnormalities are minimal, mitotic figures are few 
and undifferentiated cells are confined to the lower 
epithelial layer. 
CIN2 Nuclear changes are more marked, and mitotic figures are 
more common with cellular dysplasia confined to the 
lower half of the epithelium. 
CIN3 Nuclear dysplasia and mitotic figures are seen throughout 
the epithelium. 
 
involves an assessment of nuclear abnormalities consistent with neoplastic change, 
prevalence of mitotic figures (which are indicative of high cellular division rates) and 
the thickness of epithelium that is dysplastic (see Table 1.5). Other cellular changes, 
such as those secondary to inflammation can complicate the diagnosis of CIN and 
reduce inter-observer agreement. However, accuracy can be improved by 
performing a consensus review in which difficult cases are assessed by more than 
one pathologist (De Vet et al 1995). Not all CIN lesions progress to invasive cancer, 
some persist and most regress. However, the higher the grade of CIN, the more 
likely it is that women will develop invasive cervical cancer and that this change will 
occur within a shorter period of time. Without taking differing follow-up time into 
account, one review of studies on CIN progression (as assessed by cytology or 
histology) estimated that regression occurred in approximately 57, 43 and 32% of 
cases for women diagnosed with CIN1, 2 and 3, respectively. On the other hand, 
progression to invasive cancer occurred in 1, 5 and 12% of cases, respectively 
(Östör 1993). To avoid confusion, it should be noted that some pathologists also 
use CIN terminology to classify cytology results and may report this instead of, or in 
addition to SIL. 
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1.3.4 HPV, cervical cancer and the vaginal microbiome 
As previously mentioned, the human vaginal microbiota is thought to play an 
important role in the prevention or acquisition of sexually transmitted diseases. 
Several studies have found a positive association between BV (as determined by 
Amsel or Nugent score) and both HPV infection and cervical cancer, and this has 
been confirmed by the results of two systematic reviews and meta-analyses (Gillet 
et al 2011, Gillet et al 2012). Most of the reviewed studies were cross-sectional, 
making it difficult to draw conclusions about the temporality of this association. 
However, the results of two large longitudinal studies suggest that a Nugent score of 
7 or above is a risk factor for incident HPV infection (King et al 2011, Watts et al 
2005). 
There are a handful of published studies that have used molecular techniques to 
investigate the association between the VMB and HPV infection. One study using a 
Lactobacillus-specific micro-array found that prevalent HIV and HPV infection were 
less common in women with L. crispatus-type dominated flora and more common in 
L. brevis-type dominated flora in South African women (Dols et al 2012). A further 
cross-sectional study on women in China that characterised the VMB using DGGE 
found an association between higher bacterial diversity and HPV infection. 
Specifically, the detection of L. gasseri and G. vaginalis were associated with 
prevalent HPV infection, and there was a non-significant trend for an association 
with the presence of A. vaginae. In contrast the majority of VMB profiles dominated 
by Lactobacillus gallinarum-type (which could not be speciated more accurately, but 
probably represents L. crispatus) and L. iners were HPV negative (Gao et al 2013). 
A further cross-sectional study using a phylogenetic micro-array showed that in a 
group of 174 Rwandan female sex workers, those with L. crispatus dominated VMB 
(and to a lesser extent women with a L. iners-dominated VMB) were significantly 
less likely to have HPV infection than women with other types of VMB (Borgdorff et 
al 2014). 
There are currently only five published studies that have utilised next generation 
sequencing to investigate the relationship between the VMB and HPV infection. The 
first of these was conducted by Lee and others, and was a cross-sectional study in 
a small cohort of Korean twins. The authors concluded that HPV positivity was 
associated with the presence of Fusobacteria (including Sneathia spp.), Prevotella 
spp. and Clostridiales. Sneathia spp. in particular were associated with high-risk 
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HPV infection. Sub-analysis of nine monozygotic twin pairs showed that the VMB of 
HPV-positive twins were more diverse with a significantly lower number of 
lactobacilli (particularly L. iners) and increased proportions of Prevotella, Sneathia, 
Dialister and Bacillus spp. Despite these differences, there was no significant 
relationship between the VMB community type (determined by clustering microbial 
profiles according to diversity and relative abundance of all detected bacterial 
phylotypes) and HPV infection status (Lee et al 2013). The second publication using 
next generation sequencing reported on a longitudinal study on a small cohort of US 
women. In this study, the VMB community type was significantly associated with 
HPV clearance at the next sampling time point 3-4 days later. However, there was 
no significant association with incident HPV infection. The community type 
dominated by L. jensenii was associated with the fastest clearance rate, while a 
high diversity lactobacillus-low VMB community type (including amongst others 
higher proportions of Atopobium, Gardnerella, and Prevotella spp.) was associated 
with the slowest clearance rate (Brotman et al 2014). A further study in 278 Nigerian 
women found differences in within-group beta diversity between HR-HPV positive 
and negative groups, but only among women who were HIV negative. The main 
differences between these groups were an increase in Leptotrichiaceae (which 
includes the genera Sneathia and Leptotrichia), Prevotellaceae, Clostridiaceae and 
Peptostreptococcaceae in the HR-HPV positive group (Dareng et al 2016). A further 
small study in HIV-positive and -negative women concluded that women with higher 
levels of L. crispatus have reduced HR-HPV infection levels, while women in the 
high diversity VMB tertile were significantly more likely to have HR-HPV (Reimers et 
al 2016). A very recent publication on a small group of Italian women found that a 
microbiome type dominated by variable proportions of Gardnerella, Prevotella, 
Atopobium and Sneathia was associated with persistence of HR-HPV infection at 
one-year follow-up. Of these genera, linear discriminant analysis effect size (LEfSe) 
analysis identified Atopobium as significantly increased in the women with HR-HPV 
persistence compared to women that cleared infection. Furthermore, women in the 
persistence group had significantly higher amounts of a Gardnerella sialidase gene 
involved in biofilm formation, compared to women who cleared infection. 
Additionally, Sneathia, Megasphaera, Pseudomonas, Pediococcus and 
Brevibacterium were enriched in women who were HR-HPV positive at baseline 
compared to those who were not (Di Paola et al 2017). Larger longitudinal studies 
are now needed to clarify the association of the VMB with incident HPV infection. 
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Four additional studies have employed molecular methods to investigate the 
relationship between the VMB and cervical cancer. One study on women in the UK 
found that the high diversity vaginal community type was proportionally more 
common with increasing vaginal cytological abnormalities, but this trend was not 
statistically significant (Mitra et al 2015). A similar study in Korean women found that 
having a predominance of A. vaginae, L. iners and G. vaginalis and low proportional 
abundance of L. crispatus (as determined by factor analysis) was associated with a 
higher risk for high grade cytology. When comparing the abundance of these 
species individually, only A. vaginae showed a significant difference in median 
abundance between groups. Women who had high grade cytology also had a 
higher A. vaginae:L. iners ratio, which could be confirmed by real-time PCR (Oh et 
al 2015). A further study in a small group of Mexican women found that higher 
cytological grades were associated with higher alpha-diversity and within-group beta 
diversity compared to HR-HPV negative women with normal cytology. Samples from 
women with normal cytology and no HR-HPV tended to contain predominantly L. 
crispatus and L. iners, whereas women with abnormal cytology tended to have 
higher proportions of Sneathia and Fusobacterium spp. (Audirac-Chalifour et al 
2016). However, in light of the small sample number, these results should be 
interpreted with caution. Conversely, a larger study involving 430 US women with 
abnormal cytology results found that women with CIN2 and above were more likely 
to have a vaginal community dominated by L. iners and L. crispatus than women 
with CIN1 (considered normal). Similarly, LEfSe analysis found that women with 
CIN2 or higher had significantly higher levels of Lactobacillaceae, Lactobacillus spp. 
and Lactobacillus reuteri (Piyathilake et al 2016). It is possible the differences seen 
in this study could be partly due to the choice of control group. Further studies, 
particularly those of a longitudinal nature are needed to clarify the relationship of the 
VMB with CIN and to differentiate it from that with HR-HPV. 
Currently, very little is known about the underlying mechanisms by which the 
composition of the VMB is linked to HPV infection and the progression to cervical 
cancer. However, potential mechanisms have been proposed. As previously 
described, a key step to infection with HPV is access of the virus to the basal 
keratinocyte. A recent study involving 50 Rwandan female sex workers found that 
vaginal dysbiosis correlated with protein markers that were indicative of disruption of 
the cervicovaginal mucosal barrier, finding evidence of cytoskeletal alterations and 
increased markers of cell death and proteolysis (Borgdorff et al 2016b). These 
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changes are a potential route of entry for the HPV virus. The authors also found that 
increasing VMB diversity was associated with higher levels of pro-inflammatory 
cytokines, a finding that is supported by the results of other studies (Hedge et al 
2006, Jespers et al 2017). Chronic inflammation is a known risk factor for 
carcinogenesis, providing a possible mechanism by which a dysbiotic VMB could 
produce conditions that favour the development of cancer. Furthermore, epithelial 
barrier disruption and inflammation may lead to the activation of cellular repair 
mechanisms and associated increased cellular division, favouring the replication of 
the HPV virus. It is possible that the cellular damage associated with a VMB typical 
of bacterial vaginosis is due to specific bacterial species. The bacterium G. vaginalis 
is often associated with BV and is capable of producing the cellular toxin 
vaginolysin, which has a cytotoxic effect on human epithelial and cervical cells 
(Gelber et al 2008), suggesting that it could be directly responsible for the cellular 
death associated with a high diversity VMB. Vaginolysin is a cholesterol-dependent 
cytolysin and interestingly the bacterium L. iners contains an analoguous protein-
encoding gene. Transcription of both vaginolysin and the L. iners cytotoxin are 
upregulated in BV (Macklaim et al 2013). 
1.4 The HIV epidemic and HPV in Africa 
Infection with human immunodeficiency virus (HIV) and the associated progression 
to acquired immunodeficiency syndrome (AIDS) remains one of the biggest global 
health challenges facing humanity today. In 2012, there were an estimated 35.3 
million people living with HIV across the globe (UNAIDS 2013). While this 
represents an increase over previous years, this appears to be a consequence of 
better treatments and treatment coverage resulting in better survival of HIV positive 
patients, rather than higher infection rates. Accordingly, the estimated number of 
new infections was around 2.3 million in 2012, representing a 33% decrease 
compared with 2001 (UNAIDS 2013). With an estimated 70% of all new infections 
and an average prevalence of 5.8%, sub-Saharan Africa represents the epicentre of 
the current HIV crisis. Within that region, the Republic of South Africa has the 
highest number of people living with HIV, totalling 6.1 million in 2012. In other 
words, one in six HIV-positive people live in South Africa (UNAIDS 2013). 
Sub-Saharan Africa also suffers from high prevalences of other infectious diseases 
such as malaria, herpes simplex virus type 2 and tuberculosis. Co-infections with 
HIV and other infectious disease are therefore a common phenomenon, and may be 
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a factor driving the high HIV transmission rates in this region (Barnabas et al 2011). 
Additionally, co-infections are responsible for the increased risk of morbidity and 
mortality in people living with HIV. This includes infection with human 
papillomaviruses. 
Previous studies have shown that women with HIV/AIDS have a higher prevalence 
of HPV than the general population. In one meta-analysis, the estimated overall 
prevalence of HPV in women with HIV without cytological anomalies was 36.3%, 
and within that, the average prevalence was higher in the five studies carried out in 
sub-Saharan Africa at 57% (Clifford et al 2006). In a recent study conducted in 
Cape Town, South Africa, the prevalence of HPV infection amongst HIV-positive 
women was similarly high at 52%, compared with only 21% in the control population 
(McDonald et al 2014). A further study in Ouagadougou, Burkina Faso found an 
even higher prevalence of 60% in women with HIV (Djigma et al 2011). This 
increased prevalence is most likely related to increased persistence of the virus due 
to HIV-induced immunosuppression (Moscicki et al 2004). Accordingly, in HIV 
positive women, the prevalence of HPV increases with worsening immune status as 
measured by a decrease in CD4 count. Interestingly, the association is less strong 
for HPV-16, perhaps because this type is better able to subvert the immune system, 
even in immunocompetent individuals (Strickler et al 2003). The increased 
prevalence of HPV infection in HIV positive women translates into an increased risk 
of in situ and invasive cervical cancer in patients living with HIV, and this risk 
increases as HIV progresses (Frisch et al 2000, Goedert et al 1998, Mbulaiteye et al 
2003). This is likely to be at least partly due to the fact that one of the main risk 
factors for the development of serious sequelae following infection with HR-HPV is 
persistence of the virus (Scheurer et al 2005) and several studies have shown that 
HPV infection is more likely to persist in women who are co-infected with HIV 
(Denny et al 2012). As a result, HPV associated cervical cancer is of particular 
concern in HIV positive women and this group of women are therefore the focus of 
the present study. 
1.5 Cervical Cancer Prevention 
1.5.1 Cervical cancer prevention strategies  
There are several approaches being employed to prevent morbidity and mortality 
from cervical cancer worldwide. These approaches can be divided into primary 
prevention of HPV infection with the use of public education and the administration 
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of vaccines, and secondary prevention in the form of screening programmes for 
early identification of women with persistent HR-HPV infection. 
Widespread screening for cervical cancer was initiated following the demonstration 
by Papanicolaou in the 1940s that early HPV-induced alterations could be detected 
by cytological examination of exfoliated cervical cells allowing the early identification 
of asymptomatic precancerous changes - a test now widely known as the Pap 
smear (Vilos 1998). The Pap smear identifies cellular changes that are indicative of 
precancerous or cancerous histological changes in the cervix. The degree of 
dyskaryosis (abnormality of the nucleus) observed partly corresponds with the 
histological grade of cervical neoplasia (Impey and Child 2012). The test has been 
adapted to try and lower the rate of false negatives with the use of liquid-based 
cytology media that reduce morphologic artefacts and the use of computer 
technology to screen slides (Nanda et al 2000). Despite this, it is important to 
remember that the Pap smear is a screening test that does not have sufficient 
sensitivity and specificity to be used as a diagnostic test: a negative result does not 
rule out abnormal cervical changes and a positive result has to be confirmed by 
histology. The true number of cases that are prevented by screening is difficult to 
estimate, but studies suggest that the incidence of cervical cancer in countries with 
effective programmes is reduced by around 50% (Hoppenot et al 2012). 
Alternative screening approaches to cervical cytology are available and, although 
inferior, remain potentially useful in low resource settings as they are more 
affordable. This includes visual inspection with acetic acid (VIA) and visual 
inspection with Lugol's iodine (VILI) which involve visual examination of the cervix 
using a speculum after the application of acetic acid or Lugol's iodine, respectively. 
In both cases, this application differentially stains abnormal cervical epithelium. The 
advantages of these tests include the fact that a result is immediately available, 
removing the need for an effective recall system and existing laboratory 
infrastructure. However, although both tests have comparable sensitivity to cytology, 
they suffer from considerably lower specificity and are prone to observer bias, which 
currently prohibits their widespread use in screening programmes 
(Sankaranarayanan et al 2012). 
Due to the invariable presence of HR-HPV infection at some point in the 
progression to cervical cancer, adjunctive testing with HR-HPV testing has been 
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used, either to allow extension of recall intervals or to rule out progressive lesions 
following an abnormal Pap test result (Cuzick et al 2006, Impey and Child 2012). In 
some settings, HPV testing is more sensitive than cytology (Cuzick et al 2006) and 
has been considered as a sole screening test (Wright 2007). However due to the 
ubiquitous nature of the virus, the specificity of such testing is relatively low, greatly 
increasing the cost of screening and has therefore not been widely adopted. 
Since 2007, many developed countries have additionally begun to offer vaccination 
against HR-HPV infection. These vaccinations are effective against the two most 
common and pathogenic HPV types HPV-16 and HPV-18 and some also provide 
protection against the low risk HPV types 6 and 8 that cause genital warts. A 
systematic review and meta-analysis of the success of these vaccinations in high-
income countries showed that the overall prevalence of HPV-16 and HPV-18 in girls 
aged between 13 and 19 years dropped by 64%. Furthermore, a protective herd 
effect was observed in countries where coverage amongst girls was at least 50% 
(Drolet et al 2015). Recently, the pharmaceutical company Merck has licenced a 
vaccine that extends coverage to the HR-HPV types 31, 33, 45, 52, and 58 (Kirby 
2015). However, there is epidemiological evidence that the quadrivalent vaccine 
already provides some cross-protection against at least some of these types (Drolet 
et al 2015) and improved efficacy of this new vaccine has not yet been conclusively 
shown. Despite the success of HPV vaccination programmes, they do not offer 
complete protection (and are currently only offered to young girls) and most high 
income countries continue to employ screening programmes for cervical cancer 
prevention. 
There is currently no epidemiological information on vaccine efficacy available from 
developing countries, where high vaccine cost has prevented widespread uptake. 
However, beginning in 2011 some lower-income African countries have initiated 
HPV vaccination programmes with the aid of supplier-donated vaccines and funding 
from the Global Alliance for Vaccines and Immunisation (Bustreo et al 2015). 
Although differences in sexual behaviour, HPV epidemiology and high co-infection 
rates with diseases such as HIV may alter the efficacy of vaccines, there is currently 
no evidence to suggest that efficacy would be reduced in low- or middle-income 
countries (Drolet et al 2015). However, there is some concern that differences in the 
prevalence of HR-HPV types in women with HIV might result in lower vaccine 
efficacy in this group (Denny et al 2012). The fact that HPV vaccination has recently 
24 
 
been shown to be safe and immunogenic in HIV-positive women is encouraging 
(Denny et al 2013), but effectiveness in preventing high grade intraepithelial lesions 
and cervical cancer in HIV-infected women remains to be demonstrated (Toft et al 
2014). 
Nationwide screening and vaccination can be very effective at reducing the 
incidence of cervical cancer, but success is greatly reduced by cost and logistic 
barriers in low resource settings. Alternatives to currently available strategies are 
therefore needed in countries such as South Africa, where current control 
programmes are suboptimal. 
1.5.2 Cervical cancer prevention in South Africa 
South Africa runs a national programme for cervical cancer prevention which offers 
Pap smears for women. However, the current programme offers only three smears 
over a woman's life time from the age of 30, with a long screening interval of ten 
years. As a result, cases could be diagnosed at the point when treatment is no 
longer effective. This is especially true for women who are HIV positive and in which 
disease progression is accelerated. Furthermore, success of the programme has 
been limited by non-implementation in several parts of the country - particularly the 
most destitute areas - as well as poor uptake, and relatively high loss to follow-up 
(Botha and Richter 2015, Laubscher et al 2015). 
HPV vaccines have been available privately in South Africa since 2008. However, 
coverage has remained low with cost and insufficient public awareness having been 
cited as possible causes. In April 2014, the Department of Health initiated a school-
based vaccination programme for girls (Botha and Richter 2015) and in due course 
studies will be able to assess how effective vaccination is in this country where HIV 
incidence is exceptionally high. Regardless of their efficacy, vaccination 
programmes are unlikely to be fully implemented in low-resource settings where 
they are arguably most needed (Brotman et al 2014). 
While there are ongoing projects to identify ways to reduce the cost of cervical 
cancer screening programmes - including the HPV in Africa Research Partnership 
study, that forms the parent study to this PhD project - it is unlikely that nationwide 
screening will be implemented in South Africa because of a lack of adequate 
resources (Laubscher et al 2015). Due to the poor success of cervical cancer 
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prevention schemes in countries such as South Africa where resources are 
stretched, there is an urgent need for novel strategies that are both successful and 
cost-effective. 
1.6 Aims of the Study 
Owing to the important barrier function of the human microbiota, manipulation of the 
VMB is a promising candidate as a preventative treatment for HPV and other 
sexually-transmitted infections. It is particularly important to develop cost-effective 
strategies for primary HPV disease prevention in HIV-positive women who are at 
particularly high risk of developing cervical cancer. Exploration of the association 
between the VMB, HPV infection and cervical cancer in women living with HIV 
infection is a first step towards improving health outcomes in this group of women 
and is the main aim of this project. 
Additionally, this knowledge is vital in enabling researchers and medical 
professionals to fully evaluate the outcomes of clinical interventions that have the 
potential to alter the composition of the VMB. For such clinical trials, an awareness 
of the significance of an altered VMB state is a prerequisite for assessing whether a 
potential treatment could pose hidden risks to the patient, for example by increasing 
their susceptibility to HPV infection. 
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CHAPTER 2: Laboratory Methods Validation 
Part of the text and results in this chapter (sections 2.6 and 2.7) have been 
published in: 
Gill C, Van de Wijgert JH, Blow F, Darby AC (2016). Evaluation of Lysis Methods for 
the Extraction of Bacterial DNA for Analysis of the Vaginal Microbiota. PloS One 
11:e0163148. 
I conceived, designed and carried out the experiments and drafted this manuscript. 
JHvdW and ACD provided input on conception and design. FB assisted with data 
analysis. All authors contributed to the interpretation of the data and the content of 
the manuscript and approved the final version. 
2.1 Introduction 
In order to determine the association between the vaginal microbiome (VMB), HPV 
infection and cervical cancer it is necessary to accurately determine the types of 
bacteria that make up the VMB in each sample. Although characterisation of the 
VMB by sequencing all DNA in the sample (whole genome shotgun sequencing) is 
considered the gold standard when it comes to determining true sample 
composition (and also captures other organisms such as fungi and eukaryotes) this 
relies on a much higher sequencing effort which would be prohibitively expensive for 
large numbers of samples. A popular approach to characterise the human 
 
Figure 2.1 Schematic overview of 16S rRNA gene amplicon studies for characterisation of the 
bacterial microbiota. 
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microbiota is therefore based on amplifying by PCR and then sequencing a 
universal bacterial gene, most often a part of the 16S rRNA gene (Figure 2.1). This 
gene has the advantage that it is present in all bacterial species, in theory resulting 
in PCR amplicons that are proportionally representative of the bacteria present in 
the original sample. Additionally, comprehensive 16S rRNA databases are now 
available, allowing identification of a wide range of bacteria from their 16S rRNA 
gene sequences (Cole et al 2014, DeSantis et al 2006). For these reasons, 16S 
rRNA gene sequencing was chosen to characterise the VMB in this study. 
Processing of samples for 16S rRNA amplicon studies begins with the collection of 
suitable samples and their storage under appropriate conditions until they can be 
processed further. Genomic DNA is then extracted from samples, usually with the 
use of a commercially available DNA extraction kit. Following this, the 16S rRNA 
gene is amplified by PCR using primers that are specific to conserved regions of the 
gene, theoretically creating amplicons from the genomic DNA of all bacteria present 
in the sample. By design, these amplicons will contain one or more of the 16S rRNA 
gene’s hypervariable regions (which are numbered V1 through to V9) which allows 
identification of the bacteria whose DNA they were amplified from. Once the 
amplicons have been created, their DNA can be sequenced using one of several 
high throughput sequencing platforms. This produces several thousands of DNA 
sequences for each sample which each represent an amplicon (Figure 2.1). Using 
computational approaches (known as “bioinformatics”), amplicon sequences can 
then be assigned to groups based on similarity to other amplicons in the project. 
The typical cut-off used is 97% similarity, such that sequences within one group 
share at least 97% of their DNA with the reference or centroid sequence, making 
them roughly equivalent to bacterial species (see Chapter 3). However, since the 
definition of bacterial species is complex and based on a variety of factors such as 
phenotypic characteristics, DNA-DNA hybridisation and/or full length gene 
sequences (Gevers et al 2005), the resulting groups are not the same as bacterial 
species and are therefore referred to as “operational taxonomic units” (OTUs) 
(Nguyen et al 2016). New methods are emerging which do not apply such an 
arbitrary similarity threshold but instead group reads by other means, increasing the 
resolution of 16S rRNA studies (see Chapter 3). Ideally, the above steps would 
result in an accurate profile of the bacterial population in the original sample, giving 
the proportion of each bacterial OTU present. However, each of these processing 
steps has the potential to introduce bias, which may result in inaccurate OTU 
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proportions and even entire groups of bacteria being missed (Brooks et al 2015). 
Furthermore, PCR amplification has the disadvantage that it may introduce bias by 
preferential amplification of particular sequences and due to the presence of 
variable numbers of (and potentially dissimilar) gene copies in different bacterial 
strains (Nguyen et al 2016). It is vital for the accurate interpretation of results that 
researchers understand any potential bias and attempt to minimise it. Considerable 
effort was therefore made to validate DNA storage and extraction for the analysis of 
vaginal samples, the results of which are presented in this chapter. 
2.2 Methods Part I: Sample Storage and DNA Extraction 
2.2.1 Sample characteristics 
Samples collected for microbiota analysis had been stored in BoonFix® (a patented 
fixative containing ethanol and polyethylene glycol) at room temperature. This 
medium has been used for molecular studies of the VMB and was selected for 
practical reasons prior to the decision to use 16S rRNA amplicon sequencing. Since 
this medium has not been validated for these types of studies, we set out to 
determine whether samples stored at room temperature in BoonFix® were suited to 
microbiome analysis by 16S rRNA gene sequencing. For this purpose, a set of eight 
paired samples from the endline visit of the HARP study (the parent study of the 
work presented in the following chapters, see section 4.2) was used. Each sample 
pair consisted of a vaginal swab sample stored in 2 ml BoonFix® at room 
temperature and a cervical brush sample taken at the same time and stored in 10 
ml PBS-methanol at -80°C. Ethical approval for the determination of the VMB from 
these samples had been obtained from the local ethics committees at Wits 
University in Johannesburg, South Africa; the London School of Hygiene and 
Tropical Medicine, UK; and the University of Liverpool, UK (Physical Interventions 
Sub-Committee). The purpose of this study was to determine whether differences in 
microbiome composition could be observed between the different storage and 
extraction procedures. 
2.2.2 DNA extraction 
The vaginal swab samples stored in BoonFix® were processed after removal of the 
swab by thoroughly vortex mixing the remaining liquid and then subjecting 200 µl to 
30 min of lysis at 37°C using enzymatic lysis buffer containing lysozyme from 
chicken egg white (20mg/ml; Sigma-Aldrich, Dorset, UK), followed by DNA 
extraction using the QIAsymphony DSP Virus/Pathogen Kit (Qiagen, Manchester,  
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Figure 2.2 Overview of experimental design of sample storage and DNA extraction experiment 
showing how DNA was extracted from samples. 
UK) on the QIAsymphony robot (Complex800_V6_DSP protocol which includes a 
proteinase K/"buffer AL" digestion step; extract designated "BF-QS", see Figure 
2.2).  At the same time, two DNA extracts were produced from 400 µl and 1500 µl of 
the paired PBS-methanol samples as follows: after vortexing, the samples were 
centrifuged at 5000 x g for 10 minutes and the supernatant was removed. The pellet 
was then subjected to lysozyme digestion as above, followed by DNA extraction 
using either the QIAsymphony robot (as above) for the 400 µl sample (extract 
designated "PBS-QS"), or following the remaining steps in the Qiagen DNeasy 
Blood and Tissue kit's spin column protocol (equivalent to the recommended 
pretreatment for Gram-positive bacteria as per the Qiagen DNeasy Blood and 
Tissue kit Handbook) for the 1500 µl sample (extract designated "PBS-BT"; see 
Figure 2.2). DNA was eluted in 60 µl of elution buffer for samples run on the 
QIAsymphony robot and 75 µl of elution buffer for samples extracted using the 
Qiagen DNeasy Blood and Tissue kit. The genomic DNA concentration of extracts 
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was determined using the Qubit Fluorometer with the dsDNA HS Assay kit 
(Invitrogen Life Technologies, Paisley, UK). Negative extraction controls were 
produced from nuclease free water (Invitrogen, UK) and processed alongside 
samples using either the QIAsymphony robot (four controls) or the Qiagen DNeasy 
Blood and Tissue kit (three controls). 
2.2.3 Amplicon library preparation 
The V3-V4 region of the 16S rRNA gene was amplified in a 50 µl reaction 
containing no more than 200 ng of genomic DNA (samples over 10 ng/µl were 
diluted 1:10 to save sample), 25 µl of NEBNext® High-Fidelity 2x PCR Master Mix 
(New England Biolabs, Hitchin, UK) and 2.5 µl each of a 10 µM concentration of the  
conserved bacterial 16S rRNA primers 319F 5'-ACTCCTACGGGAGGCAGCAG-3' 
and 806R 5'-GGACTACHVGGGTWTCTAAT-3' (Fadrosh et al 2014) adapted with 
linker regions to allow barcoding of sequences using a dual-indexing approach 
(D’Amore et al 2016). For the first PCR (16S rRNA gene amplification) the samples 
were initially denatured at 98°C for 30 s, followed by 10 cycles of 98°C for 15 s, 
58°C for 15 s and 72°C for 15 s, with a final extension at 72°C for 60 s. The 
annealing temperature was optimised by gradient PCR on a vaginal sample to 
provide optimal amplicon yield while allowing universal coverage (higher 
temperatures produced a narrower band, indicating possible selectivity for some 
bacterial species over others). The PCR products were then purified using SeraPure 
magnetic beads (Faircloth and Glenn), before undergoing a second PCR to attach 
sample-specific barcodes and further amplify the region of interest. The second 
PCR consisted of a 25 µl reaction containing 10.5 µl of clean PCR product, 12.5 µl 
of NEBNext® High-Fidelity 2X PCR Master Mix and 1 µl each of a 3 µM 
concentration of the Illumina specific barcoding primers with the standard Illumina 
Nextera 8-nt index sequences. Samples were initially denatured at 95°C for 2 min, 
followed by 15 cycles of 98°C for 20 s, 55°C for 15 s and 72°C for 40 s, with a final 
extension at 72°C for 60 s. PCR products were purified, eluted in a volume of 15 µl 
TE buffer (Sigma-Aldrich) and quantified using the Qubit Fluorometer with the 
dsDNA HS Assay kit to determine amplicon yield. Purified PCR amplicons were run 
on a 2% agarose gel at 100V to determine purity of the amplicon. Amplicons were 
then pooled and sequenced on the Illumina MiSeq platform (2x250bp; Illumina, San 
Diego, CA) at the University of Liverpool Centre for Genomics Research. 
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2.2.4 Bioinformatics 
Sequencing reads were demultiplexed and trimmed for the presence of Illumina 
adapter sequences and low quality bases (quality threshold Q = 20) using Cutadapt 
v. 1.2.1 (Martin 2011) and Sickle v. 1.200 (github.com/najoshi/sickle), respectively. 
The resulting reads were error corrected using SPAdes v 3.1.0 (Bankevich et al 
2012) and paired-end alignment was performed using PANDAseq v. 2.4 (Masella et 
al 2012). The obtained sequences were then binned into OTUs based on 97% 
sequence similarity using USEARCH v. 5.2.236 (Edgar 2010) through Quantitative 
Insights Into Microbial Ecology (QIIME v. 1.7.0)(Caporaso et al 2010). Low 
abundance OTUs were removed (OTUs containing less than 4 reads in total). 
Taxonomic assignment of representative sequences (most abundant) was carried 
out for each OTU by RDP classifier against the Greengenes 13_8 database in 
QIIME and assignments were corrected manually by NCBI BLAST search (Zhang et 
al 2000) for all the most abundant OTUs (≥1% in at least one extract). 
2.2.5 Data analysis 
Calculation of alpha and beta diversity measures and statistical analyses were 
performed in R version 3.2.2 (R Core Team 2015) and using the vegan package 
version 2.3-1 (Oksanen et al 2015). Observed OTUs and the Simpson Index (1-D) 
were calculated to assess differences in alpha diversity. Hypothesis testing relating 
to DNA yield and alpha diversity was performed using the Wilcoxon signed-rank test 
for paired samples, thereby correcting for differences due to variation between study 
participants. Bray-Curtis dissimilarity and its complement, Bray-Curtis similarity, 
were used to report and assess differences in beta diversity. Permutational 
multivariate ANOVA (PERMANOVA) (Anderson 2001) was used to assess 
differences in beta diversity between different extracts. The OTU heatmap and the 
principal coordinate plots were generated in R using the phyloseq package version 
1.14.0 (McMurdie and Holmes 2013). 
2.3 Results Part I: Sample Storage and DNA Extraction 
2.3.1 DNA extraction yield 
When comparing the extracts produced on the QIAsymphony robot from the 
BoonFix® sample (BF-QS) with those from the PBS-methanol sample (PBS-QS), 
the BF-QS samples had a lower DNA yield (median = 12.7 ng, range 4.4-45.4 ng) 
when compared to PBS-QS (median = 39.9 ng, range 2.2-104 ng). When 
comparing the DNA yield from the extraction of the PBS-methanol samples that 
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were produced using the QIAsymphony robot (PBS-QS) with that produced using 
the Qiagen DNeasy Blood and Tissue kit (PBS-BT), the PBS-BT samples had a 
higher yield even after correction for higher sample input volume (median yield from 
400 µl of sample = 157 ng, range 20-982 ng). Neither of these differences were 
statistically significant (Wilcoxon signed rank test, P = 0.11 in both cases). By 
comparison, the total DNA yield from the negative extraction controls was <1.5 ng 
(below the measurable range) with the Qiagen DNeasy Blood and Tissue kit and 
between 13 and 33 ng with the QIAsymphony robot. 
2.3.2 Amplicon PCR product 
The amplicon yield ranged from <0.1 (recorded as 0) to 16 ng/µl. The median 
amplicon concentration for each method mirrored the DNA extract concentration, 
being the lowest for BF-QS (median = 0 ng/µl), higher for PBS-QS (median = 0.51 
ng/µl) and highest for PBS-BT (median = 4.98 ng/µl). For those PCR products 
where amplicon yield was sufficient (DNA concentrations of at least 0.382 ng/µl), gel 
electrophoresis showed a single band at approximately 600bp, with the exception of 
a single PBS-BT extract which produced a double-band (see Appendix A). This 
sample had a relatively high DNA input and produced a correspondingly high 
amplicon yield (11.9 ng/ µl). Sequencing showed that this sample contained a 
diverse array of bacteria and the double band could be due to differences in 
amplicon length of different bacterial species, although non-specific amplification 
cannot be ruled out. Unsurprisingly, there was a positive correlation between DNA 
input into the PCR reaction and amplicon yield (Spearman’s rank correlation 
coefficient = 0.71, P <0.0001). 
2.3.3 Sequencing results 
A total of 4,288,509 paired 16S rRNA sequence reads were generated from the 
cervical brush and vaginal swab samples (8 sample pairs x 3 extractions). After 
error correction, paired-end alignment and assignment to OTUs, a total of 2,235,017 
reads were retained, with a median read count of 90,506 reads ranging from 1,222 
to 169,158 reads. A total of 573 OTUs were identified, of which 51 were present at 
1% or more in at least one sample extract.  Positive and negative controls were 
included on the sequencing run. The main contaminant present in the profiles of all 
the negative DNA extraction controls was a Rhodanobacter sp. (66.9-86.6%). This 
OTU was virtually absent from the negative PCR control (2 reads mapping to this 
OTU are probably the result of incorrect assignment to this sample) and has 
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therefore most likely originated from the DNA extraction kits. Although two different 
extraction kits have been used, they are both made by the same manufacturer and 
were ordered around the same time. The Rhodanobacter OTU was also present in 
samples at up to 25.8% (present at >1% in 10 extracts; median 0.5%), 
demonstrating that there was significant reagent contamination in some samples. 
The proportion of this OTU was found to be inversely proportional to PCR product 
concentration (see Appendix B), indicating that contamination is more important for 
low biomass samples, which is consistent with the findings of other studies (Salter 
et al 2014). OTUs that were identified as reagent contaminants (i.e. those that were 
proportionally more prevalent in negative extraction controls and where the 
difference was significant by t test) were removed prior to data analysis. With the 
exception of Rhodanobacter sp. and Pseudoalteromonas sp. (the latter being 
present at 1.6% in one extract which also had a high proportion of Rhodanobacter 
at 20.2%), these were not present in any sample extract at more than 0.2%. 
Following removal of these contaminants (from here on described as "reagent 
contaminants" to distinguish them from sample contaminants described later), 379 
OTUs remained with a read count ranging from 944 to 169,142 per sample. The 
positive control sample contained DNA from Lactobacillus amylovorus only and this 
sample was dominated by three OTUs (together making up 96.9% of the sample), 
each assigned to Lactobacillus sp. by RDP classifier and identified further as 
Lactobacillus crispatus group (includes L. acidophilus, L. helveticus, L. gallinarum, 
L. crispatus, L. jensenii and L. delbruekii) by BLAST search. Although this 'OTU-
splitting' could be due to actual biological differences between reads or read error, 
re-analysis of the positive control at a later date suggested that this was most likely 
due to an error correction step integrated in the OTU picking step of QIIME (see 
Appendix C). The remaining OTUs in the positive control were for the most part also 
identified as L. crispatus group, with the two largest OTUs that were not identified as 
such being Lactobacillus iners (0.02%) and Gardnerella (0.002%), the most 
abundant OTUs across the run as a whole and therefore most likely the result of 
incorrect assignment to this sample (also known as barcode switching), although 
cross-contamination cannot be ruled out. 
2.3.4 Vaginal bacterial community composition 
As is typical of the vaginal niche, the bacterial community profiles obtained for each 
study participant were either low diversity (dominated by either L. crispatus group 
and/or L. iners), or high diversity containing a mixture of strict and facultative 
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anaerobes including Gardnerella vaginalis, Atopobium vaginae, Prevotella, 
Sneathia/Leptotrichia, Megasphaera and the bacterial vaginosis associated bacteria 
BVAB1 and BVAB2 (Figure 2.3). At a glance the PBS-methanol samples extracted 
on the QIAsymphony look similar to their counterparts extracted with the DNeasy 
Blood and Tissue kit. Broadly, this also holds true when comparing the BoonFix®  
 
Figure 2.3 Heat map showing most abundant operational taxonomic units in sample storage and 
DNA extraction experiment. Sample extracts are arranged by hierarchical clustering, after removal of 
reagent contaminants. All OTUs that were present at 1% or higher in at least one sample extract are 
shown. Extracts are arranged according to sample, with the participant identifier given at the top 
and extraction method indicated at the bottom. OTU taxonomy is given on the right, with putative 
sample contaminants indicated in red. Reads have been assigned to OTUs based on 97% sequence 
similarity of the V3-V4 region. Note that in some cases this has resulted in multiple OTUs with the 
same taxonomic species identifier, which may be due to error correction in the QIIME OTU picking 
step (see Appendix C), intraspecies variability in this region of the gene, or incorrect base calling. 
Lactobacillus species that could not be identified to species level at the 97% cut-off have been 
assigned to L. crispatus group (which includes L. acidophilus, L. helveticus, L. gallinarum, L. crispatus, 
L. jensenii and L. delbruekii). 
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with the PBS-methanol samples but there are some striking differences among 
some sample pairs. This is particularly true in the case of subject P07 (Figure 2.3), 
in which several OTUs are dominant in both PBS-methanol extracts but completely 
absent in the BoonFix® sample. These OTUs have been identified as 
Methylobacterium sp., Micrococcineae, Oxalobacteraceae, Bosea sp, and 
Cellulomonadaceae. Methylobacterium spp. are normally associated with soil and 
water (Dourado et al 2015) and have been identified as contaminants in sequencing 
experiments previously (Salter et al 2014). This OTU is present in six of the PBS- 
methanol samples (P03-P08). These bacteria are strict aerobes and are able to 
grow using methanol (Dourado et al 2015), making it likely that they contaminated 
the PBS-methanol medium prior to sample collection. In line with that theory, PBS-
methanol samples from P01 and P02, which did not have any significant 
Methylobacterium contamination, were collected earlier than the other samples. 
Three of the other contaminants in P07, namely bacteria in the suborder 
Micrococcineae, bacteria in the family Oxalobacteraceae and Bosea sp, have also 
been reported as contaminants (Salter et al 2014). A further difference is seen 
between PBS-methanol and BoonFix® extracts of participant P02. In this case, the 
PBS-methanol samples contain Proteus and Enterococcus, whereas the BoonFix® 
extract does not. Both genera are found as commensals in the intestine and 
sometimes cause opportunistic infections (Chow et al 2011). This difference is 
interesting as the PBS-methanol sample was taken from the cervix, whereas the 
BoonFix® sample was obtained from the lateral vaginal wall. Although previous 
studies have shown that the microbiota profiles from these locations are very similar 
(Anahtar et al 2015), it could be that these two OTUs represent true colonisation of 
the cervix, and concurrent absence from the midvagina. It has also been shown 
that, while generally highly similar, there may be differences in samples obtained 
using swabs such as were used to collect the BoonFix® sample when compared to 
cytobrushes such as were used for the collection of the PBS-methanol sample 
(Mitra et al 2017). Alternatively, contamination of this sample with these bacteria 
may have occurred at the time of collection. Further analyses were carried out after 
these contaminants (hereafter referred to as "sample contaminants" to distinguish 
them from reagent contaminants) were removed (including Proteus and 
Enterococcus which may or may not be true contaminants). This resulted in 366 
OTUs remaining with a read count ranging from 943 to 169,110 per sample. 
Samples were rarefied to 943 reads for all further analyses. However, based on 
rarefaction curves of Faith’s phylogenetic diversity index, this rarefaction depth was 
borderline in terms of being able to assess a sample’s full diversity and all analyses 
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were repeated using a depth of 4901 reads (the next smallest read count), but this 
did not alter the statistical significance of any of the comparisons described below. 
2.3.5 Effect on observed alpha diversity 
The presence or absence of OTUs was consistent between the two different 
extraction methods (i.e. between extract PBS-QS made using the QIAsymphony 
robot and extract PBS-BT using the Qiagen DNeasy Blood and Tissue kit) and any 
differences were due to low abundance OTUs that made up no more than 0.4% of 
any extract. The picture was more complicated when comparing the PBS-methanol 
extract (PBS-QS) with the BoonFix® extract (BF-QS) produced using the 
QIAsymphony robot, due to the presence of the sample contaminants listed above 
(see Figure 2.3). However, after these were removed there was overall agreement 
between sample pairs with the largest relative abundance of any discordant OTU 
being 1.8%. There was no statistically significant difference in the number of 
observed OTUs between the PBS-QS and PBS-BT extracts (Wilcoxon signed rank 
test; P = 0.29) or between the PBS-QS and BF-QS extracts (P = 0.20). Calculation 
of the Simpson Index (1-D) confirmed a wide range of diversities (range = 0.11-
0.92). The degree of variation between the PBS-QS and PBS-BT extracts was small 
 
Figure 2.4 Principal coordinate analysis ordination of a Bray-Curtis dissimilarity matrix for the sample 
storage and DNA extraction experiment. Bray-Curtis dissimilarity was performed on read counts 
after removal of reagent and sample contaminants and rarefaction to 943 reads. Extracts are 
coloured by subject of origin and the sample type and extraction method are indicated by different 
shapes (see key). Extracts cluster closely with other extracts originating from the same subject, with 
the BF-QS extracts being slightly further removed from the other two extracts. 
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(maximum difference between extracts = 0.06), but was considerably higher 
between the BF-QS and PBS-QS extracts (maximum difference between extracts 
was seen for sample P08 = 0.39). However, these differences were not statistically 
significant (Wilcoxon signed rank test; P = 0.38, P = 0.48, respectively). Due to the 
OTU splitting described above, the monoculture positive control had a higher 
Simpson index than expected (0.56). 
2.3.6 Effect on observed beta diversity 
Between-extract diversity was calculated using Bray-Curtis similarity. Within-subject 
similarity ranged from 81.5-98.1% between the two PBS-methanol extracts and from 
47.1-95.3% between the PBS-methanol and BoonFix® extracts. In both cases, any 
differences appeared to be mainly due to differences in OTU relative abundance, 
rather than differences in presence or absence of OTUs.  
PERMANOVA analysis of Bray-Curtis dissimilarity showed that the differences 
between extracts originating from different women (R2 = 0.92, P = 0.001) were far 
greater than differences between different extraction methods (R2 = 0.005, P = 
0.40) or between sample types (R2 = 0.006, P = 0.28). Therefore, although this 
study may have lacked power to find a difference between the PBS-methanol and 
BoonFix® extracts or between the two extraction methods, the effect of either is 
likely to be much smaller than the differences caused by inter-subject variation. This 
is reflected in the clustering of extracts by principal coordinate analysis ordination of 
the Bray-Curtis dissimilarity matrix (Figure 2.4), which resulted in clustering of the 
extracts by sample rather than lysis method or sample type. 
2.4 Methods Part II: Yield Optimisation 
2.4.1 Sample characteristics 
As the results above showed that the DNA yield from some study samples was low 
and resulted in proportionally higher levels of reagent contamination an attempt was 
made to optimise the DNA yield from vaginal swab samples stored at room 
temperature in BoonFix®. To do so, a set of ten samples from the HARP study (see 
section 4.2) was randomly selected among those that did not meet the eligibility 
criteria for the main study described later (see Chapter 4) and for which sufficient 
material was available. Ethical approval for determination of the VMB from these 
samples was obtained as above (see section 2.2.1). 
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2.4.2 DNA extraction 
Samples were thoroughly mixed by vortexing and divided into aliquots for DNA 
extraction using six different methods as follows (Figure 2.5): 
Three extracts were produced by subjecting the swab head and 166 µl of liquid 
each to 30 min of lysis at 37°C using enzymatic lysis buffer containing lysozyme 
from chicken egg white (20mg/ml; Sigma-Aldrich, Dorset, UK). Following this, one 
extract (designated "S-QS") was produced by extracting the resulting liquid using 
the QIAsymphony DSP Virus/Pathogen Kit (Qiagen, Manchester, UK) on the 
QIAsymphony robot (Complex800_V6_DSP protocol which includes a proteinase 
K/"buffer AL" digestion step). Proteinase K and Buffer AL (Qiagen) were added to  
 
Figure 2.5 Overview of experimental design for yield optimisation from BoonFix®-stored samples. 
Schematic showing how DNA was extracted from samples. 
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the remaining liquid and swab head, and incubated at 56°C for 30 min. After 
discarding the swab, half of the sample was extracted using the QIAsymphony DSP 
Virus/Pathogen Kit on the QIAsymphony robot (thereby undergoing a second 
proteinase K/"buffer AL" digestion without the swab head; extract designated "S-
QS-PK") and the other half was extracted following the remaining steps in the 
Qiagen DNeasy Blood and Tissue kit's spin column protocol (equivalent to the 
recommended pretreatment for Gram-positive bacteria as per the Qiagen DNeasy 
Blood and Tissue kit Handbook; extract designated "S-BT").Additionally, three 
extracts were produced from the liquid portion of the BoonFix® sample without 
including the swab head in the extraction. Two of these were produced from 200 µl 
liquid sample each, subjected to 30 min of lysis at 37°C using enzymatic lysis buffer 
containing lysozyme and then extracted using either the QIAsymphony DSP 
Virus/Pathogen Kit on the QIAsymphony robot (extract designated "L-QS") or by 
incubation with Proteinase K and Buffer AL at 56°C for 30 min, followed by the 
remaining steps in the Qiagen DNeasy Blood and Tissue kit's spin column protocol 
(equivalent to the recommended pretreatment for Gram-positive bacteria as per the 
Qiagen DNeasy Blood and Tissue kit Handbook; extract designated "L-BT"). In 
order to test whether the presence of ethanol in the sample affected the extraction, 
a third extract was produced from 400 µl of liquid BoonFix® sample by first 
removing ethanol as follows: pure ethanol (Sigma-Aldrich) and sodium acetate (3M, 
pH 5.2) were added to the sample to produce a solution containing 70% v/v ethanol 
(taking account of the ethanol already in the sample) and 3% v/v sodium acetate. 
This was incubated on ice for 30 minutes and then centrifuged at 14,000 x g for 30 
minutes at 4°C. The supernatant was discarded, 1 ml of 70% ethanol added and 
centrifuged at 16,100 x g for 2 min. The resulting pellet was then air dried before 
lysis at 37°C for 30 min in enzymatic lysis buffer containing lysozyme, followed by 
incubation with Proteinase K and Buffer AL at 56°C for 30 min and extraction 
according to the remaining steps in the Qiagen DNeasy Blood and Tissue kit's spin 
column protocol (extract designated "L-BT-EP"). DNA was eluted in 60 µl of elution 
buffer for samples run on the QIAsymphony robot and 75 µl of elution buffer for 
samples extracted using the Qiagen DNeasy Blood and Tissue kit. The genomic 
DNA concentration of extracts was determined using the Qubit Fluorometer with the 
dsDNA HS Assay kit (Invitrogen Life Technologies, Paisley, UK). DNA quality was 
assessed using the 260/280 optical density ratio measured on the NanoDrop ND-
1000 spectrophotometer (Thermo Fisher Scientific, USA), with a measurement of 
1.8 and above considered pure. Negative extraction controls were produced from 
nuclease free water (Invitrogen, UK) and processed alongside samples using either 
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the QIAsymphony robot (four controls) or the Qiagen DNeasy Blood and Tissue kit 
(four controls). 
2.4.3 Amplicon library preparation 
The V3-V4 region of the 16S rRNA gene was amplified as described in section 
2.2.3. Purified PCR amplicons were run on a 2% agarose gel at 100V to determine 
purity of the amplicon. 
2.4.4 Data analysis 
All statistical testing and graphing of data was performed in R version 3.3.2 (R Core 
Team 2015). Hypothesis testing relating to DNA yield was performed using the 
Skillings-Mack Test (Skillings and Mack 1981) in the Skillings.Mack package v1.10, 
a non-parametric equivalent of the repeated measures ANOVA (which can be 
performed on experiments with block designs that have missing values), hence 
correcting for differences in yield occurring due to the sample being extracted. 
Significant results were followed by pairwise comparisons using the Wilcoxon 
signed-rank test (with p-values adjusted using the Holm–Bonferroni method). 
Spearman's rank correlation coefficient was calculated to determine whether there 
was an association between extract DNA concentration and amplicon yield. Linear 
regression was used to determine whether this relationship was affected by DNA 
extract dilution (performed on high yield samples to avoid non-specific amplification) 
or extraction method. 
2.5 Results Part II: Yield Optimisation 
2.5.1 DNA extraction yield and purity 
The DNA quality and yield using six different methods for extraction of bacterial 
DNA from vaginal swab samples stored in Boonfix® was compared in this study 
(Figure 2.6). Methods L-QS and S-QS-PK did not produce any DNA extract with 
samples F and G, respectively. The reason for this is unknown as no error was 
reported by the QIAsymphony robot. 
Among the different methods tested, the mean total DNA yield was highest for 
samples extracted using method S-BT (inclusion of the swab head and extraction 
using the Qiagen DNeasy Blood and Tissue kit) at 1243 ng, followed by method S-
QS (extraction using the QIAsymphony robot with inclusion of the swab head in both 
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prelysis with lysozyme and proteinase K/"buffer AL") at 250 ng. All other methods 
had a much lower mean total yield ranging from 15 to 26 ng. By comparison, total 
DNA yield from negative extraction controls was <1.5 ng (below the measurable 
range) with the Qiagen DNeasy Blood and Tissue kit and between 10 and 13 ng 
with the QIAsymphony robot. It should be noted that the sample input volume was 
unequal between methods, as this was 400 µl for method L-BT-EP, 200 µl for other 
methods using only sample liquid and 166 µl for methods including the swab head 
(plus any swab-associated liquid). This was not adjusted for in the statistical 
analysis because the volume of liquid and associated biomass retained in the swab 
could not be accurately estimated, therefore the results reflect the methodology as 
well as the associated sample volume used. 
 
Figure 2.6 Box and whisker plot of DNA yield obtained for samples stored in BoonFix® with each 
extraction method. Note that the y axis is logarithmic. Boxes extend from the lower quartiles to the 
upper quartiles with median values indicated by the line within each box. Whiskers represent 
maximum and minimum values, excluding any outliers (values indicated by circles which lie outside 
1.5 times the interquartile range). Significant and near significant differences (paired Wilcoxon 
signed rank test with Holm–Bonferroni correction) between methods are indicated (•P <0.1; * P 
<0.05; ** P ≤0.01; *** P ≤0.001). 
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The Skillings-Mack Test showed that differences between methods were statistically 
significant (P < 0.0001). Pairwise comparisons showed that method S-BT produced 
significantly higher DNA yield than all other methods (P = 0.047 when compared 
with L-QS and S-QS-PK and P = 0.029 compared with all other methods). Note that 
the difference in P value is due to the failure of an extraction each with methods L-
QS and S-QS-P, resulting in reduced statistical power. Excluding method S-BT, 
method S-QS-PK produced significantly higher DNA yields than all other methods 
(P = 0.047), except when compared to L-QS (P = 0.055). The latter comparison 
lacked statistical power since only 8 sample pairs could be compared due to one 
missing sample from each of the two methods. Therefore the difference is not 
statistically significant (after correction for multiple testing), despite all S-QS-PK 
extracts producing considerably higher DNA yields compared to method L-QS (see 
Figure 2.6). 
DNA purity as defined by the 260/280 spectrophotometry absorbance ratio was poor 
for methods L-BT and L-BT-EP (median of 1.65 and 1.70, respectively) and good for 
method S-BT (median 2.11). The readings for the methods using the QiaSymphony 
were generally higher (S-QS, L-QS and S-QS-PK having a median ratio of 3.59, 
3.60 and 3.09, respectively and this was due to a higher absorption at 260 nm, 
rather than lower absorption at 280 nm. This is therefore most likely due to the 
addition of carrier RNA (which, like DNA, has an absorbance maximum at 260 nm) 
during the QiaSymphony extraction process since these samples do not contain 
higher amounts of DNA. 
2.5.2 Amplicon PCR optimisation 
The amplicon yield ranged from <0.1 (recorded as 0) to 2.5 ng/µl with a median of 
0.6 ng/µl and a positively skewed distribution (mirroring DNA concentration of the 
extracts). One sample and one of the extraction methods (L-QS) failed to produce 
any measurable amplicon in all cases. For those PCR products where amplicon 
yield was sufficient, gel electrophoresis showed a single band at approximately 
600bp, indicating that the majority of DNA in the sample was amplicon. As 
expected, there was a positive correlation between the amount of input DNA used in 
the PCR reaction and amplicon yield (Spearman’s rank correlation coefficient = 
0.71, P <0.0001; see Figure 2.7). Using a linear regression model with DNA input 
and whether the sample has been diluted prior to PCR or not (samples with 
concentrations of 10 ng/µl, N = 7; see section 2.3.3) as fixed effects and sample 
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Figure 2.7 Scatter plot of PCR product concentration obtained after two stage PCR against total DNA 
input for the yield optimisation experiment. 
as a random effect (to control for any effect caused by sample and therefore 
differences in eukaryotic:bacterial DNA), the association between DNA extract 
concentration and amplicon yield remained highly significant (estimate = 0.0080, P 
< 0.0001), with dilution also having a positive effect on amplicon yield (estimate = 
0.76, P = 0.0001). Addition of extraction method to the model did not improve fit 
(according to the Akaike information criterion). 
2.6 Methods Part III: Bacterial Cell Lysis and Storage in BoonFix® 
Studies on the vaginal microbiota most commonly use a commercially available 
DNA extraction kit (Aagaard et al 2012, Gajer et al 2012, Ravel et al 2011, 
Shipitsyna et al 2013, Srinivasan et al 2012) but these methods have been poorly 
validated for studies on the human microbiota, and the choice of kit is often 
arbitrary. Commercial kits use a combination of different techniques to lyse cells, 
including mechanical (usually bead beating), chemical and enzymatic lysis and 
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heating. Methods that include a bead beating step have the advantage that they 
concurrently homogenise the sample, but this can shear the DNA into short 
fragments and may increase the risk of contamination during processing (Abusleme 
et al 2014, Salonen et al 2010). Methods using chemical and enzymatic lysis are 
less likely to damage DNA, but are thought to increase the potential for extraction 
bias (Salonen et al 2010). In order to determine whether different pretreatment lysis 
methods result in significant differences in DNA yield, observed taxa and community 
structure, we used natural vaginal bacterial communities sampled by cervicovaginal 
lavage. Additionally, an aliquot from each sample was stored in Boonfix® at room 
temperature prior to extraction, in order to determine if this provided equivalent 
results. 
2.6.1 Sample characteristics 
The 18 cervicovaginal lavage samples used here were a subset of anonymised 
samples that had been collected in Rwanda as part of a study that aimed to 
determine whether there was an association between the type of vaginal bacterial 
community and prevalent infection with sexually transmitted viral diseases 
(Borgdorff et al 2014). Ethical approval was obtained from the Rwanda National 
Ethics Committee and the Columbia University Medical Centre Review Board. The 
purpose of the current study was to evaluate lysis procedures, and samples were 
chosen solely because the bacterial communities had previously been well-
characterised by microarray analysis. We did not have access to personal identifiers 
and did not use any other data from the study. The 18 samples were chosen to be 
representative of the community clusters identified previously, including both low 
diversity communities dominated by either L. crispatus or L. iners and high diversity 
communities containing a mixture of strict and facultative anaerobes, representative 
of the complexity and richness of real vaginal communities. Samples were stored 
at -80°C until analysis. 
2.6.2 Lysis methods 
To test for differences in the results of microbiota analyses resulting from different 
pretreatment lysis strategies, samples were thoroughly mixed by vortexing before 
dividing into 5 aliquots of 100 µl each and then processed using one of four different 
lysis protocols (Figure 2.8). Vaginal samples may contain viscous mucoid material 
and if this was the case, any such material was discarded prior to vortex mixing. 
Two aliquots (designated "LN1" and "LN2") were subjected to 30 min of lysis at 
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37°C using enzymatic lysis buffer containing lysozyme from chicken egg white 
(20mg/ml; Sigma-Aldrich, Dorset, UK). This corresponds to the recommended 
pretreatment for Gram-positive bacteria as per the Qiagen DNeasy Blood and 
Tissue kit Handbook (Qiagen, Manchester, UK). One aliquot (designated "LON") 
was subjected to 16 hours of extended lysis at 37°C using enzymatic lysis buffer 
containing lysozyme (20 mg/ml). One aliquot (designated "EC") was subjected to 60 
min of lysis at 37°C using enzymatic lysis buffer containing lysozyme (20mg/ml), 
mutanolysin (250U/ml; Sigma-Aldrich) and lysostaphin (22 U/ml; Sigma-Aldrich). 
The last aliquot (designated "LTL") was subjected to 30 min of lysis at 37°C using 
enzymatic lysis buffer containing lysozyme (20 mg/ml), followed by 30 s mechanical 
lysis at 25 Hz using 200 mg of 0.1-mm-diameter zirconia/silica beads in the Tissue 
Lyser II (Qiagen, Manchester, UK).   
 
Figure 2.8 Overview of experimental design for cell lysis and BoonFix® storage experiment. 
Schematic showing how samples were processed for 16S rRNA amplicon sequencing. 
2.6.3 DNA extraction 
Proteinase K and Buffer AL from the Qiagen DNeasy Blood and Tissue kit (Qiagen) 
were added to all aliquots before incubation at 56°C for 30 min which was followed 
by the remaining steps in the kit's spin column protocol, in accordance with the 
manufacturer's instructions and DNA was eluted in 75 µl of elution buffer.  Lysis and 
DNA extraction was completed for all aliquots within a period of 36 hours using a 
previously unopened extraction kit and all work was carried out by the same person. 
The genomic DNA concentration of extracts was determined using the Qubit 
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Fluorometer with the dsDNA HS Assay kit (Invitrogen Life Technologies, Paisley, 
UK). 
2.6.4 Amplicon library preparation and DNA sequencing 
The V3-V4 region of the 16S rRNA gene was amplified in a 25 µl reaction 
containing 10 ng of genomic DNA, 12.5 µl of NEBNext® High-Fidelity 2x PCR 
Master Mix and 1.25 µl each of a 10 µM concentration of the conserved bacterial 
16S rRNA primers 319F 5'-ACTCCTACGGGAGGCAGCAG-3' and 806R 5'-
GGACTACHVGGGTWTCTAAT-3' (Fadrosh et al 2014) adapted with linker regions 
to allow barcoding of sequences using a dual-indexing approach (D’Amore et al 
2016). Thermocycling conditions, barcoding, amplicon purification, DNA 
quantification and sequencing were performed as described above (see section 
2.2.3). 
2.6.5 Room temperature storage in BoonFix® 
To test the suitability of samples stored at room temperature in BoonFix® fixative for 
use in microbiome analysis, a further 100 µl aliquot (designated "BF") from each of 
the 18 samples described in section 2.6.1 above was added to 500 µl of BoonFix® 
and stored at room temperature for a period of 33 weeks (7.5 months). Samples 
were then centrifuged at 16,100 x g for 10 min and the supernatant was removed 
prior to the addition of enzymatic lysis buffer containing lysozyme. Samples were 
further processed as described for methods "LN1" and "LN2" in section 2.6.2 and 
DNA was extracted as described in section 2.6.3 (except using a different Qiagen 
DNeasy Blood and Tissue kit). Amplicon library preparation and sequencing were 
carried out as described in section 2.6.3 (at a later date and therefore separately to 
the samples described in 2.6.2 above). 
2.6.6 Bioinformatics 
Sequencing reads were demultiplexed and primer sequences were trimmed using 
Cutadapt v. 1.2.1 (Martin 2011). The resulting reads were error corrected using 
SPAdes v 3.1.0 (Bankevich et al 2012) and paired-end alignment was performed 
using PEAR v0.9.6 (Zhang et al 2014). The obtained sequences were then binned 
into de novo OTUs based on 97% sequence similarity using USEARCH v. 6.1.544 
(Edgar 2010) through Quantitative Insights Into Microbial Ecology (QIIME v. 
1.8.0)(Caporaso et al 2010). Taxonomic assignment of representative sequences 
(most abundant) was carried out for each OTU by RDP classifier against the 
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Greengenes 13_8 database in QIIME and assignments were checked manually by 
NCBI BLAST search (Zhang et al 2000) for all the most abundant OTUs (≥1% in at 
least one extract). OTUs that contained less than 0.005% of total reads were 
removed as likely sequencing errors (Bokulich et al 2013). Note that this analysis 
had to be repeated once the sequencing data for the aliquots stored in BoonFix® 
fixative became available and the results therefore differ slightly from those 
published in Gill et al (2016), but this has not altered any of the conclusions made. 
However, the bioinformatics pipeline had to be altered from that originally used, 
because the second set of sequencing results were of lower quality towards the end 
of read 2, when compared to the previous results which affected the relative 
abundance of OTUs (see Appendix D). 
2.6.7 Data analysis 
Calculation of alpha and beta diversity measures, hierarchical clustering and 
statistical analyses were performed in R version 3.2.2 (R Core Team 2015) and 
using the vegan package version 2.3-1 (Oksanen et al 2015). Observed OTUs and 
the Simpson Index (1-D) were calculated to assess differences in alpha diversity. 
Hypothesis testing relating to DNA yield and alpha diversity was performed using 
repeated measures analysis of variance (ANOVA), correcting for differences due to 
the sample being extracted. Bray-Curtis dissimilarity and its complement, Bray-
Curtis similarity, were used to report and assess differences in beta diversity. 
Permutational multivariate ANOVA (PERMANOVA) (Anderson 2001) was used to 
assess differences in beta diversity between different lysis methods. Hierarchical 
clustering was performed using the Unweighted Pair Group Method with Arithmetic 
Mean (UPGMA) on the Bray-Curtis dissimilarity matrix. The OTU heatmap and the 
principal coordinate plot were generated in R version 3.2.2 using the phyloseq 
package version 1.14.0 (McMurdie and Holmes 2013). 
2.7 Results Part III: Bacterial Cell Lysis and Storage in BoonFix® 
A total of 10,374,312 16S rRNA sequence reads were obtained from the 90 
cervicovaginal lavage sample extracts (18 samples x 5 extractions) and an 
additional 2,795,096 reads were obtained from the aliquots stored in BoonFix®. 
After error correction, paired-end alignment, assignment to OTUs and removal of 
low abundance OTUs, a total of 9,413,508 reads were retained, with a mean read 
count of 87,162 reads per sample ranging from 5,307 to 145,306 reads. The lowest 
read count was found to be sufficient to accurately describe sample diversity based 
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on rarefaction curves of Faith’s phylogenetic diversity index, and unless otherwise 
stated all further analyses were carried out after samples were rarefied to 5,307 
reads. A total of 117 OTUs were identified, of which 41 were present at 1% or more 
in at least one sample extract.  Positive and negative controls were included on both 
sequencing runs. The main contaminant present in the profiles of all the negative 
DNA extraction controls was a Rhodanobacter sp. (14.9-96.7%). This OTU was 
absent from the two negative PCR controls and has therefore most likely originated 
from the DNA extraction kit. Abundance of this OTU was less than or equal to 
0.04% of reads of any one sample extract, indicating that contaminants originating 
from the extraction and amplification process were negligible in this study. The two 
positive control samples contained DNA from L. amylovorus only and were 
dominated by a single OTU with taxonomical assignment to a Lactobacillus sp., 
making up 99.9% and 100.0% after removal of small OTUs (see section 2.6.6), 
indicating that the size cut-off used was adequate for removal of erroneous 
sequences. The next largest OTU in both control samples was also identified as a 
Lactobacillus sp. (0.01% and 0.04%). The representative sequence for this OTU 
had 97% sequence similarity with the dominant OTU. Interestingly, the presence of 
these OTUs appeared correlated across the samples, but there were differences in 
the ratios between the two (which were consistent across different extracts of the 
same sample). It is possible that this represents biological variation in the 
sequences of the 16S rRNA gene copies present within different bacterial strains or 
the presence of different (but closely related) bacterial species. One of the positive 
controls also contained Rhodanobacter (0.01%), and the remaining OTUs present 
consisted of various vaginal bacteria and the largest of these was L. iners (0.02%), 
the most abundant OTU across all samples. These could represent contamination, 
but are more likely the result of incorrect sample assignment. 
2.7.1 Effect on DNA yield 
Four different methods for the pretreatment lysis of bacterial cells in 18 
cervicovaginal lavage samples from different women were used in this study. 
Additionally, long term storage in BoonFix® medium at room temperature was 
tested (Figure 2.8). Following extraction of DNA using a commercial kit, the total 
yield of genomic DNA was determined and compared between different lysis 
methods. The mean DNA yield was highest for aliquots extracted following storage 
in BoonFix® (method BF, median yield = 64 ng/µl; extracted using pretreatment 
lysis with lysozyme only) and lowest for samples extracted using enzymatic lysis  
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Figure 2.9 Box and whisker plot of DNA yield obtained for samples stored in BoonFix®, and with each 
pretreatment lysis method in cell lysis and BoonFix® storage experiment. Boxes extend from the 
lower quartiles to the upper quartiles with median values indicated by the line within each box. 
Whiskers represent maximum and minimum values, excluding any outliers (values indicated by 
circles which lie outside 1.5 times the interquartile range). Significant differences (paired t-test with 
Bonferroni correction) between methods are starred (* P <0.05; ** P ≤0.01; *** P ≤0.001). [Modified 
from Gill et al 2016 to include "BF" samples] 
with lysozyme only followed by mechanical lysis (method LTL, median yield = 12 
ng/µl; Figure 2.9). Since the input volume of sample used was equal in every 
extraction, the measured DNA concentration can be used to directly compare 
totalgenomic DNA yield obtained by each method. Repeated measures ANOVA 
showed that the difference in DNA concentration obtained using the four different 
lysis methods and BoonFix® storage was significant (P <0.0001). Pairwise 
comparisons showed that storage in BoonFix® medium at room temperature 
(method BF) produced a significantly higher DNA yield than aliquots extracted 
directly from frozen using 30 min pretreatment lysis with lysozyme only (P = 0.036 
and P = 0.030, for replicate runs LN1 and LN2, respectively), aliquots extracted by 
extended lysis with lysozyme (LON; P = 0.024) or aliquots extracted by enzymatic 
lysis with lysozyme combined with bead beating (LTL; P = 0.016). Furthermore, 
enzymatic lysis with lysozyme combined with bead beating (LTL) produced a 
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significantly lower DNA yield than lysis with the enzyme cocktail (EC; P = 0.0004) or 
30 min lysis with lysozyme only (P = 0.034 and P = 0.004, for replicate runs LN1 
and LN2, respectively). All other comparisons were not statistically significant at a 
significance level of 0.05 (after Bonferroni correction). 
2.7.2 Vaginal bacterial community composition 
The samples extracted in this study had been selected to represent a variety of 
microbiota profiles based on previously obtained microarray data (Borgdorff et al 
2014). As expected, bacterial community profiles obtained for each extract in this 
study were either low in bacterial diversity (dominated by either L. crispatus group or 
L. iners with or without G. vaginalis), or high in bacterial diversity containing a 
mixture of strict and facultative anaerobes including G. vaginalis, A. vaginae, 
Prevotella, Aerococcus, Anaerococcus, Streptococcus, Sneathia, Ureaplasma, 
Megasphaera, Mycoplasma, Gemella and the bacterial vaginosis associated 
bacteria BVAB1, BVAB2, Mageeibacillus indolicus (BVAB3) and BVAB TM7 (Figure 
2.10). 
2.7.3 Effect on observed alpha diversity 
The presence or absence of OTUs was consistent between extracts produced from 
the same sample using the different lysis methods and BoonFix® storage, with any 
discrepancies arising due to low abundance OTUs that made up no more than 0.2% 
of any extract, and in 93% of those cases made up less than 0.1%. There was no 
statistically significant difference in the number of observed OTUs between different 
lysis and storage methods (repeated measures ANOVA; P = 0.58). Calculation of 
the Simpson Index (1-D) confirmed a wide range of diversities (range = 0.02-0.89). 
Furthermore, the degree of variation between extracts from the same sample was 
small (maximum difference between extracts = 0.15). There was no statistically 
significant difference in the Simpson Index between the different methods (repeated 
measures ANOVA; P = 0.32). For the two monoculture positive controls, the 
Simpson index behaved as expected (0.00 in both cases), but the number of 
observed OTUs was distorted by singletons for one of these controls (observed 
OTUs = 1 and 6), illustrating that the Simpson index is a more accurate alpha 
diversity measure for this type of data as it is not sensitive to rare OTU read counts, 
which may represent read errors or incorrect sample assignment. 
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Figure 2.10 Heat map showing 
most abundant (1% or higher in at 
least one extract) operational 
taxonomic units with extracts 
arranged by UPGMA clustering on 
the Bray-Curtis dissimilarity matrix 
for cell lysis and BoonFix® 
storage experiment. Extracts are 
named according to the sample of 
origin followed by the lysis and 
storage method used. The 
coloured bar indicates which 
extracts have clustered most 
closely with all other extracts from 
the same sample (green) and those 
that have not (red). Lactobacillus 
species that could not be identified 
to species level at the 97% cut-off 
have been assigned to subgroups: 
L. gasseri group (includes L. gasseri 
and L. johnsonii), L. crispatus group 
(includes L. acidophilus, L. 
helveticus, L. gallinarum, L. 
crispatus, L. jensenii and L. 
delbruekii), L. vaginalis group 
(includes L. vaginalis and L. reuteri) 
and L. coleohominis group 
(includes L. coleohominis and L. 
pontis). 
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2.7.4 Effect on observed beta diversity 
Between extract diversity was calculated using Bray-Curtis similarity and ranged 
from 57.4-99.7% within samples and from 0.0-99.9% between samples. The mean 
difference between replicate extractions LN1 and LN2 was 4.0% (range 0.5-11.0%). 
Differences between extracts from the same sample were due to differences in 
proportions of OTUs, rather than differences in the presence/absence of OTUs.  
There was a negative correlation between the minimum within-sample Bray-Curtis 
similarity and the mean number of observed OTUs for that sample (Spearman’s 
rank correlation: r = -0.67; P = 0.002). In other words, samples with higher OTU 
richness tended to have increased dissimilarity between extracts. 
PERMANOVA analysis of Bray-Curtis dissimilarity showed that the differences 
between extracts originating from different samples (R2 = 0.99, P = 0.001) were far 
greater than differences between different lysis methods (R2 = 0.001, P = 0.002). 
Although the effect of lysis method was significant in this analysis, the magnitude of 
this effect was negligible when compared to the differences due to the sample of 
origin. This is reflected in the hierarchical clustering of the extracts based on Bray-
Curtis dissimilarity scores (Figure 2.10) and the clustering of extracts by principal 
coordinate analysis ordination of the Bray-Curtis dissimilarity matrix (Figure 2.11), 
which resulted in clustering of the extracts by sample rather than lysis method. 
Pairwise comparisons revealed that the most significant differences were between 
methods BF (storage in BoonFix®) and methods LN2 (PERMANOVA; R2 = 0.0019, 
unadjusted P value = 0.004) and between method BF and LON (PERMANOVA; R2 
= 0.0036, unadjusted P value = 0.009), but these differences were not statistically 
significant after adjustment for multiple testing (Holm-Bonferroni correction). 
The largest cluster of extracts was composed of samples that were dominated by L. 
iners (66-99%) with a variable proportion of G. vaginalis (0-32%). In this group, 
several sets of extracts (from samples S08, S14 and S18) did not form discrete sub-
clusters, as a result of higher Bray-Curtis similarity with extracts of other samples. 
This is due to small differences in observed proportions of OTUs and has occurred 
because of the high degree of similarity between the seven samples in this cluster. 
The Bray-Curtis similarity score ranged from 66-99% between extracts from 
different samples in this group. Since the composition of these samples was similar, 
we repeated the PERMANOVA analysis on this subset alone to minimise any effect 
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Figure 2.11 Principal coordinate analysis ordination of a Bray-Curtis dissimilarity matrix for cell lysis 
and BoonFix® storage experiment. Extracts are coloured by sample of origin. Extracts cluster closely 
with other extracts originating from the same sample and there is no observable effect of 
pretreatment lysis method. Extracts from samples that are dominated by Lactobacillus iners with 
variable proportions of Gardnerella have clustered on the left, extracts from samples that are 
dominated by L. crispatus group have clustered on the bottom right and extracts from high diversity 
samples that contained a mixture of strict and facultative anaerobes cluster towards the top. 
of differences in alpha diversity on the magnitude of beta diversity scores. In this 
analysis, the differences due to sample remained highly statistically significant (R2 = 
0.99, P = 0.001), but differences between different lysis and storage methods did 
not (R2 = 0.001, P = 0.26). 
2.7.5 Effect on individual OTUs 
Certain bacterial species have previously been reported to be resistant to lysozyme, 
including Neisseria gonorrhoeae (Rosenthal et al 1982) and staphylococci 
(Schindler and Schuhardt 1964). Furthermore, the results of a recent study indicate 
that streptococci may be underestimated in microbiota analyses (Brooks et al 2015). 
In order to investigate whether different lysis methods influenced the proportions of 
these bacteria, OTUs assigned to these taxa were identified and compared between 
different methods. Since these taxa were present at very low levels, calculations 
were performed on proportions calculated from raw read counts (i.e. prior to 
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rarefaction). One OTU identified in this study was assigned to the genus Neisseria. 
This could not be identified to species level due to 100% sequence similarity of 
related species in this region of the 16S rRNA gene, but is most likely to represent 
N. gonorrhoeae in this niche. This OTU was present at a low level (≤0.19%) in 
extracts from 5 different samples. Despite the low levels of this OTU, all of the 
extracts from these samples contained reads mapping to this OTU, with the 
exception of the sample with the lowest relative abundance (≤0.009%), where there 
were no reads in the extract that had been lysed with lysozyme overnight. There 
was no statistically significant difference between the percentage of this OTU 
between different lysis and storage methods (repeated measures ANOVA; P = 
0.54). Two OTUs mapped to Streptococcus spp. These were consistently present in 
five and six samples, but were both present in only one sample at >0.1% (ranging 
from 1.3-2.9% and 1.0-4.1% in this sample), with all remaining sample extracts 
containing less than <0.08% of either OTU. There was no statistically significant 
difference between the percentage of this OTU between different methods for either 
OTU (repeated measures ANOVA; P ≥ 0.4). Staphylococcus spp. were not present 
in the dataset after removal of small OTUs. 
2.8 Discussion 
Previous studies on the VMB have used either vaginal or cervical swabs (Aagaard 
et al 2012, Brotman et al 2012, Brotman et al 2014, Chaban et al 2014, Fettweis et 
al 2014, Forney et al 2010, Gajer et al 2012, Ghartey et al 2014, Hickey et al 2013, 
Huang et al 2015, Human Microbiome Project Consortium 2012, Jayaram et al 
2014, Ling et al 2010, Martin 2012, Ravel et al 2011, Romero et al 2014, 
Schellenberg et al 2011, Smith et al 2012, Srinivasan et al 2012, Walther-António et 
al 2014), or cervicovaginal lavage samples (Frank et al 2012, Mehta et al 2015, 
Spear et al 2008, Spear et al 2011, Ursell et al 2014). In order to prevent post-
sampling changes in the microbiota composition, most studies elected to freeze 
samples at -70°C or below shortly after sampling. Very few studies have utilised 
samples stored for any length of time in a fixative at room temperature (Chaban et 
al 2014, Martin et al 2012). The samples for the work presented in Chapter 4 were 
made available from a large epidemiological study investigating the efficacy and 
cost effectiveness of screening methods for cervical cancer in women with HIV (the 
HARP study - see Chapter 4 for a more detailed description of this project). These 
samples consisted of Dacron swabs stored in the coagulant fixative "BoonFix®" 
which contains ethanol, low molecular weight polyethylene glycol and acetic acid. 
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Although this medium was originally formulated as a fixative for histology and 
cytology, it has been used to characterise the VMB by microarray (Dols et al 2011) 
and detect bacterial DNA by PCR amplification (Klomp et al 2008). However, the 
use of alcohol-based fixatives is not widespread and little has been published about 
their use, in particular for molecular studies (Van Essen et al 2010). Therefore, in 
order to validate this storage method for microbiome analysis, we compared eight 
samples stored in BoonFix® at ambient temperature in South Africa to samples 
stored in PBS-methanol at -80°C. Although there was a tendency for the BoonFix® 
microbiome profiles to have slightly less Bray-Curtis similarity with the two PBS-
methanol profiles, overall the results were comparable. This difference may have 
been due to the two samples having been taken from different sampling sites, since 
the BoonFix® sample was taken from the lateral vaginal wall, while the PBS-
methanol sample came from the cervix. Other studies have found that these two 
sampling sites are very similar (Anahtar et al 2015, Huang et al 2015, Smith et al 
2014, Virtanen et al 2017), but some degree of variation between these sites is not 
unexpected. It should be noted that the PBS-methanol samples contained a high 
degree of contaminants and these were most likely already present in the medium 
when sampling took place, since significant growth of bacteria after freezing is 
unlikely. These were easy to identify in this case because environmental bacteria 
were not expected to be present in these samples. However, it does highlight the 
importance of appropriate media selection for microbiome work, as such 
contaminants cause wasted sequencing effort at best and may lead to erroneous 
conclusions at worst. In order to further validate storage in BoonFix®, we compared 
the microbiome profiles of 18 cervicovaginal lavage samples before and after a 7.5 
month period of storage in BoonFix® at room temperature. This showed that, 
although there were some differences in beta-diversity, these differences were 
minor compared to the differences between women. Interestingly, with these 
samples, storage in BoonFix® increased DNA yield. The reason for this is not 
known. However, since ethanol can decrease bacterial membrane integrity (Da 
Silveira et al 2002), this could relate to improved cell lysis. If this were to be the 
case, there is potential for this fixative to improve DNA extraction from difficult-to-
lyse bacteria and thereby improve the accuracy of microbiome profiling, but this 
theory would require further testing. Overall, these results show that cervicovaginal 
samples stored in BoonFix® are suitable for microbiome analysis and the results 
are comparable to samples stored frozen. Furthermore, significant sample 
contaminants were not detected in BoonFix® medium in either study, which is 
consistent with it having bacteriocidal (or bacteriostatic) properties and hence 
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preventing distortion of the microbiome after sampling in samples stored at room 
temperature. 
One potential problem encountered using the samples stored in BoonFix® was that 
the DNA yield was initially very low (see part I). Recent work has highlighted that, in 
studies using next-generation sequencing technology to characterise the bacterial 
microbiota, low amounts of template DNA are associated with a proportional 
increase in contaminant taxa originating from laboratory reagents (Biesbroek et al 
2012, Kennedy et al 2014, Salter et al 2014) and this is consistent with our own 
results (see Appendix B). These contaminants can lead to erroneous conclusions. 
Furthermore, we showed that amplicon yield is dependent on DNA extract 
concentration and good amplicon yield is necessary to allow accurate equimolar 
pooling of amplicons prior to sequencing. It was therefore important to optimise 
DNA extraction from BoonFix® samples and we tested whether inclusion of the 
vaginal swab in the extraction process could improve DNA concentration of extracts. 
We found that DNA yield could be significantly increased by including the swab 
head in the proteinase K/"buffer AL" digestion step, which was then at a level 
considered sufficient to avoid significant reagent contamination for most samples 
(see Appendix B). This result is consistent with experiments on human DNA yield 
from forensic swabs, for which the inclusion of the swab head in the proteinase 
K/"buffer AL" digestion step is routine when using the QIAamp DNA Investigator kit, 
also made by Qiagen (Adamowicz et al 2014). A study by Adamowicz and others 
(2014) found that DNA yield from swab samples can further be improved by 
increasing the length of the proteinase K digestion step (to between 3 and 18 hours) 
and by performing periodic resuspension of the swab (centrifuging the swab in a 
spin basket and collecting the eluate in the same sample tube used in the extraction 
process) (Adamowicz et al 2014). However, yield was deemed sufficient for 
downstream analyses and further optimisation was therefore not necessary in this 
study. In part III of this chapter, 10 ng of template DNA was used in each 25 µl PCR 
reaction. This amount of DNA has been found to result in significantly lower 
variability in microbiota community structure in studies profiling the faecal microbiota 
(Kennedy et al 2014). Furthermore, in our laboratory, this concentration of DNA in 
cervicovaginal samples resulted in negligible levels of reagent contamination (see 
Appendix B), which is supported by the low levels of the contaminant 
Rhodanobacter OTU in this study. Rhodanobacter spp. have been isolated from 
environmental soil and water samples (Hemme et al 2015, Van Den Heuvel et al 
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2010). Interestingly, this genus has also been reported as a member of the human 
microbiota from studies using Qiagen extraction kits (Audirac-Chalifour et al 2016, 
Weng et al 2014), highlighting the need to adequately control for contamination 
occurring during laboratory processing of samples for 16S rRNA microbiota 
profiling. 
A further variable that may distort microbiome profiles is differential lysis efficiency 
of the various species that may be present in vaginal samples. Previous studies 
have used mock communities to be able to assess different lysis methods 
(Abusleme et al 2014, Yuan et al 2012). Mock community studies have the 
advantage that the community profile of the samples is known, allowing assessment 
of the accuracy of the results (Yuan et al 2012). In this study, we chose to use 
naturally occurring bacterial communities for which the true composition was not 
known and as a result the accuracy of each lysis method could not be determined. 
However, using biological samples that cover a range of different community types 
has the advantage of allowing comparison of lysis and storage methods on a wider 
range of bacteria commonly encountered in the vaginal niche, including those that 
have not or have rarely been cultured. This includes the bacterial vaginosis-
associated bacteria, which can make up a substantial proportion of the bacterial 
population in some individuals (Oakley et al 2008). Additionally, using vaginal 
samples allowed us to compare the magnitude of the effect of method with that 
resulting from biological differences between samples from different individuals. It 
should also be noted that vaginal samples can vary in consistency (Chappell et al 
2014) and may contain viscous mucoid material that is difficult to homogenise. In 
this study, we have chosen to remove any such material where present prior to 
processing to minimise any potential variation between extracts resulting from 
inadequate homogenisation. It is possible that the composition of the microbiota 
associated with the removed material differed from the remaining material and could 
therefore have changed the overall profile of the samples. However, as with the 
effect of storage in BoonFix®, the results of this study clearly show that sample has 
a far greater effect on the microbiota profile than the pretreatment lysis method. This 
is consistent with the results of studies that have compared different extraction kits 
or protocols for faecal samples (Salonen et al 2010, Wagner Mackenzie et al 2015, 
Wesolowska-Andersen et al 2014) and saliva (Willner et al 2012). Additionally, 
epidemiological studies investigating the effect of vaginal bacterial communities on 
health commonly group samples by clustering based on overall community 
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structure, assigning each sample to a “community type” (Borgdorff et al 2014, 
Brotman et al 2014, Frank et al 2012, Hummelen et al 2010, Lee et al 2013, Ravel 
et al 2011) and accurate clustering of extracts was not affected by either 
pretreatment lysis method or BoonFix® storage in this study. However, biological 
differences resulting from subtle variation in proportions of taxa may be difficult to 
separate from experimental variation as evidenced by up to 11.0% dissimilarity 
between replicate extracts LN1 and LN2, and should therefore be interpreted with 
caution. A larger sample size and greater number of experimental replicates would 
be required to investigate this variation further, particularly to determine whether the 
other lysis methods and BoonFix® storage used in this study would produce a 
similar degree of dissimilarity. 
In comparing pretreatment lysis methods, we used the recommended protocol for 
the pretreatment of Gram-positive bacteria with lysozyme as standard since it is 
thought to improve species representation (Abusleme et al 2014). As a result, we 
cannot make any conclusions about the necessity of this enzyme for bacterial lysis 
from the data in this study. Lysozyme breaks down the bacterial cell wall by cleaving 
peptidoglycan and may be particularly important for the breakdown of the thick 
peptidoglycan layer of the Gram-positive cell wall (Davis and Weiser 2011). 
However, modifications to peptidoglycan structure can render bacteria resistant to 
lysozyme digestion. This has been reported in N. gonorrhoeae (Rosenthal et al 
1982) and staphylococci (Schindler and Schuhardt 1964), both of which could be 
present in vaginal samples (Donders et al 2002, Wiesenfeld et al 2003). The use of 
the enzymes mutanolysin and lysostaphin in addition to lysozyme has been 
recommended for the lysis of vaginal samples in order to lyse bacterial species that 
are resistant to lysozyme digestion (Yuan et al 2012). Lysostaphin specifically lyses 
some Staphylococcus spp. (Schindler and Schuhardt 1964) and mutanolysin is 
active against the cell wall of some streptococci (Yokogawa et al 1974). In this 
study, we failed to identify any differences between lysis methods for the 
aforementioned bacterial taxa. However, the number of 16S rRNA reads mapping to 
these genera was small, resulting in low statistical power to detect relatively small 
differences. Additionally, the bacterial species/strains sequenced in this study may 
not have been resistant to lysozyme lysis. For example, differences in susceptibility 
to lysozyme digestion between different strains of N. gonorrhoeae have been 
reported (Rosenthal et al 1982). It is possible that differences in lysis efficiency may 
have been evident if different species or strains had been present in the samples 
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used. However, the addition of mutanolysin and/or lysostaphin to samples in this 
study, which contained the majority of major vaginal bacterial taxa, was not found to 
significantly alter the presence/absence of OTUs or their relative abundance. It is 
therefore unlikely that the addition of these enzymes would alter the conclusions of 
studies designed to investigate the impact of vaginal community type on human 
health. A further additional treatment that can be used to improve lysis of cells is 
mechanical disruption, usually by bead-beating. Bead beating has been reported to 
increase the observed richness in previous microbiota studies (Guo and Zhang 
2013, Salonen et al 2010). This was not the case in this study in which we found no 
significant difference in alpha diversity. It should be noted that bead-beating may 
have a greater influence on fresh samples compared with those that have been 
stored in the freezer, possibly due to disruption of the Gram-positive cell wall by 
freeze-thawing (Wesolowska-Andersen et al 2014). The samples used in this study 
were stored at -80°C, as is common for vaginal microbiota studies (Brotman et al 
2012, Brotman et al 2014, Forney et al 2010, Frank et al 2012, Huang et al 2015, 
Jayaram et al 2014, Ling et al 2010, Mehta et al 2015, Ravel et al 2011, 
Schellenberg et al 2011, Smith et al 2012, Walther-António et al 2014) and it is 
possible that an effect of bead beating would have been evident if fresh samples 
had been used, by resulting in reduced richness in those extracts that were not 
subjected to bead beating. 
In contrast to the effect on diversity, we found that the addition of a bead-beating 
step significantly reduced the DNA concentration of the extract, which is consistent 
with previous results using mock bacterial communities (Abusleme et al 2014, Yuan 
et al 2012), and is most likely due to some material being lost with the beads when 
they are removed from the sample. DNA yield is commonly used to assess the 
efficiency of different lysis and extraction protocols. Other studies have reported that 
the inclusion of a bead-beating step led to an increase in DNA yield from activated 
sludge (Guo and Zhang 2013) and faecal samples (Maukonen et al 2012). 
However, these samples may be more heterogeneous and particulate in nature, 
which could explain this difference and emphasises the importance of validating 
methods for microbiota analysis on the sample type of interest. Consistent with our 
results, higher DNA yield has not been shown to be associated with improved 
accuracy of microbiota profiles in mock community studies (Abusleme et al 2014, 
Yuan et al 2012), and the reduced DNA yield with method LTL is not of particular 
concern. However, increased contamination caused by inclusion of a bead-beating 
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step has been reported (Abusleme et al 2014) and may be best avoided in the 
absence of a clear advantage. It should be noted that DNA extraction to test the 
effect of different pretreatment lysis strategies was carried out with the same type of 
commercial kit (Qiagen DNeasy Blood and Tissue) for all samples. Proprietary 
extraction kits employ a variety of different techniques to lyse cells and purify DNA. 
Hence the importance of pretreatment with additional lysis methods may vary 
between kits. 
2.9 Conclusions 
It is widely acknowledged that bias exists in 16S rRNA studies describing microbiota 
profiles and that no currently available method is able to perfectly describe the 
community being analysed. However, an understanding of how the choice of 
laboratory methods affects the results of such studies is important in order to 
accurately interpret the results and make valid comparisons between different 
studies. Although we were able to identify statistically significant differences in DNA 
yield and diversity between the different lysis methods and BoonFix® storage, the 
effects of this were much smaller than those due to the individual variation between 
subjects, and did not alter the grouping of extracts by hierarchical clustering and 
principal coordinate analysis. 
Going forward, it was decided to use the Qiagen Blood and Tissue Kit for the 
extraction of BoonFix® samples with inclusion of the swab in the proteinase K step, 
since this produced the best DNA yields and was therefore less likely to be 
associated with significant reagent contamination of microbiome profiles. The 
recommended pretreatment for Gram-positive bacteria as per the kit's handbook 
(treatment with enzymatic lysis buffer containing lysozyme) was decided upon as 
the results were comparable to the other, more involved, lysis methods tested.  
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CHAPTER 3: Bioinformatics Methods 
3.1 Introduction 
Studies using next generation sequencing of 16S rRNA gene amplicons generate 
several million DNA sequence reads. While this allows for deep sampling of the 
microbiota, it also produces a large amount of data that needs to be summarised in 
silico (i.e. performed on a computer) before diversity can be calculated and 
statistical tests can be performed to determine whether there is a significant 
association between the microbiota profiles and health outcomes. In order to 
condense data into a manageable form, reads are grouped based on their DNA 
sequences. One of the challenges with this is that 16S rRNA sequencing data 
contains errors. In Illumina data, sequence error is created through base 
substitutions during PCR, the formation of PCR chimeras and incorrect base calling 
by the sequencer (Tikhonov et al 2015). PCR substitution error can be reduced 
through the use of a proofreading DNA polymerase which has the ability to excise 
incorrectly paired bases (Gohl et al 2016) and can be partially mitigated in silico by 
performing an error correction step (Schirmer et al 2015). Chimeric sequences are 
created during PCR from two different templates and this type of error can be 
reduced by restricting the number of PCR cycles, usually to 25 or less (Kanagawa 
2003) and is also affected by the choice of DNA polymerase (Gohl et al 2016). Any 
chimeric sequences that do form should be removed after sequencing in silico. 
Sequencing error can only be dealt with in silico and is perhaps the biggest 
challenge when grouping or "clustering" reads. The most common type of 
sequencing error in Illumina data are base substitutions (Schirmer et al 2015).  
The first algorithms used to condense 16S rRNA sequencing data cluster reads into 
"operational taxonomic units" (OTUs) – a process also referred to as "OTU picking" 
– include USEARCH and CD-HIT. These work by randomly selecting a read as the 
OTU centroid, and then consigning all similar sequences to that OTU, based on an 
arbitrary global similarity threshold to the selected centroid, commonly 97% (Edgar 
2010, Fu et al 2012). In this context "global" refers to the similarity between two 
DNA sequences along their entire length. The centroid sequence may be picked 
either by the algorithm (termed de novo OTU picking since they do not require user 
input) or selected from a user-defined database (closed OTU picking), or a 
combination of the two (open OTU picking). These approaches are “greedy” 
because they use a relatively simple strategy to solve a more complex problem by 
utilising a local optimum (i.e. picking a centroid) in the hope of finding the global 
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optimum (i.e. that this centroid will produce an accurately delineated OTU). For 
these algorithms, employing a similarity threshold is necessary due to the presence 
of error in the sequencing results which artificially decreases pairwise sequence 
similarity and would thereby – without the use of a similarity threshold – erroneously 
inflate diversity estimates. However, while this approach is simple to implement 
computationally, it has some disadvantages. For example, some experts argue that 
it does not accurately reflect biological diversity (Eren et al 2016). Organisms evolve 
at different rates such that slowly evolving lineages share a high degree of pairwise 
sequence similarity while those that evolve more quickly have a lower degree of 
similarity. Hence, by using the same threshold for all lineages, bacterial species that 
have evolved slowly are separated poorly, while those that have evolved more 
quickly are insufficiently clustered (Koeppel and Wu 2013). In the vaginal niche, 
differentiation of the Lactobacillus spp. is of particular interest and many species 
cannot be resolved using a 97% similarity threshold (and in many cases not even 
with a 98 or 99% similarity threshold, see Appendix E). Furthermore, by picking an 
arbitrary centroid it is possible that closely related sequences are placed in different 
OTUs (Mahé et al 2014). 
More recently, new de novo algorithms have been designed that aim to address 
some of these issues and better describe biological variation, despite the presence 
of read error. This increased level of detail has the potential to provide more 
information about population structure that may have clinical and epidemiological 
relevance (Eren et al 2011). These methods include oligotyping (Eren et al 2013), 
Swarm (Mahé et al 2014) and DADA2 (Callahan et al 2016). Oligotyping works by 
using Shannon entropy (a measure of information uncertainty) to identify positions 
within the sequence data where there is true biological variability (i.e. where the 
variation is greater than would be expected due to sequencing error) and uses this 
information to bin sequences into groups. To differentiate these groups from those 
produced using methods that rely on a global similarity threshold the authors use 
the term "oligotypes" in place of OTUs (Eren et al 2013). Swarm uses information 
from pairwise sequence alignment, but rather than comparing to a centroid, 
comparisons are made to all other reads in the dataset and sequences are included 
in the same cluster if they are all linked to one another by sequences that differ by 
no more than d bases (where a difference is defined as either a substitution, 
insertion or deletion; d is set to 1 by default). Clusters generated in this way are then 
further refined by identifying weak links within a cluster, i.e. where the number of  
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Figure 3.1 Schematic summary of clustering strategies employed by USEARCH, Swarm and DADA2. 
Individual reads are indicated by dots as they might appear on a PCoA plot. USEARCH selects an 
(arbitrary) centroid, indicated in red. All reads that are within a given similarity threshold (t; often 
set to 97%) from that centroid are assigned to the same OTU. The diagram illustrates the potential 
problem with this approach where the dataset contains multiple closely related sequence clusters. 
Swarm uses a local clustering threshold (d; usually set to 1) and iteratively adds reads to an OTU if 
they differ by no more than d bases. DADA2 attempts to correct read error prior to assigning reads 
to OTUs, and reads are assigned to the same OTU is their corrected sequences are identical. Adapted 
from [Mahe 2014]. 
sequences that link two parts of a cluster is low, and separating these parts in a 
process termed "OTU breaking" (Mahé et al 2014). DADA2 infers expected error 
rates from sequence composition and quality data, defining the rate at which 
erroneous sequences are expected to be produced from each parent sequence. 
This information is then used to create clusters that contain the parent sequence as 
well as the expected number of associated erroneous sequences determined by the 
error model (Callahan et al 2016). To decide which method of sequence clustering 
was most appropriate for analysis of the vaginal microbiome (VMB) in the study 
described in the following chapters, we tested Swarm v. 2.1.13 and DADA2 v. 1.4.0 
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on a control dataset and compared the results to those obtained by USEARCH v. 
6.1.544, with and without a reference database (Figure 3.1). 
3.2 Methods 
In order to test the accuracy and efficiency of clustering methods for 16S rRNA 
data, we used a set of controls as follows. 
3.2.1 Description of controls 
Three types of bacterial DNA sources were utilised in this study: the commercially 
available Zymo Microbial DNA Standard (Zymo Research, Irvine, USA), DNA 
extracts of cultured vaginal bacteria and clinical vaginal samples. In addition, 
nuclease-free water was extracted using the same DNA extraction kit for use as a 
negative control to identify reagent contaminants. 
The Zymo Microbial DNA Standard contains pooled DNA extracted from pure 
cultures of eight bacterial species (Pseudomonas aeruginosa, Escherichia coli, 
Salmonella enterica, Lactobacillus fermentum, Enterococcus faecalis, 
Staphylococcus aureus, Listeria monocytogenes and Bacillus subtilis). These 
bacterial strains are well characterised and information on genome size, average 
GC content and 16S rRNA copy number is available. Each batch is created to 
provide a standardised theoretical composition and the results of shotgun 
metagenomics sequencing for each batch can be accessed, providing a gold 
standard measure of sample composition. 
Six vaginal bacterial cultures (Lactobacillus crispatus, Lactobacillus iners, 
Lactobacillus jensenii, Atopobium vaginae, Prevotella bivia and Gardnerella 
vaginalis) were obtained from the HIV/STI Reference Laboratory, Institute of 
Tropical Medicine, Antwerp. These were stored in BoonFix® at room temperature, 
pelleted by centrifugation at 5000 x g for 10 minutes and extracted using the Qiagen 
DNeasy Blood and Tissue kit as previously described (see section 2.2.2). 
Additionally, a pure culture of Lactobacillus amylovorus (originally isolated from 
porcine intestine) was obtained from a colleague at the Institute of Integrative 
Biology, University of Liverpool, UK. This lactobacillus was included based on its 
high degree of sequence similarity to L. crispatus in the V3-V4 region (99.5%, 
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differing by two base substitutions). The sample was stored frozen at -20°C for a 
brief period prior to extraction using the same protocol. 
Two cervicovaginal lavage sample extracts (S11 and S14) produced previously 
(described in section 2.6.1 and extracted according to method "LN1", see sections 
2.6.2 and 2.6.3) were also sequenced. 
3.2.2 Amplicon library preparation and DNA sequencing 
The V3-V4 region of the 16S rRNA gene was amplified in a 25 µl reaction 
comprising 12.5 µl of NEBNext® High-Fidelity 2x PCR Master Mix (containing DNA 
polymerase Q5), 1.25 µl each of a 10 µM concentration of the conserved bacterial 
16S rRNA primers 319F 5'-ACTCCTACGGGAGGCAGCAG-3' and 806R 5'-
GGACTACHVGGGTWTCTAAT-3' (Fadrosh et al 2014) adapted with linker regions 
to allow barcoding of sequences using a dual-indexing approach (D’Amore et al 
2016). The V3-V4 region was chosen since – despite having slightly reduced ability 
to discriminate between Lactobacillus spp. – this region has substantially lower 
levels of Lactobacillus intra-species sequence diversity (see Appendix E), thereby 
reducing the likelihood of sequences from the same species being separated and, 
within the lactobacilli, there is also a comparatively low degree of sequence 
variability within the same genome (see Appendix E). Furthermore, two other 
regions commonly used in VMB studies (V1-V2 and V6) tend to overestimate alpha 
diversity (Youssef et al 2009). PCR products were produced from 2 ng of genomic 
DNA for the Zymo Microbial DNA Standard (2 replicates each on 11 PCR runs). 
Vaginal bacteria (two replicates each) and L. amylovorus (single amplification) were 
PCR amplified separately in reactions containing 40 ng of genomic DNA for vaginal 
bacteria, with the exception of L. iners and L. jensenii extracts for which total DNA 
yield was too low (6.4 ng and 2.3 ng used, respectively). Additionally, a pool was 
created containing approximately equal genome copies from each of the six vaginal 
species (the "VMB mock community"). Genome copy number was estimated based 
on genome size according to the NCBI database (Acland et al 2014) and 40 ng of 
pooled DNA was used per PCR reaction (2 replicates each on 12 PCR runs). For 
the cervicovaginal lavage samples 30 ng per reaction was used (a total of 23 and 24 
replicates for S11 and S14 respectively, across 12 PCR runs). PCR products from 
negative extraction controls were produced from 10 µl of undiluted extract (39 
replicates). 
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For the first PCR (16S rRNA gene amplification) the samples were initially 
denatured at 98°C for 30 s, followed by 10 cycles of 98°C for 10 s, 58°C for 30 s 
and 72°C for 30 s, with a final extension at 72°C for 5 min. The PCR products were 
then purified using SeraPure magnetic beads (Faircloth and Glenn), before 
undergoing a second PCR to attach sample-specific barcodes and further amplify 
the region of interest. The second PCR consisted of a 25 µl reaction containing 7.5 
µl of clean PCR product, 12.5 µl of NEBNext® High-Fidelity 2X PCR Master Mix and 
2.5 µl each of Nextera XT Index Kit v2 (Illumina, San Diego, USA) indexing primers. 
Samples were initially denatured at 98°C for 3 min, followed by 15 cycles of 98°C for 
30 s, 55°C for 30 s and 72°C for 30 s, with a final extension at 72°C for 5 min. PCR 
products were purified, eluted in a volume of 10 µl TE buffer (Sigma-Aldrich) and 
quantified using the Qubit Fluorometer with the dsDNA HS Assay kit to determine 
amplicon yield. Purified PCR amplicons measuring ≥ 2 ng/µl were run on a 2% 
agarose gel at 100V to verify purity of the amplicon. Additionally, to test for PCR 
bias, the single vaginal species were individually PCR amplified as above using four 
different barcode combinations and then pooled in equal concentrations prior to 
sequencing (“VMB mock community pooled post-PCR”; 3 replicates of each of the 4 
barcode combinations sequenced). Amplicons were then pooled and sequenced at 
the University of Liverpool Centre for Genomics Research on the Illumina HiSeq 
platform (2x300bp; Illumina) on two separate runs, one consisting of two lanes on 
the same flowcell (designated "X" and "Y") and one consisting of a single lane 
(designated "Z").  
3.2.3 Bioinformatics 
Sequencing reads were demultiplexed and primer sequences were trimmed using 
Cutadapt v. 1.2.1 (Martin 2011). The resulting reads were then processed according 
to one of three different bioinformatics pipelines as follows: 
USEARCH: Primer trimmed reads were error corrected using SPAdes v. 3.1.0 
(Bankevich et al 2012) and paired-end alignment was performed using PEAR v. 
0.9.6 (Zhang et al 2014) with a size cut-off of 380-480 bases. After removal of 
chimeric sequences detected by USEARCH de novo and against the Silva v. 128 
database (sequences flagged by both methods removed), sequences were binned 
into OTUs either de novo or closed (i.e. against a vaginal reference database) using 
USEARCH v. 6.1.544 (Edgar 2010) through Quantitative Insights Into Microbial 
Ecology (QIIME) v. 1.8.0 (Caporaso et al 2010) with the similarity threshold set at 
67 
 
97% or 99%. Taxonomic assignment of representative sequences (most abundant) 
was carried out for each OTU by RDP classifier with a minimum bootstrap value of 
50% for both closed and de novo clustered data (Wang et al 2007) against the Silva 
v. 128 database (non-redundant, clustered at 97% for OTUs created using a 97% 
similarity threshold and at 99% only for OTUs created using a 99% similarity 
threshold) (Pruesse et al 2007) in QIIME. For the OTUs created with a 97% 
similarity threshold, taxonomy assignment was also performed using the 99% 
database, to see if this could be used to improve taxonomical assignment, based on 
the assumption that the most abundant sequence in the OTU is most likely to be the 
“real” sequence. Unless otherwise stated, the reported taxonomy is the one 
assigned by the 97% clustered database. After clustering de novo, OTUs that 
contained less than 0.005% of total reads were removed as likely sequencing errors 
(Bokulich et al 2013). For closed OTU picking, a non-redundant V3-V4 reference 
database was created using sequence identifiers from the Vaginal 16S rDNA 
Reference Database (Fettweis et al 2012) which contains sequences for the V1-V3 
region of vaginal bacteria. Sequences for the bacteria in the Zymo control were also 
included if not already in the database (i.e. Salmonella enterica, Listeria 
monocytogenes and Bacillus subtilis), as was the sequence for the Rhodanobacter 
sp. found previously in negative extraction controls. 
Swarm: Primer trimmed reads were error corrected using SPAdes v. 3.1.0 
(Bankevich et al 2012) and paired-end alignment was performed using PEAR v. 
0.9.6 (Zhang et al 2014) with a size cut-off of 380-480 bases. The obtained 
sequences then underwent removal of ambiguous bases and dereplication using 
Vsearch v. 2.4.3 (Rognes et al 2016). Sequences were clustered into OTUs de novo 
using Swarm v. 2.1.13 (Mahé et al 2015) with the difference parameter (d) set at 1 
and option “fastidious” enabled. The resulting representative sequences (most 
abundant) were abundance sorted and checked for chimeric sequences with 
Vsearch, using the UCHIME algorithm (Edgar et al 2011) de novo and against the 
Silva v. 128 database (only sequences detected by both methods removed). 
Taxonomic assignment of representative sequences (most abundant) was carried 
out for each OTU by RDP classifier with a minimum bootstrap value of 50% (Wang 
et al 2007) against the Silva v. 128 database (non-redundant, clustered at 99%) 
(Pruesse et al 2007) in QIIME. OTUs with a total read count below 100 were 
discarded prior to further analysis. 
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DADA2: Paired end sequences were trimmed to remove the poor quality ends and 
filtered to remove poor quality reads through the DADA2 v. 1.4.0 (Callahan et al 
2016) pipeline for large paired end datasets. The length to which the forward and 
reverse reads were trimmed was chosen based on quality plots and later adjusted 
(shortened) to optimise retention of reads. At the same time the maxEE parameter 
(which sets the maximum number of allowed “expected errors” per read) was 
increased and the truncQ value set to 0, to achieve ~90% read retention. Final 
parameters for the forward and reverse reads were trimming to 250 bp and 230 bp 
with a maxEE value of 5 and 8, respectively. The error rates of forward and reverse 
reads were determined separately for each set of sequences from the three Illumina 
HiSeq lanes, as recommended by the developers. The DADA2 pipeline then 
proceeded with sample inference (analogous to OTU picking) and paired end 
alignment. Finally, obtained sequence tables were merged, de novo chimera 
checking was performed and taxonomy was assigned using RDP classifier with a 
minimum bootstrap value of 50%  (Wang et al 2007) against the Silva v. 128 
database (non-redundant, clustered at 99%) (Pruesse et al 2007). Species 
assignments were made using DADA2’s addSpecies method which identifies exact 
sequence matches to the database. The settings were such that only reference 
sequences with unique matches were assigned a species classification. 
3.2.4 Data analysis 
The NCBI BLAST search tool (Altschul et al 1990) and Clustal Omega (Sievers et al 
2011) were used to match the obtained reference sequences to those held in the 
NCBI database and to compare sequence similarity, respectively. 
Calculation of alpha and beta diversity measures, statistical analyses and graphing 
of data were performed in R version 3.2.2 (R Core Team 2015) and using the vegan 
package version 2.3-2 (Oksanen et al 2015) and nlme package version 3.1-131 
(Pinheiro et al 2017). For the Zymo Microbial DNA standard control profiles, a mixed 
effects linear regression model was used to identify differences in accuracy (as 
determined by Bray Curtis similarity of each replicate to the expected profile) 
between different clustering methods, with replicate ID as a random effect (to 
control for differences due to PCR and sequencing). Bray-Curtis similarity on 
relative abundance data was used to report and assess differences in beta diversity. 
Permutational multivariate ANOVA (PERMANOVA) (Anderson 2001) was used to 
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assess differences in beta diversity (Bray Curtis similarity) between different 
sequencing runs/lanes. 
3.3 Results 
A total of 17,835,288 16S rRNA sequence reads were obtained from the 106 control 
samples. One of the VMB mock samples failed to sequence, despite producing an 
adequate amount of amplicon, most likely due to a pooling mistake (i.e. the sample 
was not added to the final pool of amplicons that were put on the Illumina HiSeq). 
The raw read count per sample ranged from 43,095 to 1,856,798 reads, with a 
median count of 142,979 reads. Following processing through the bioinformatics 
pipelines, the median read count per sample in the final OTU table was highest for 
USEARCH closed at 97% similarity (136,377 reads), followed by Swarm (median = 
132,820), DADA2 (131,812 reads), USEARCH closed at 99% similarity (128,359 
reads), USEARCH de novo at 97% similarity (126,317 reads) and lowest for 
USEARCH de novo at 99% similarity (median = 124,288). 
3.3.1 Analysis time and ease of use 
Good documentation is available for the use of USEARCH within QIIME and for 
DADA2, providing workflows that are relatively simple to follow. Although Swarm 
has been incorporated into various bioinformatics pipelines such as QIIME, the 
newest version was only available as standalone software. This meant that 
assembling an OTU table from the clustered data was less straightforward than with 
the other clustering methods. However, an example workflow is available online 
(Mahé 2016). 
When running a clustering algorithm on multiple core platforms, speed in real time 
depends not only on the platform used and how the clustering strategy is 
implemented, but also on whether it allows multithreading (i.e. whether the code can 
be run on several processors simultaneously). USEARCH is reported to be the 
fastest greedy clustering algorithm available and can be faster than Swarm (Mahé 
et al 2014). However, when clustering de novo, USEARCH is not capable of multi-
threading, meaning it can only use one processor/thread at a time. Therefore, in real 
time, Swarm is often still faster than USEARCH, depending on the number of 
processors/threads available. Additionally, when clustering de novo with a 99% 
similarity threshold, USEARCH used up more CPU time compared with Swarm in 
this study (Table 3.1). In contrast, when clustering against a database, USEARCH 
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does allow multi-threading and is very fast. DADA2 is comparable to Swarm and 
USEARCH in terms of CPU time taken up and is also capable of multithreading, 
reducing real processing time. 
It should also be mentioned that de novo chimera checking took a considerable 
amount of time in the Swarm (48 hours (h) 31 minutes (m) 29 seconds (s) using 
Vsearch) and USEARCH (79h54m56s using USEARCH) pipelines. In these 
pipelines the number of reads that were checked was relatively high. By 
comparison, the DADA2 pipeline is considerably faster (8m1s in real time). This is 
probably due to the fact that DADA2 performs this check only on the relatively small 
set of representative sequences remaining after filtering of error prone reads and 
error correction (see 3.2.3). 
Table 3.1 Time taken for each OTU clustering algorithm to run. Real time refers to actual time 
elapsed, user and system time are the actual CPU time taken up with executing the process in user 
mode and within the kernel, respectively. Note that DADA2 processing also includes paired end 
alignment, which was performed with PEAR prior to Swarm and USEARCH. 
ALGORITHM REAL TIME USER TIME SYSTEM TIME 
DADA2: Calculating error rates  82m9s 225m45s 4m30s 
DADA2: Sample inference, paired end merging 35m34s 105m6s 1m30s 
Swarm: Clustering 94m59s 460m12s 11m39s 
USEARCH denovo 97%: 
Clustering and generation of OTU map 
350m33s 333m55s 0m56s 
USEARCH denovo 99%: 
Clustering and generation of OTU map 
1044m35s 1029m30s 1m45s 
USEARCH closed 97%: 
Clustering and generation of OTU map 
12m1s 0m42s 0m35s 
USEARCH closed 99%: 
Clustering and generation of OTU map 
11m4s 6m51s 0m33s 
 
3.3.2 Zymo Microbial DNA Standard: Species identification and accuracy 
For the Zymo Microbial DNA Standard, the overall profiles obtained by each method 
were very similar (Figure 3.2). The representative sequences for the eight most 
abundant sequence clusters identified by each method were identical to the 
expected DNA sequence (as provided by Zymo). However, although this usually 
resulted in correct taxonomical assignments by RDP classifier, in some cases, 
Bacillus subtilis was identified as Bacillus mojavensis (see Figure 3.2). This has 
occurred because both species have the same DNA sequence in this region and 
illustrates the stochastic nature of this classification process. Since DADA2 uses 
exact matches for species identification, this has not occurred with this method. 
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Both DADA2 and Swarm generated small but sizeable additional sequence clusters: 
both produced a sequence cluster consisting of Salmonella sequences (1.4-1.6% in 
both methods), with the reference sequence differing from the expected sequence 
by two base substitutions. In addition, DADA2 generated a Bacillus sequence 
cluster (2.0-2.5%) with the reference sequence differing from the expected 
sequence by a single base substitution. Swarm is not expected to be able to 
separate sequences differing by a single nucleotide which explains why Swarm did  
 
Figure 3.2 Profiles obtained from the Zymo Microbial DNA Standard using six different clustering 
algorithms. PCR and sequencing run ID is given at the top. OTUs/sequence clusters are coloured 
according to their taxonomic assignment (see key), with the confidence in the assignment given in 
brackets. Discarded reads are shown as a proportion of total reads present in the OTU table. The 
expected profile (which takes account of 16S copy number) is shown at the right side of each chart. 
Continued on next page. 
72 
 
 
Figure 3.2 (continued) 
not generate this cluster. It is difficult to determine whether these clusters reflect a 
mutation that has occurred in culture, or whether this represents a common 
sequencing or PCR error. When comparing replicates within a clustering method, 
the similarity as measured by Bray Curtis score was high for all methods, ranging 
from 93.4-99.5%, with all methods performing similarly well. Furthermore, similarity 
scores between the obtained and expected profiles (as determined by shotgun 
sequencing) were high, ranging from 88.5-93.3%, with the highest similarity scores 
achieved by DADA2 (90.5-93.3%). It should be noted that this similarity does not 
take into account the additional smaller sequence clusters generated by Swarm and 
DADA2, which would increase the similarity slightly for these methods. The 
differences between methods were significant in a mixed effects linear regression 
model which controlled for differences due to PCR and sequencing (P <0.0001). 
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However, the size of the estimated difference due to clustering method was small, 
ranging from 0.4-1.6% (95% confidence interval 0.2-1.8%) when compared to 
DADA2. It should be noted that, since accuracy determined in this way is also 
influenced by PCR and sequencing error and is therefore sample dependent, 
DADA2 may not always produce the most accurate result. The addition of 
sequencing run/lane as a fixed effect did not improve the model fit. However, the 
effect of run/lane on beta diversity as measured by Bray Curtis was significant by 
PERMANOVA (DADA2: R2 = 0.65, P = 0.001; Swarm: R2 = 0.26, P = 0.001; 
USEARCH de novo 97%: R2 = 0.29, P = 0.001; USEARCH de novo 99%: R2 = 
0.45, P = 0.001; USEARCH closed 97%: R2 = 0.47, P = 0.001; USEARCH de novo 
97%: R2 = 0.35, P = 0.001). Pairwise comparisons found that these differences 
occurred between the two HiSeq runs as well as between the two lanes on the 
same run (Figure 3.3). The differences were small, with the mean within-lane Bray 
Curtis similarity being only slightly higher than the mean between-lane Bray Curtis 
similarity (difference of mean within-lane and between-lane diversity: DADA2: 1.3%; 
Swarm: 0.3%; USEARCH de novo 97%: 0.4%; USEARCH de novo 99%: 0.8%; 
USEARCH closed 97%: 0.7%; USEARCH de novo 97%: 0.5%). 
A previous study has also reported bias in sequencing data causing variation 
between runs which was correlated to genomic G+C content (He et al 2010). The 
authors hypothesised that the differences between runs were caused by differences 
in run quality with the lower quality run systematically underrepresenting G+C rich 
taxa. Interestingly, we have also found that run quality can result in bias between 
runs (see Appendix D), but were unable to correlate this to G+C content. We also 
found no correlation between genome G+C content and bias in the Zymo Microbial 
DNA standard replicates (data not shown). Bias between lanes on the same flowcell 
has also been reported by others (Aird et al 2011). 
3.3.3 Single species samples: Species identification and differentiation  
For the single-species vaginal bacterial samples, USEARCH failed to distinguish 
between L. crispatus and L. amylovorus in all cases (Figure 3.4). Additionally, with 
de novo clustering at 97% similarity threshold, the L. jensenii control was split into 
two large OTUs, one of which also contained the majority of the L. crispatus and L. 
amylovorus sequences (Figure 3.4). L. crispatus and L. amylovorus have over 
99.5% sequence similarity in the V3-V4 region and the inability of USEARCH to 
separate them at 97% or 99% similarity threshold is therefore to be expected. The 
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Figure 3.3 Principal coordinates analysis plot of Bray Curtis similarity scores for the Zymo Microbial 
DNA Standard replicates coloured by HiSeq lane. Lanes X and Y were on the same HiSeq run, while 
lane Z is on a separate run. Figures in brackets indicate the percentage variation explained by PC1 
and PC2. 
similarity between L. crispatus and L. jensenii is lower, around 97% (see Appendix 
E), with the exact value depending on the sequence variant. The separation of the 
L. jensenii control into two large OTUs has probably occurred because many 
sequences in that sample were just within the 97% similarity cut-off when compared 
to the chosen centroid sequence whereas other sequences were just outside this 
cut-off. It is likely that the selected centroid originated from L. crispatus (or the 
closely related L. amylovorus), as this would fit with the L. jensenii control being split 
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into two OTUs, rather than the L. crispatus control. USEARCH is input order 
dependent in that it chooses the first sequence it comes across as centroid (He et al 
2015, Mahé et al 2014), if the centroid sequence had come from the L. jensenii 
sample, the controls would likely have looked very different. This "OTU instability" is 
a major disadvantage, because it makes it potentially difficult to compare between 
different analyses, even if the exact same bioinformatics pipeline was used (He et al 
2015). Similarly, when clustering de novo at a 99% similarity threshold, USEARCH 
produced two large OTUs in both the L. amylovorus and G. vaginalis controls, most 
likely for similar reasons (note that in the case of G. vaginalis, there were other 
strains present in the clinical samples which could have affected the clustering of 
the Gardnerella controls, see later). In contrast, OTU picking against a reference 
database did not result in significant OTU splitting, even though this is theoretically 
possible. 
In contrast to clustering with USEARCH, all species were distinguished by DADA2 
and Swarm. However, there was some splitting of samples into several sequence 
clusters in the case of DADA2. The Prevotella bivia sample consisted of three such 
clusters, with the representative sequences differing from one another by no more 
than 2 base substitutions. The single sequenced genome of Prevotella bivia 
currently held in the NCBI database (accession NZ_AJVZ00000000.1) is reported to 
have 4 copies of the 16S rRNA gene. Since the sequence clusters are roughly in 
the ratio of 2:1:1, the DADA2 profile could reflect true biological variation of 16S 
rRNA gene copies within the genome. Swarm would be expected to merge these 
clusters due to their high degree of similarity (d=1). DADA2 also produced a large 
number of smaller sequence clusters in the L. iners and L. jensenii controls. These 
were not present in Swarm clustered profiles, even before filtering of small OTUs. 
The majority of these were identified as Lactobacillus (with only some very small 
clusters totalling ≤0.08% of the sample identified as other genera). The majority of 
these were the same length as the main sequence cluster in each control and 
differed to this by only a single base substitution. The locations of these 
substitutions occurred throughout the length of the read. Although this could 
represent biological variation between individual cultured bacteria, it is more likely 
that this is due to insufficient correction of sequencing (or PCR) error, since many of 
the sequencing clusters present in one replicate and representing up to 2.3% of that 
sample are completely absent from the other replicate. The presence of these small 
clusters will erroneously inflate measures of alpha diversity. 
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The representative sequences for the main sequence clusters identified by DADA2 
and Swarm are identical, with the exception of the L. iners controls for which the 
sequence differs by a single nucleotide. The whole genomes of the bacterial strains 
used in this study have not been sequenced and it is therefore not possible to 
determine with certainty which is the “correct” sequence. However, DADA2 
identified two sequence clusters matching L. iners in sample S14 (see later), one of 
which is the same as that in the single-species control and the other one matches 
that identified by Swarm. Since Swarm is expected to merge reads with only one 
base difference, it is likely that the reference sequence for Swarm derives from the 
numerically more abundant reads in S14, explaining the single base difference to 
the reference sequence identified by DADA2. The remaining representative 
sequences are identical to 16S rRNA sequences in the NCBI database for their 
respective species. In the case of the four USEARCH datasets, all representative 
sequences are identical to one another, except where the Lactobacillus reads have 
been subsumed into the same OTU, in which case the representative sequence is 
the same as for the L. crispatus reference obtained by DADA2 and Swarm. This 
makes sense considering that the majority of sequences within this OTU are from 
the L. crispatus controls (since there is only one L. amylovorus control). With the 
exception of these lactobacilli and Gardnerella, the representative sequences 
obtained by USEARCH are the same as those obtained by Swarm. The 
representative sequences for the Gardnerella controls differ from each other by one 
insertion/deletion and three base substitutions, but both are identical to sequences 
held in the NCBI database for this species. However, neither DADA2 nor Swarm 
identified multiple sequence clusters in the Gardnerella controls, as would be 
expected if both sequences really were present in these controls. The reason for 
this discrepancy appears to be the high abundance of Gardnerella in the S14 
controls (see later). This Gardnerella strain and that found in the positive control 
have been placed in separate sequence clusters by both DADA2 and Swarm. In 
contrast, USEARCH has merged these reads into one OTU, and the more abundant 
reads from S14 have therefore been assigned as the representative sequence for 
this OTU. In other words, the representative sequence determined by USEARCH is 
probably not actually present in the single-species Gardnerella controls. 
In terms of taxonomic assignments, DADA2 generated the most species-level 
assignments as oppose to genus-level (Figure 3.4). DADA2 identifies species by 
exact unique matches to a database, which is based on the assumption that the  
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Figure 3.4 Barchart showing profiles of monoculture samples obtained using the six different 
clustering methods. OTUs/sequence clusters are coloured according to their taxonomical 
assignment (see key), with dark shades representing species level assignments and lighter shades 
representing genus level assignments. Several shades were used for Lactobacillus OTUs, to allow 
distinguishing of major Lactobacillus OTUs/groups between samples. Both DADA2 and Swarm were 
able to distinguish between all seven species. 
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algorithm is able to compute the real DNA sequence by utilising error information. In 
this way, species that share more than 99% of their DNA sequence can still be 
accurately differentiated (Callahan et al 2016). As such it is not surprising that this 
method performed best. Taxonomy was assigned to the other datasets using the 
Silva database clustered at 97% or 99%. Unsurprisingly, the latter produced more 
species identifications, but failed to classify L. jensenii to species level in the Swarm 
dataset, even though the representative sequences were identical, which again 
highlights the stochastic nature of this process (see Figure 3.4). When the 99% 
clustered database was used to assign taxonomy for the USEARCH datasets 
clustered with a 97% similarity threshold, there were a similar level of species-level 
assignments to the USEARCH clustered datasets using a 99% cut-off. However,this 
will be inaccurate when there are closely related species present in the dataset 
because the minor species in the OTU will receive the taxonomical assignment 
determined based on the majority species and is therefore not advisable. 
When comparing replicates of the VMB mock community (pooled pre-PCR) within a 
clustering method, the Bray Curtis similarity was high for all methods, ranging from 
between 95.4-99.9%. However, although the mock community had been put 
together to result in approximately equal genome numbers, the proportions of each 
species were skewed. A degree of dissimilarity is to be expected because there are 
a variable number of 16S rRNA gene copies per genome in different species 
(Kembel et al 2012). Although 16S rRNA copy number information is not available 
for the strains used here, there is information on copy number for these species 
available in the NCBI database (one copy in L. iners and A. vaginae, two in G. 
vaginalis and four in L. jensenii, L. crispatus and P. bivia). However, this alone 
would not cause differences of the observed magnitude (Figure 3.5). Since DNA 
was pooled after extraction – assuming genome size estimation was relatively 
accurate – this bias must have been introduced either during the PCR, by the 
sequencing or by the bioinformatics pipeline. Bias of this type during the sequencing 
process is reportedly low (Brooks et al 2015) and is unlikely to have caused the 
differences seen here since the observed pattern does not reflect the total read 
count for each of the single-species samples, as might be expected if such bias 
existed. Bias resulting from the bioinformatics pipeline may occur due to differential 
read quality from sequences originating from different bacterial species leading to 
preferential discarding of reads from a particular species (see Appendix D). 
However, the proportion of discarded reads in these samples was relatively low with  
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Figure 3.5 Barchart showing microbiome profiles of a single replicate of the VMB mock community 
(pooled prior to PCR) produced by the different clustering algorithms. The expected profile is based 
on an estimate of 16S rRNA copy number. 
all methods (median 11.5% across all methods), and could therefore not result in 
differences of this magnitude. Therefore, the most likely source of bias is the PCR 
reaction, which has resulted in overrepresentation of L. crispatus and P. bivia and 
underrepresentation of L. iners, L. jensenii, A. vaginae and G. vaginalis. This was 
supported by the results of the VMB mock community in which pooling the same six 
vaginal species was done after PCR, producing profiles that were much closer to 
those expected, although some differences remained, possibly due to pooling 
inaccuracies (see Figure 3.6). Previous studies have found that the PCR step 
(including primer choice) is one of the most significant sources of bias in 16S rRNA 
amplicon studies (Brooks et al 2015, Hong et al 2009, Schirmer et al 2015, 
Tremblay et al 2015). It has been suggested that this may be the result of primer 
mismatches or degeneracies (Tremblay et al 2015), but in this case the sequence in 
the primer regions was predicted to be the same for all six species (as determined 
from NCBI database matches to representative sequence). A further hypothetical 
explanation for PCR bias is that templates with low G+C are preferentially amplified 
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because they dissociate more efficiency into single-stranded DNA (Suzuki and 
Giovannoni 1996). This may explain the low proportions of G. vaginalis and A. 
vaginae seen as these have a high G+C content (56.8 and 58.5%, respectively) in 
the amplified region. However, it does not explain the difference in the case of L. 
iners and L. jensenii which have a very similar G+C content (50.3 and 51.5%, 
respectively) to L. crispatus and P. bivia (51.0 and 50.2%, respectively). Amplicon 
length does not explain the observed patterns either since this was the same for all 
Lactobacillus species (429 bases), followed by Prevotella (424 bases), Gardnerella 
(412 bases) and Atopobium (410 bases). 
 
Figure 3.6 Barchart showing microbiome profiles for the VMB mock community pooled post-PCR. 
Two experimental replicates are shown, each from a different pool and clustered by each of the 
different clustering algorithms. The three replicates produced from each of the four pools produced 
similar profiles regardless of clustering algorithm, but there was a significant effect of pool on the 
profiles obtained (PERMANOVA; P = 0.001 for all clustering methods). The most likely cause for this 
difference is inaccuracies during sample pooling, which is explained by the low amplicon yields 
obtained from these controls. A single replicate is shown for each of two of the pools that 
consistently showed the highest degree of Bray Curtis dissimilarity. 
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3.3.4 Vaginal samples: Consistency across PCRs and sequencing runs 
The main taxa observed in the two vaginal samples were consistent across different 
methods. S14 consisted mainly of L. iners and G. vaginalis reads (Figure 3.7) and 
the reference sequence for the largest cluster for each bacterium (making up 67-
83% and 15-23%, respectively) was identical across all methods. With the exception 
of closed clustering with USEARCH, sample profiles also contained smaller OTUs 
identified as L. iners and G. vaginalis. Furthermore, all methods identified 
sequences from Lactobacillus (vaginalis and coleohominis types) and 
Streptococcus (pneumoniae type), which made up no more than 0.74% of any 
replicate. However, the representative sequences for these smaller OTUs were not 
necessarily exactly the same. In addition, all methods except DADA2 consistently 
identified Ureaplasma and Dialister/Veillonellaceae, making up no more than 0.07 
and 0.02%, respectively. These taxa were also present in some replicates classified 
by DADA2 at similar levels, but were completely absent from others. 
S11 was a high diversity sample in which all methods detected sequence clusters 
from Peptostreptococcus (anaerobius; 19-28%), Sneathia (amnii; 20-26%), 
Prevotella (timonensis; 6-16%), Mycoplasma (hominis; 5-6%), Prevotella (bivia; 5-
22%), Streptococcus (1.6-2.5%), Aerococcus (christensenii; 0.7-1.2%), Bacteroides 
(fragilis; 0.3-0.6%), Dialister/Veillonellaceae (0.2-0.7%) and Peptoniphilus (0.2-
0.3%), with the same reference sequence across all methods (Figure 3.7). Note that 
the species names were mostly assigned only by DADA2. The high degree of 
variation in relative abundance of Prevotella (timonensis) and Prevotella (bivia) is 
due to their lower relative abundance in the DADA2 classified reads. However, 
DADA2 detected two and one additional sequence clusters for these species 
respectively, which together make up a similar relative abundance to other methods. 
In addition to these taxa, all methods detected a sequence cluster for Gardnerella 
(vaginalis; 0.8-1.5%), but with slightly different reference sequences (similarity 
>99%). As determined by oligotyping, Gardnerella is reported to be a highly diverse 
genus and this may have biological implications (Eren et al 2011). In this case, the 
reference determined by DADA2 is probably the correct one. This is because 
DADA2 is the only method that consistently identified a different Gardnerella cluster 
(across all replicates) in the S11 control when compared to both the S14 control and 
the Gardnerella single-species control. The reference sequences for USEARCH 
likely derive from S14 (see above) and that from Swarm derives from the 
Gardnerella single-species control, which (according to DADA2) differs by only one  
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Figure 3.7 Profiles obtained from vaginal samples S11 and S14 using the six different clustering 
algorithms. Sequencing run ID is given at the top. OTUs/sequence clusters are coloured according to 
their taxonomic assignment (see key), with dark shades representing species level assignments and 
lighter shades representing genus level assignments. Discarded reads are shown as a proportion of 
total reads present in the OTU table. Continued on next page. 
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Figure 3.7 (continued) 
base substitution to that in S11. An inability to separate sequences differing by only 
one base is one of the limitations of Swarm. Taxa detected only by the de novo 
methods were Senegalimassilia (1.1-1.3%), Aggregatibacter (aphrophilus; 0.34-
0.53%), Howardella (0.09-0.16%) and Paracoccus (0.03-0.07%), as these taxa are 
not contained in the vaginal database. However, they have been isolated from other 
human body sites (Cundell 2016, Lagier et al 2013, Rylev et al 2011, Yang et al 
2015) and could therefore represent genuine members of the microbiota. 
Paracoccus has also been reported as a reagent contaminant (Salter et al 2014), 
but was not present in the negative extraction controls in this study. The reference 
sequences for these bacteria were identical for all methods. A further four sequence 
84 
 
clusters were detected by all methods except closed USEARCH at 99%: 
Streptococcus (2.8-3.5%), two Prevotella clusters (5-11% and 0.16-0.37%), and 
Fusobacterium (0.002-0.09%) presumably because the sequence similarity 
threshold of 99% was too stringent to capture all (or most) of the reads when 
clustered against the vaginal database. The reference sequences were identical for 
all of these taxa, except Fusobacterium for which Swarm, DADA2 and USEARCH 
(de novo at 99%) identified the same sequence and the remaining USEARCH 
methods (de novo and closed at 97%) identified another. Although these shared 
only 97% sequence similarity with one another, both sequences have identical 
matches in the NCBI database. In addition to these taxa, Swarm consistently 
identified Anaerococcus (0.004-0.017%), Olsenella (0.003-0.015%), L. iners (0.001-
0.012%), Bulleidia (0.001-0.008%) and Finegoldia (0.001-0.008%) in the S11 
control. These same taxa were also identified by DADA2 (with the same reference 
sequences except for Bulleidia which differed by one base substitution), but 
inconsistently so. Some of these were also detected consistently by USEARCH: 
Anaerococcus, L. iners, Bulleidia (only with similarity threshold of 97%) and 
Finegoldia (only with closed). Since these were low abundance taxa, they may have 
been absent from some of the USEARCH clustered datasets due to the size cut-off 
used for filtering small OTUs. All methods, but in particular Swarm and USEARCH 
de novo contained additional small sequence clusters that were identified as the 
same taxa as larger clusters already mentioned. These may represent sequence 
variants due to error or less likely, biological variation. In the case of Swarm and 
USEARCH de novo (97% similarity), the relative abundance of these clusters was 
no greater than <0.2%, but was higher for Usearch de novo (99% similarity), which 
makes sense since the variation in a given sequence cluster is more limited and 
increased numbers of reads that would otherwise have been assigned to a larger 
OTU are assigned to a different OTU as they lie beyond the 99% cut-off. In order to 
reduce the number of OTUs that represent sequencing error, a size cut-off was 
employed to filter small OTUs from the dataset. This is based on the assumption 
that small OTUs are more likely to represent read error than real biological variation 
and is thought to greatly improve estimates of diversity (Bokulich et al 2013). Even 
though this strategy risks filtering out rare taxa which can have significant ecological 
importance (Lynch and Neufeld 2015), it is interesting to note that the consistency of 
detection of small OTUs was superior to that of DADA2 which employs a different 
strategy in which filtering of small sequence clusters is not applied. 
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In general the consistency across methods for each of the two vaginal samples was 
high with similar results obtained for all methods. Bray Curtis similarity ranged from 
93.0-99.7% for S11 and 94.3-99.9% for S14 (the slightly higher similarity between 
replicates of S14 is expected since this sample was lower diversity). However, in 
some cases there is a small but discernible difference between replicates from 
different HiSeq runs. This is most noticeable with the results for S14 clustered by 
DADA2 and USEARCH closed at 99% similarity, where the replicates from run Z 
have a slightly higher proportion of the L. iners sequence cluster and a lower 
proportion of the G. vaginalis sequence cluster, compared with the lanes from the 
other sequencing run (Figure 3.7). This difference was significant by PERMANOVA 
(DADA2: R2 = 0.76, P = 0.001; USEARCH: R2 = 0.60, P = 0.001). Pairwise 
comparisons showed that this difference was due to variation between the two 
HiSeq runs rather than between the two lanes from the same run. The difference 
between mean within-lane and between-lane diversity was 1.5% for DADA2 and 
0.7% for USEARCH. With the other methods, no difference could be discerned for 
this sample (Figure 3.8) and the mean within-lane beta diversity was no greater than 
the between-lane diversity. In the case of DADA2, the relative abundance shift was 
more marked in an earlier analysis that had used more stringent quality cut-offs. 
These differences may be related to differential loss of sequencing reads that did 
not pass the quality cut-off. Run Z had an earlier quality drop-off in read 2 compared 
to the two lanes from the other run, which resulted in comparatively higher read loss 
due to quality filtering (Figure 3.7). Since read loss can be biased towards certain 
species (see Appendix D), this could have caused the differences between runs. 
The reason for the difference seen with USEARCH is unknown, since the quality 
filtering used was the same as for the Swarm and other USEARCH pipelines. 
Additionally, the percentage of raw reads retained in the final OTU table was 
comparable to USEARCH de novo clustering at 99% cut-off. Sample S11 is of 
higher diversity, making it more difficult to visualise differences between runs. 
However, there are differences between runs observed on PCoA plots for all 
methods (Figure 3.9), which are statistically significant by PERMANOVA (DADA2: 
R2 = 0.33, P = 0.002; Swarm: R2 = 0.32, P = 0.008; USEARCH de novo 97%: R2 = 
0.37, P = 0.003; USEARCH de novo 99%: R2 = 0.43, P = 0.001; USEARCH closed 
97%: R2 = 0.58, P = 0.001; USEARCH de novo 97%: R2 = 0.39, P = 0.002). 
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Figure 3.8 Principal coordinates analysis plot of Bray Curtis similarity scores for replicates of sample 
S14 coloured by HiSeq lane. Lanes X and Y were on the same HiSeq run, while lane Z is on a separate 
run. Figures in brackets indicate the percentage variation explained by PC1 and PC2. 
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Figure 3.9 Principal coordinates analysis plot of Bray Curtis similarity scores for replicates of sample 
S11 coloured by HiSeq lane. Lanes X and Y were on the same HiSeq run, while lane Z is on a separate 
run. Figures in brackets indicate the percentage variation explained by PC1 and PC2. 
Pairwise comparisons showed that this difference was due to variation between the 
two HiSeq runs rather than between the two lanes from the same run. These 
differences were again relatively small (difference of mean within-lane and between-
lane diversity: DADA2: 0.4%; Swarm: 0.3%; USEARCH de novo 97%: 0.6%; 
USEARCH de novo 99%: 0.8%; USEARCH closed 97%: 0.8%; USEARCH de novo 
97%: 0.4%). 
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Figure 3.10 Alpha diversity analysis of control samples using different clustering algorithms 
3.3.5 Effect on alpha diversity 
The Simpson index (1-D) was used as a measure of alpha diversity as this is 
relatively robust to changes in the numbers of small OTUs and therefore provides a 
fair comparison that is not affected by small scale errors such as barcode switching 
and variable cut-offs for discarding of small OTUs (Figure 3.10). DADA2 tended to 
produce the highest diversity estimates and, where the expected diversity was 
known, usually overestimated diversity. The exception to this was the VMB mock 
community that had been pooled prior to PCR, for which all methods 
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underestimated alpha diversity due to the skewing of the relative abundance of 
species caused by PCR bias (see section 3.3.3). While the diversity index for the 
DADA2 profiles is closest to that expected, this can be at least partially explained by 
the splitting of P. bivia into three separate clusters (see section 3.3.3) which would 
have compensated somewhat for the PCR bias. This splitting also increased the 
diversity estimates of the single species samples clustered with DADA2, where not 
only the P. bivia samples (0.63 in both cases), but also the L. iners (0.36 and 0.40) 
and L. jensenii samples (0.20 and 0.28) had much higher diversity indices. In the 
case of P. bivia this increased diversity is perhaps not biologically correct since 
there is only a single species present in the sample. However it makes 
computational sense. On the other hand, the increased diversity estimates of the L. 
iners and L. jensenii samples have occurred due to the presence of high numbers of 
presumably erroneous OTUs. 
Using reference-based (closed) OTU-picking with USEARCH, the diversity of the 
vaginal samples was lower compared with the other clustering methods, particularly 
using a cut-off of 99%. While it is possible that this is due to fewer erroneous OTUs 
being identified, it is more probable that some OTUs are missed due to their 
absence in the database. 
3.4 Discussion 
As the use of 16S rRNA amplicon studies has become more widespread, there has 
been increased interest in experimental error resulting from this technique. One 
area that has received particular interest is the use of negative extraction controls to 
identify reagent contaminants, allowing subsequent identification and removal of 
these sequences from microbiome profiles (Salter et al 2014) and this is rapidly 
becoming the norm. However, more recently the use of positive controls (e.g. mock 
communities of known composition) is also being advocated in order to be able to 
better understand bias resulting from library preparation, sequencing and 
bioinformatics (Brooks et al 2015, D’Amore et al 2016). These samples can also aid 
in the optimal choice of methods which may differ depending on the community 
being studied and the aims of the research. While it is accepted that a degree of 
bias in 16S rRNA amplicon studies cannot be avoided, an understanding of the 
biases that are likely to be present in the data is key to accurate interpretation of 
results. As is evident from the results seen here, different types of controls can be 
used to answer different questions and the choice of positive controls should 
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therefore be carefully thought through when designing any 16S rRNA amplicon 
study. For example, in this study, only the closely related single-species controls 
were able to detect the shortcomings of USEARCH in classifying closely related 
taxa. 
The ability to distinguish between closely related species is important when 
characterising the VMB since different species within the Lactobacillus genus are 
known to differ in their associations with health outcomes (Verstraelen et al 2009). 
In this context, the performance of USEARCH was poor, because it failed to 
separate closely related species. Additionally, USEARCH de novo merged reads 
originating from different species incompletely, resulting in multiple OTUs in some of 
the single-species controls, which would confuse downstream analyses. This effect 
was evident with both similarity thresholds tested (i.e. 97% and 99%). He and others 
(He et al 2015) recently reported that de novo OTU clustering suffered from OTU 
instability, whilst closed OTU picking did not. The reason for this appears to be the 
input order dependence of de novo clustering with USEARCH which results in a 
different centroid sequence being chosen with each new input ordering. Whilst 
closed OTU picking is reported to be stable, this is only the case if the same 
reference database is used with each iteration, since the stability is affected by the 
order of sequences in the database (Westcott and Schloss 2015). Furthermore, one 
recent study found that increased OTU stability did not necessarily translate to 
increased OTU accuracy as defined by the actual distances between sequences 
meeting the specified cut-off (Westcott and Schloss 2015). However, the 
methodology of this comparison is perhaps questionable when considering that a 
97% similarity threshold could legitimately result in a pairwise sequence similarity as 
low as 94% between any two sequences within the same OTU cluster. 
In contrast to USEARCH, both Swarm and DADA2 were able to differentiate all 
seven species tested. However, DADA2 generated a large amount of small 
sequencing clusters in two of the positive controls, which increased alpha diversity 
measurements and are likely erroneous. Since the reference sequences for these 
clusters were all highly similar, USEARCH would most likely have put all of these 
reads into the same cluster and Swarm may also have done so if the differences 
between reads were small enough. Alternatively, these errors may have been 
removed by error correction with SPAdes which was not performed in the DADA2 
pipeline as this would have interfered with the error rate inference. The methodology 
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behind Swarm appears to deal effectively with sequencing error in all the controls 
analysed here. However, it does mean that Swarm is unable to differentiate 
between sequences that differ by one base, which was evident for example in the 
case of Gardnerella in sample S11 and the single-species Gardnerella control, 
which was only separated into distinct clusters by DADA2. Of the tested algorithms 
only DADA2 achieved maximum possible resolution. It should be noted that whilst 
this increased resolution allows the identification of subtle differences in the DNA 
sequence data, it does not necessarily correlate perfectly with phylogeny or 
phenotypic characteristics (Berry et al 2017). One could argue that this high degree 
of resolution, while computationally correct, may lead to biologically misleading 
results. For example, DADA2 detected three sequence clusters in the Prevotella 
control, which are likely present within the same genome and this led to an inflated 
estimate of alpha diversity. It would therefore be difficult to directly compare alpha 
diversity measures between datasets that have been created using different 
sequence clustering algorithms. However, this improved degree of resolution does 
allow for the best possible accuracy in taxonomical assignments, which is of great 
advantage when studying closely related species, such as the lactobacilli in the 
vaginal niche. A further advantage of this high resolution is that the obtained 
sequence clusters are likely to be more consistent and comparable between 
different studies (Callahan et al 2017). 
All methods used in this study were able to detect all species expected to be 
present in both the VMB and Zymo mock communities. However, both Swarm and 
DADA2 detected additional sequences in the Zymo standard. A recent study 
comparing three sequence clustering algorithms, including DADA2, on amplicon 
data from the V4-V5 region also found that DADA2 detected all expected bacterial 
sequences with 100% sequence similarity, and additionally found three further 
sequences that were within 97% sequence similarity to the expected sequences 
(Nearing et al 2018). However, contrary to our results, the expected ratios of 
bacterial species were somewhat skewed, which may be due to the use of a 
different region of the 16S rRNA gene. Interestingly, the authors also concluded that 
of the methods tested, DADA2 was better at detecting very rare organisms, while in 
our study DADA2 failed to detect rare species in some replicates. However, this 
difference may be explained that the two studies did not compare DADA2 to the 
same algorithms. 
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With the exception of clusters that were insufficiently separated, the representative 
sequence obtained by all methods was highly accurate. In the case of DADA2 – 
which relies on identical sequence matches to call species – this accuracy meant 
that many of the representative sequences could be assigned to the species level. 
This is in accordance with the findings of Kopylova and others (2016), who reported 
that both Swarm and USEARCH 6.1 achieved a high degree of taxonomic accuracy 
for simulated datasets, but also reported that Swarm outperformed USEARCH 6.1 
in this regard on mock communities. In our study, only unique matches were used 
for species assignments, but DADA2 also allows identification of multiple species 
with the same sequence, which can be very useful in the vaginal niche where some 
species share the same sequence over the V3-V4 region, but can still be separated 
into species groups (see Appendix E). The other methods were similarly accurate in 
determining the expected representative sequence and it should therefore be 
possible to use the DADA2 species identification algorithm on the representative set 
to classify reads to species level. However, this approach falls down with 
USEARCH when similar taxa are present because they may be merged into one 
OTU. This is likely to be much less of an issue with Swarm, as representative 
sequences are unlikely to differ by more than a single base from the true sequence. 
In addition to allowing testing of various clustering methods, the positive controls 
used in this study also allowed the identification of additional sources of bias. This 
includes an effect of the sequencing run/lane on the observed beta-diversity. The 
exact mechanism for this is unknown, but may relate to differences in error profiles. 
DADA2 appeared to be particularly affected by this, despite the fact that it did not 
have the highest amount of discarded reads compared to the other methods. This 
suggests, that it may relate to the way that DADA2 uses error data to classify reads. 
Comparatively speaking, the differences in beta diversity seen here were very small 
and are unlikely to be biologically meaningful. Nevertheless, this potential for bias 
should be borne in mind in the experimental design and interpretation of 16S rRNA 
amplicon studies. 
A more significant source of bias was identified by the vaginal mock community, 
which showed that the PCR reaction resulted in bias by an unknown mechanism. 
This is a common source of bias in 16S rRNA studies and cannot be avoided with 
currently available technologies. However, it is reassuring that – while taxa were not 
in the expected ratio – the community profiles did contain all six vaginal species as 
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expected. Additionally, while this bias affects measures of alpha diversity, beta 
diversity measures comparing samples processed in the same way appear to be 
fairly robust to this type of bias (D’Amore et al 2016, Tremblay et al 2015) and 
clustering of samples into community types is therefore unlikely to be affected. 
3.5 Conclusion 
In conclusion, both USEARCH de novo and closed are unable to accurately 
differentiate species if they share a high degree of sequence similarity. This is of 
particular concern in the vaginal niche where accurate differentiation of the 
lactobacilli is of particular interest. USEARCH de novo suffers from the additional 
problem of splitting sequences originating from the same bacterial strain into several 
OTUs if the chosen centroid belongs to a closely related but different bacterium. 
Although this was not observed with USEARCH closed, OTU splitting could 
theoretically occur in the same way. In addition, any bacteria not present in the 
database are missed with this approach, preventing researchers from taking 
advantage of the ability of sequencing to detect novel species. However, USEARCH 
closed is extremely fast and as such is highly suited to providing a quick initial look 
at the results of 16S rRNA sequencing studies. 
Table 3.2 Summary of key points regarding different sequence clustering methods. Points in bold 
represent conclusions from this study. 
DADA2 Swarm 
x Accurate species identification 
x May miss very rare sequence clusters 
x May erroneously inflate alpha diversity 
x Can differentiate single base differences 
x Easy to follow pipeline 
x User defined parameters may affect how 
sensitive pipeline is to differences in 
quality between runs 
x Deals effectively with read error 
x Can differentiate 2 or more base 
differences 
USEARCH de novo USEARCH closed 
x Merges separate species if sequence 
similarity is within similarity threshold 
x May split a single species if sequence 
similarity is without similarity threshold 
x May split single species into more than 
one OTU if closely related species present 
in dataset 
 
x Merges separate species if sequence 
similarity is within similarity threshold 
x May split a single species if sequence 
similarity is without similarity threshold 
x Unable to detect species not in 
database 
x Fast 
 
In contrast, both DADA2 and Swarm were highly efficient at differentiating closely 
related species. However, DADA2 may miss very rare sequence clusters and may 
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erroneously inflate alpha diversity of some samples. Neither of these problems was 
seen with Swarm. While Swarm is unable to distinguish single base differences, this 
property could be what prevents the alpha diversity inflation seen with DADA2. 
Considering these results, we will use the Swarm clustering pipeline in the analyses 
described in the following chapters. In addition, we will use the species identification 
algorithm implemented in DADA2 on the reference sequences obtained by Swarm 
in order to achieve more accurate taxonomical assignments. Table 3.2 summarises 
the key points relating to each clustering method tested. 
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CHAPTER 4: The VMB-HARP Study 
4.1 Introduction 
The human microbiome is increasingly being studied as a potential factor in the 
pathogenesis of infectious diseases and cancer. As previously described, the 
cervicovaginal microbiome has been implicated as a contributing factor in the 
acquisition of high-risk human papillomavirus (HR-HPV) infection and the 
progression to cervical cancer (see section 1.3.4). The increasing affordability of 
molecular techniques has allowed much more detailed investigation of the 
microbiome in these states, but the results of currently published studies are often 
inconclusive and sometimes contradictory. 
Between 2011 and 2013 the HPV in Africa Research Partnership (HARP), 
coordinated by the London School of Hygiene and Tropical Medicine, carried out an 
epidemiological study designed to improve the early detection rates and treatment 
for cervical cancer in Africa. During the HARP study, 1250 HIV-positive women 
were recruited at two clinical centres in Burkina Faso and South Africa to determine 
HR-HPV infection status and the presence of precancerous cervical lesions by 
histology. Women without high grade lesions were recalled a median of 16 months 
later for repeat examination. At both time points vaginal swabs were collected, 
providing a unique opportunity to study the vaginal microbiome (VMB) in this large 
cohort of women. The results of this sub-study (the VMB-HARP study) which utilised 
samples from the South Africa site are described in this chapter. 
The HARP study was deliberately limited to HIV-positive women due to their 
increased risk of persistent HR-HPV infection and the associated increased risk of 
developing cervical cancer (see section 1.4). Furthermore, HIV infection is 
particularly prevalent in sub-Saharan Africa (especially in South Africa), making an 
investigation into the health of HIV positive women particularly pertinent within this 
region. With relevance to the VMB-HARP sub-study, there is some evidence that 
HIV infection may modify the relationship between the VMB and HR-HPV infection 
(Dareng et al 2016) which means that taking account of HIV infection status is vital 
for the correct interpretation of any studies investigating this relationship. By 
including only HIV-positive women, the VMB-HARP study ensures that this factor is 
controlled for, whilst still having a good sample size to detect any associations 
between the VMB and HR-HPV infection in this group of women. 
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Previous studies investigating the association of the VMB with cervical cancer have 
either relied partially or wholly on Pap smear results (Audirac-Chalifour et al 2016, 
Mitra et al 2015, Oh et al 2015) or excluded women with normal cytology results 
(Piyathilake et al 2016). The VMB-HARP study benefits from the fact that all women 
in the parent study underwent four-quadrant cervical biopsies to determine cervical 
intraepithelial neoplasia (CIN) status, unless they were very unlikely to have any 
cervical lesions (see section 4.2.6 for further details). All samples classified as high 
grade (i.e. CIN2 and 3, referred to in this thesis as “CIN2+”) and a proportion of 
those classified as low grade (CIN1) also underwent a consensus review to 
maximise accuracy of the histology results. 
The overall aim of the VMB-HARP sub-study was to determine the association 
between the VMB and both HR-HPV infection and cervical cancer in HIV-positive 
South African women. This was achieved by characterising the VMB in women 
enrolled in the HARP study using 16S rRNA sequencing and the laboratory and 
bioinformatics methods developed in the preceding chapters. 
4.2 Methods: HPV in Africa Research Partnership (HARP) 
Samples for the study presented in this chapter were obtained by the HARP team, 
which I was not a part of. The aims and methodology of the HARP study have been 
published elsewhere (Kelly et al 2017), but are summarised here where relevant to 
the VMB-HARP study. The overall aim of the HARP study was to improve cervical 
cancer prevention programs for HIV–positive women in Africa by evaluating multiple 
screening methods for effectiveness and thereby allowing the development of cost-
effective strategies for earlier detection and treatment. The study enrolled HIV-
positive women (N=624 at the South Africa site), recruiting two separate cohorts of 
women either on antiretroviral therapy (ART) for HIV and those not yet receiving 
ART, in a ratio of approximately 2:1. Each participant was screened for human 
papillomavirus (HPV) and cervical lesions at baseline. Women without significant 
lesions, defined as CIN1 or lower, were re-examined a median of 16 months later to 
detect incident cervical lesions and persistence, incidence and clearance of HR-
HPV. The HARP study also recorded various socio-demographic variables and HIV-
related factors (e.g. ART status, plasma HIV viral load, CD4+ counts), and screened 
for concurrent genital and sexually transmitted infections (STIs). 
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Figure 4.1 Summary diagram of HARP study visits. Samples collected at visit 1 and 5 were 
used in the VMB-HARP sub-study. 
4.2.1 Study population 
The South Africa cohort of the HARP study was recruited at the University of 
Witwatersrand Reproductive Health and HIV Institute (WRHI) research clinic in 
Johannesburg. Due to cost and logistical reasons, the VMB-HARP study utilised 
98 
 
only samples collected at this site. Women were included in the study if the 
following criteria were met: 
x HIV-1 positive (this was determined by HIV serology or alternatively by the 
participant providing reliable proof of status) 
x 25-50 years of age (inclusive) 
x Resident in Johannesburg  with no intention of moving in the next 12 months 
x No history of cervical cancer or hysterectomy 
x Not pregnant at enrolment, not given birth in the last 8 weeks, and not 
planning to get pregnant in the next 6 months 
4.2.2 Participant management 
Women that were enrolled in the HARP study attended a number of visits (see 
Figure 4.1). The planned timings of these visits are given in Figure 4.1, but may not 
correspond exactly to the actual average length of time between visits. The 
enrolment visit (visit 1, month 0) involved administration of a questionnaire (to 
collect data on socio-demographics and the participants’ medical, gynaecological 
and sexual history), a clinical exam (including a speculum exam and visual 
inspection with acetic acid and lugol’s iodine, VIA/VILI, to identify cervical lesions), 
collection of cervico-vaginal specimens (to test for infections and to determine 
vaginal cytology) and a blood sample. Participants were counselled and treated for 
genital infections as per local guidelines if any abnormalities were found. A second 
visit (visit 2) was scheduled shortly after visit 1 (allowing time for any results from 
visit 1 to become available) at which colposcopy and cervical biopsies (if indicated, 
see section 4.2.6) were performed. The result of the biopsy was communicated 
confidentially to participants and treatment provided (if required) at a further visit 
(visit 2b). 
Participants were asked to return at month 6 (visit 3) and month 12 (visit 4) for 
routine monitoring of their HIV infection and administration of a short questionnaire. 
Additionally, a cervical (for HPV testing) and blood (for CD4 count) sample was 
taken at visit 4. 
At month 18, participants were recalled for re-examination (visit 5 and 6/6a). 
Procedures and participant management at these visits were similar to visit 1 and 
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2/2b. A pregnancy check was carried out at visit 5/6, since this would be a 
contraindication for cervical biopsy. The VMB-HARP sub-study utilised vaginal 
samples collected at visits 1 and 5.  
If women were not already on ART, it was initiated during the study once the 
measured CD4 count was 350 cells/mm3 or below, which was in accordance with 
the WHO guidelines that were in place during HARP study implementation (WHO 
2010). 
4.2.3 Testing for bacterial vaginosis and candidiasis 
Vaginal smears were taken at visit 1 (month 0) and evaluated for the presence of 
yeasts (referred to as candidiasis) and bacterial vaginosis (BV) by the Nugent’s 
score method where BV was defined as a score of 7-10. For the South African 
samples, this testing was carried out by the National Health Laboratory Service STI 
Reference Centre in Johannesburg, which subscribes to an international external 
quality assurance programme. 
4.2.4 Cervical cytology 
Cervical cytology was assessed by examination of cervical brush Pap smears taken 
at visit 1 (month 0) and visit 5 (month 18) and classified according to the Bethesda 
classification system (Solomon et al 2002). This assessment was performed locally 
by two different pathologists/cytologists and assessed by a third observer in case of 
discordance. Quality control was carried out at the University of Montpellier 1 (UM1) 
pathology department on 5-10% of slides. 
4.2.5 Blood sampling and STI testing 
Blood samples for measurement of HIV plasma viral load (PVL; COBAS Taqman, 
Roche Diagnostics, Johannesburg, South Africa; lower limit of detection of 40 
copies/ml), and for syphilis serology (combined Treponema pallidum 
haemagglutination and rapid plasma reagin using Immutrep carbon antigen RPR, 
Omega Diagnostics, Cape Town) and herpes simplex virus-2 serology (Kalon IgG2 
ELISA, Kalon Diagnostics, Guildford, UK) were taken at visit 1 (month 0) and tested 
locally. Additionally, CD4+ lymphocyte counts (FACScount, Becton-Dickinson, 
Franklin Lakes, New Jersey, USA) were obtained at visit 1 (month 0), visit 3 (month 
6), visit 4 (month 12), and visit 5 (month 18) as part of routine HIV monitoring. 
Cervical swabs to test for infection with Neisseria gonorrhoeae, Chlamydia 
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trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis by PCR (APTIMA 
Combo, Gen-Probe, San Diego, California, USA) were taken at visit 1 (month 0). 
4.2.6 Outcome measures: HPV and CIN status 
Pap smears were collected at visits 1 and 5 (month 0 and 18) to determine HPV 
status by genotyping, which was carried out at UM-1 using the InnoLipA HPV 
genotyping Extra Assay (Innogenetics, Courtaboeuf, France). This assay amplifies 
and detects HPV DNA and allows the identification of all high-risk and probable 
high-risk HPV types (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 
73, 82) as well as a number of low-risk types (6, 11, 40, 43, 44, 54, 70) and 
additional types (69, 71, 74). For HPV types that cannot be genotyped in this way, 
sequencing was carried out. UM-1 subscribes to an annual European external 
quality assurance scheme for HPV testing, and the results were 100% satisfactory. 
CIN status was determined according to the following. VIA/VILI was carried out by a 
trained nurse midwife at visits 1 and 5 (months 0 and 18). Colposcopy was carried 
out by a trained gynaecologist at visits 2 and 6 (scheduled once results from visit 1 
and 5 were available, respectively) and four-quadrant cervical biopsies (and 
directed biopsies in case of lesions) were taken if any one of the following results 
were obtained: positive HR-HPV test (by either genotyping or qualitative DNA test: 
Digene HC2 test at visit 1 and CareHPV test at visit 5), presence of cytological 
abnormalities (any grade above ASC-US), abnormal VIA/VILI results, or 
abnormalities detected on colposcopy. Histology was assessed by local pathology 
laboratories according to the CIN classification system (Richart classification). A 
consensus pathology review (endpoint committee, EPC) was completed to review 
the histology results for all samples classified locally as positive for cervical 
precancer (histological grade of CIN2+) and for 5-10% of negative samples at the 
end of the two phases of the research. This involved pathologists from the study 
sites, UM-1 and an external expert from the Institut Catala d’Oncologia, Barcelona. 
The results of the EPC will be used for the VMB-HARP sub-study. For convenience 
and in order to match the corresponding HPV results, the biopsy results from visit 2 
and 6 are referred to as visit 1 and 5 in the text that follows, respectively. Since CIN 
status at endline in women who were coinfected with HIV and HPV at baseline was 
the main outcome of interest in the HARP study, a relatively long sampling interval 
of 18 months was chosen to allow time for the development of dysplasia. 
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4.3 Methods: VMB-HARP Study 
4.3.1 Sample characteristics 
Samples used for the VMB-HARP study consisted of vaginal swabs stored in 2 ml 
BoonFix® (a fixative containing ethanol and polyethylene glycol) at room 
temperature until DNA extraction.  These were collected at visits 1 and 5 of the 
HARP study by swabbing the posterior fornices and lateral walls of the vagina using 
a Dacron swab during speculum examination. The swab was then immediately 
placed into BoonFix® medium. Ethical approval for the determination of the vaginal 
VMB from these samples had been obtained from the local ethics committees at 
Wits University in Johannesburg, South Africa and the London School of Hygiene 
and Tropical Medicine, UK; specific approval for VMB-HARP was obtained from the 
University of Liverpool, UK (Physical Interventions Sub-Committee) and by 
submission of an amendment to the VMB-HARP protocol from the ethics committee 
at Wits University. 
4.3.2 Sub-sampling for VMB-HARP 
The VMB-HARP study has two objectives: 1) to determine the association between 
the VMB type and incidence, persistence and clearance of HR-HPV in HIV-infected 
South African women and 2) to determine the association between the VMB type 
and the presence of CIN2+ lesions (prevalent or incident) among HIV-infected 
African women. In order to study these two aims, samples were split into two 
groups. Women with ≤CIN1 at both visits comprise part 1 of the study and data 
obtained in this part of the study will be used to answer objective 1. Women with 
CIN2+ at either visit comprise part 2 of the study and data obtained in this part of 
the study will be used to answer objective 2. Women who had persistent HR-HPV 
infection and were analysed in part 1 of the study will also be used as the control 
group for part 2 of the study. Hence, the case and control definitions are as follows: 
Part 1: 
 Persistent HR-HPV: At least one identical HR-HPV type present at visit 1 
and visit 5. 
 Incident HR-HPV: No HR-HPV present at visit 1 and at least one HR-HPV 
type present at visit 5. 
 Cleared HR-HPV: At least one HR-HPV type present at visit 1 and no HR-
HPV present at visit 5. 
 Type swap: At least one HR-HPV type present at visit 1 and visit 5, but none 
of the types are identical between visits. 
 Controls: Negative for HR-HPV at both time points. 
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Part 2: 
 Incident CIN2+: <CIN2 present at visit 1 and CIN2+ present at visit 5 (for 
prospective analysis). 
 Persistent CIN2+: CIN2+ at visit 1 and visit 5 (for cross-sectional analysis). 
 Cleared CIN2+: CIN2+ present at visit 1 and <CIN2 present at visit 5. 
 Prevalent CIN2+: CIN2+ at visit 1 or visit 5 with data missing for the other 
visit (for cross-sectional analysis). 
 Controls: Persistent HR-HPV at both time points with <CIN2 (same as 
persistent HR-HPV in part 1 above). 
All samples from South African women who had a valid HPV genotyping and CIN 
result (either a valid biopsy result, or biopsy was not indicated) for visits 1 and 5, 
and for whom BoonFix® samples were available for both visits, were analysed. 
Additionally, since we were particularly interested in the VMB of women with CIN2+, 
we also analysed samples from women who had CIN2+ at the corresponding visit, 
even if their data were missing and/or the sample from the other visit was missing 
(see Figure 4.2). 
4.3.3 DNA extraction 
DNA extraction was carried out according the methods developed in Chapter 2, as 
follows. Samples were thoroughly mixed by vortexing. Then the swab head and 100 
µl of liquid were subjected to 30 min of lysis at 37°C using enzymatic lysis buffer 
containing lysozyme from chicken egg white (the recommended pretreatment for 
Gram-positive bacteria as per the Qiagen DNeasy Blood and Tissue kit Handbook). 
Proteinase K and Buffer AL (Qiagen) were added and incubated at 56°C for 30 min, 
followed by the remaining steps in the kit's spin column protocol, in accordance with 
the manufacturer's instructions. DNA was eluted in 75 µl of elution buffer. The 
genomic DNA concentration was measured with the Qubit Fluorometer using the 
dsDNA HS Assay kit. A negative extraction control (containing 100 µl nuclease free 
water) was included in each extraction run. 
4.3.4 Amplicon library preparation and DNA sequencing 
The V3-V4 region of the 16S rRNA gene contained in 10 µl of DNA extract was 
amplified in a 25 µl reaction as described previously (see section 3.2.2). In order to 
optimise PCR product yield – according to the results of a pilot run – sample DNA 
extracts ≤ 25 ng/µl were not diluted, extracts > 25 ng/µl and ≤ 100 ng/µl were diluted 
1:4, and extracts > 100 ng/µl were diluted 1:8 prior to PCR. Each PCR run included 
positive controls (as described in Chapter 3) and a negative PCR control (containing 
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nuclease free water). PCR products were purified, eluted in a volume of 10 µl TE 
buffer (Sigma-Aldrich) and quantified using the Qubit Fluorometer with the dsDNA 
HS Assay kit to determine amplicon yield. Purified PCR amplicons measuring ≥ 2 
ng/µl were run on a 2% agarose gel at 100V to verify purity of the amplicon. While 
all amplicons were sequenced, those measuring ≤ 0.2 ng/µl additionally underwent 
repeated PCR and sequencing to reduce the risk of having to exclude samples due 
to insufficient read counts. Pooled amplicons were sequenced at the University of 
Liverpool Centre for Genomics Research on the Illumina HiSeq platform (2x300bp; 
Illumina) on two separate runs, one consisting of two lanes on the same flowcell 
(designated "X" and "Y") and one consisting of a single lane (designated "Z"). These 
are the same sequencing runs as described in Chapter 3. Negative extraction 
controls, negative PCR controls and the positive controls described in Chapter 3 
were also sequenced on these sequencing runs. 
4.3.5 Bioinformatics 
Sequencing data obtained was processed according to the Swarm pipeline detailed 
in section 3.2.3. Additionally, species assignments were made using DADA2’s 
assignSpecies function against the Silva v. 128 database, allowing multiple matches 
(option allowMultiple enabled). Bacterial vaginosis-associated bacteria (BVAB) 
BVAB1, BVAB2, Mageeibacillus indolicus (BVAB3) and BVAB TM7, and Fenollaria 
massiliensis are not contained in this database and were identified manually from 
representative DNA sequences. Operational taxonomic unit (OTU) representative 
sequences (i.e. most abundant in OTU) that made up at least 0.05% of the total 
read count and had no species assignment were additionally BLAST searched 
(Altschul et al 1990) to identify any identical matches in the NCBI database. If these 
were found, OTU descriptors were left unchanged unless they contradicted the 
BLAST result. In this case, the next concurring higher level descriptor was assigned. 
Note that this pipeline may result in multiple OTUs for a single species (due to 
different strains of the same species having differences in their DNA sequence in 
the V3-V4 region of the 16S rRNA gene) and may result in a single OTU that 
matches more than one species (if there are multiple sequences in the Silva v. 128 
database that have exactly the same DNA sequence in the V3-V4 region and 
therefore cannot be differentiated). 
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Figure 4.2 Sample selection for the VMB-HARP sub-study. The numbers given represent 
study participants, rather than individual samples (of which each patient may have up to 2). 
Of the 43 women that were excluded because of missing data for visit 5, 19 were lost to 
follow up, 8 moved away, 7 were withdrawn by the clinician (2 of which were referred for 
suspected cervical carcinoma without a biopsy result), 5 withdrew due to personal 
circumstances and/or being unwilling to undergo further testing and 4 died (one of which 
died from probable HIV-related causes, the other causes of death were unknown). The 
woman who was excluded from part 2 due to having a missing sample for visit 1 and no data 
for visit 5 had been withdrawn due to hysterectomy. Of the 16 women that had only the visit 
1 sample sequenced for part 2 due to missing data for visit 5, 2 were lost to follow up, 8 
moved away, 3 were withdrawn by the clinician (2 of which were withdrawn because of 
hysterectomy), 2 withdrew due to personal reasons and one died due to HIV-related causes. 
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4.3.6 OTU table generation 
The raw counts obtained from the above bioinformatics pipeline were processed as 
follows. Singletons were removed. In a minority of reads (<0.5%), there was 
incomplete removal of the barcode due to sequencing errors in this region. This 
resulted in these longer reads being assigned to a different OTU (rather than the 
OTU that they would have been assigned to without the incompletely removed 
barcode). Where the reference sequences to these OTUs were an exact match (i.e. 
when aligned, the sequences were identical in the region of overlap), they were 
merged in R version 3.2.2 (R Core Team 2015) using an algorithm written for this 
purpose. Following this, any OTUs with a read count under 100 reads were 
removed. OTUs were removed as likely contaminants if they were present in more 
than one negative extraction control or more than one negative PCR control, had a 
higher percentage in at least one negative control compared to all other samples 
and if they had an absolute read count that was not significantly higher by t test in 
samples compared with negative controls (to avoid removing OTUs that are present 
in negative controls due to barcode switching). Any OTUs identified as human or 
chloroplast DNA were removed. For any samples that had been sequenced twice, 
the profile with the lowest read count was removed. Based on rarefaction curves 
and the read counts of repeat samples where concurrence was poor (see Appendix 
F), a minimum read count of 1000 reads was decided upon. Samples were 
therefore rarefied to 1039 reads (i.e. the smallest read count ≥1000 reads) using the 
GUniFrac package version 1.0 in R version 3.4.1. Rarefied counts were used for all 
downstream analyses unless otherwise stated. 
4.3.7 Data analysis 
Calculation of alpha and beta diversity measures, clustering of VMB profiles, 
generation of graphs, nonmetric multidimensional scaling and statistical analyses 
were performed in R version 3.4.1 (R Core Team 2015) and using the vegan 
package version 2.4-2 (Oksanen et al 2015). Multinomial regression modelling 
additionally made use of the nnet package version 7.3.12 (Venables and Ripley 
2013). NMDS results were plotted using the plotly package 4.7.1 (Sievert et al 
2017). VMB profiles were clustered using complete linkage hierarchical clustering 
on the Euclidean distance metric on rarefied read counts, using a cut-off that 
visually resulted in a high degree of similarity of samples within a cluster (cut-off = 
650). These fine-scale clusters were then manually grouped into VMB types, based 
on pre-existing knowledge of the prevalence of and clinical/biological properties of 
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these compositions. See section 4.4.4 for further details. All VMB profiles from both 
visits were used for clustering and overall VMB profile descriptions (not including 
repeat sample profiles that were discarded and those with read counts <1000, see 
section 4.4.2). 
In order to determine if there was an association between different outcome 
categories and individual OTUs, we used the Linear Discriminant Analysis effect 
size (LEfSe) algorithm (Segata et al 2011). The significance level for the Kruskal-
Wallis test was 0.05 and the threshold on the logarithmic Linear Discriminant 
Analysis score was 1.5. 
Differences in characteristics between study groups were compared for categorical 
variables using Pearson's chi-squared with Yates’ continuity correction or Fisher’s 
exact test (where there were expected values below 5). For large contingency 
tables with more than two rows and columns the P value was estimated with the 
Monte Carlo method (50,000 simulations). Continuous variables were compared 
using the Kruskal Wallis test. Any significant results comparing the 5 HR-HPV or 5 
CIN categories were followed up with appropriate post-hoc pairwise tests with Holm-
Bonferroni correction (chi-squared or Fisher’s exact test using R package fifer v 1.1 
for categorical variables and Mann–Whitney U test for continuous variables). 
Differences in Lactobacillus relative abundance and alpha diversity were determined 
using the Mann–Whitney U test with Holm-Bonferroni correction. In addition, beta 
(between-sample) diversity using Bray Curtis similarity (ranges from 0 to 100%) was 
calculated between the two samples taken from each woman at visits 1 and 5 and 
the Kruskal Wallis test was used to assess changes over time.  
Epidemiological analyses used two different outcomes: the 5 HR-HPV categories 
(part 1) and the 5 CIN categories (part 2) described in section 4.3.2. The VMB 
composition was always the main predictor (forced into all models), and the 
following VMB composition measures were used in different models: VMB types by 
hierarchical clustering (N=7 VMB community types), Lactobacillus genus relative 
abundance (a proportion between 0-100%), and alpha (within-sample) diversity 
using the Simpson index (1-D; ranges from 0 to 1). Univariable multinomial logistic 
regression models were used to determine the unadjusted association between the 
VMB variables and the outcome groups. Multivariable multinomial logistic 
regression models were used to adjust for confounding. Potential confounders were 
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selected a priori, based on their potential association with both the VMB and HR-
HPV infection and/or CIN. These were included in the model by forward selection if 
they were found to be associated with the outcome in univariable regression at a 
significance level of <0.1, and if the model did not already include a predictor with 
which they were highly correlated. 
4.4 Results 
4.4.1 VMB-HARP study population characteristics 
Women selected for the VMB-HARP study who had a valid sequencing result 
described their ethnic group as either black (n=449) or coloured (n=1). The median 
age of these women was 34 years at enrolment, ranging from 25-50 and the median 
time between visit 1 and visit 5 was 485 days (15.9 months). Some statistically 
significant differences were identified between women selected for VMB-HARP and 
those that were excluded (Table 4.1). A significantly higher proportion of women 
selected for VMB-HARP was on HIV ART at study commencement (P <0.001) and 
they had a significantly lower median plasma viral load (P = 0.043). 
A number of significant differences were also found between the VMB-HARP study 
groups described in section 4.3.2 (Table 4.1). By design, differences in HR-HPV 
and any HPV infection were highly significant among the 5 HR-HPV groups in part 1 
of the study (P <0.001), with post hoc pairwise tests finding differences occurring as 
expected between groups. There was also a significant difference in HR-HPV at 
baseline among the 5 CIN groups in part 2 of the study. However, post-hoc pairwise 
testing identified a statistically significant difference only between the group with 
persistent HR-HPV but no CIN2+ and the cleared CIN2+ groups which can also be 
explained by design. Additionally, post-hoc pairwise tests found that women that 
cleared CIN2+ were significantly 1) more likely to be using injectable contraceptives 
compared to women who had either persistent HR-HPV infection without CIN2+ 
(controls; P = 0.002) and those that had incident CIN2+ (P = 0.021) and 2) more 
likely to be using any hormonal contraceptives compared to controls (P = 0.028). All 
other post-hoc pairwise tests did not reach statistical significance after Holm–
Bonferroni correction. 
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Table 4.1 Characteristics of women selected for the VMB-HARP study by study group (continued on next page). Numbers of women are shown together with 
the percentage of women with this characteristic in the study group (for categorical variables) or median value and interquartile range (for continuous 
variables). Kruskal Wallis was used for continuous variables and Chi2 or Fisher’s exact test were used for categorical variables, except for large contingency 
tables with more than two rows and columns where the p value was estimated using the Monte Carlo method (50,000 simulations).  
VMB-HARP STUDY PART PART 1 1&2 PART 2      
 Negative 
(controls) 
Incident 
HR-HPV 
Cleared 
HR-HPV 
Type swap 
HR-HPV 
Persistent 
HR-HPV 
Incident 
CIN2+ 
Cleared 
CIN2+ 
Persistent 
CIN2+ 
Prevalent 
CIN2+ 
Part 1 Part 2 VMB-HARP 
(all) 
HARP 
(all) 
 
 (n = 38) (n = 43) (n = 68) (n = 69) (n = 93) (n = 22) (n = 64) (n = 25) (n = 33) p value1 p value2 (n = 455) (n = 624) p value3 
Median age at baseline (IQR) 38 (34-42) 36 (33-41) 36  (31-39) 34 (30-40) 33 (30-39) 34 (30-35) 34 (30-36) 33 (30-36) 32 (26-38) 0.051 0.936 34 (30-39) 34 (30-39) 0.377 
Self-reported current smoker 1 (2.6%) 0 (0%) 4 (5.9%) 7 (10.1%) 6 (6.5%) 1 (4.5%) 3 (4.7%) 1 (4.0%) 2 (6.1%) 0.213 0.989 25 (5.5%) 34 (5.4%) 1.000 
SEXUAL BEHAVIOUR AND CONTRACEPTION AT BASELINE     
Ever used any form of contraception 36 (94.7%) 42 (97.7%) 67 (98.5%) 65 (94.2%) 89 (95.7%) 22 (100%) 62 (96.8%) 24 (96.0%) 32 (97.0%) 0.697 1.000 439 (96.5%) 601 (96.3%) 0.897 
Currently using any hormonal 
contraceptive 
10 (26.3%) 8 (18.6%) 15(22.1%) 12 (17.4%) 19 (20.4%) 5 (22.7%) 27 (42.2%) 12 (48.0%) 7 (21.2%) 0.846 0.006* 115 (25.3%) 152 (24.4%) 0.442 
Currently using oral contraceptive or 
patch 
1 (2.6%) 0 (0%) 3 (4.4%) 1 (1.4%) 8 (8.6%) 4 (18.2%) 2 (3.1%) 2 (8.0%) 2 (6.1%) 0.120 0.216 23 (5.0%) 29 (4.6%) 0.562 
Currently using injectable 
contraceptive 
9 (23.7%) 7 (16.3%) 11 (16.2%) 8 (11.6%) 11 (11.8%) 1 (4.5%) 25 (39.1%) 9 (36.0%) 5 (15.2%) 0.438 <0.001* 86 (18.9%) 116 (18.6%) 0.832 
Currently using contraceptive 
implants 
0 (0%) 1 (2.3%) 1 (1.5%) 3 (4.3%) 0 (0%) 0 (0%) 0 (0%) 1 (4.0%) 0 (0%) 0.187 0.198 6 (1.3%) 7 (1.1%) 0.735 
Condom use in last 3 months             
No recent sex 9 (23.7%) 8 (18.6%) 13 (19.1%) 9 (13.0%) 20 (21.5%) 1 (4.5%) 7 (10.9%) 6 (24.0%) 8 (24.2%) 0.437 0.094 81 (17.8%) 117 (18.8%) 0.680 
never 2 (5.3%) 3 (7.0%) 3 (4.4%) 7 (10.1%) 0 (0%) 3 (13.6%) 2 (3.1%) 2 (8.0%) 2 (6.1%)   24 (5.3%) 31 (5.0%)  
sometimes 10 (26.3%) 9 (20.9%) 17 (25.0%) 18 (26.1%) 27 (29.0%) 7 (31.8%) 23 (35.9%) 8 (32.0%) 10 (30.3%)   129 (28.4%) 172 (27.6%)  
always 17 (44.7%) 23 (53.5%) 35 (51.5%) 35 (50.7%) 46 (49.5%) 11 (50.0%) 32 (50.0%) 9 (36.0%) 13 (39.4%)   221 (48.6%) 304 (48.7%)  
Have a current regular male sexual 
partner 
29 (76.3%) 34 (79.1%) 53 (77.9%) 59 (85.5%) 74 (79.6%) 21 (95.5%) 55 (85.9%) 19 (76.0%) 25 (75.8) 0.763 0.244 369 (81.1) 502 (80.4%) 0.577 
1P value for differences between VMB-HARP study groups in part 1 (negative, incident, cleared, type-swap and persistent HR-HPV). 
2P value for differences between VMB-HARP study groups in part 2 (persistent HR-HPV and incident, cleared, persistent and prevalent CIN2+). 
3P value for differences between women selected for VMB-HARP and those in the HARP study not selected for VMB-HARP. 
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        Table 4.1 (cont.) 
VMB-HARP STUDY PART PART 1 1&2 PART 2      
 Negative 
(controls) 
Incident 
HR-HPV 
Cleared 
HR-HPV 
Type swap 
HR-HPV 
Persistent 
HR-HPV 
Incident 
CIN2+ 
Cleared 
CIN2+ 
Persistent 
CIN2+ 
Prevalent 
CIN2+ 
Part 1 Part 2 VMB-HARP 
(all) 
HARP 
(all) 
 
Number of lifetime male sexual partners             
1 2 (5.3%) 2 (4.7%) 4 (5.9%) 0 (0%) 1 (1.1%) 0 (0%) 2 (3.1%) 0 (0%) 0 (0%) 0.108 0.077 11 (2.4%) 17 (2.7%) 0.789 
2-4 21 (55.3%) 21 (48.8%) 21 (30.9%) 27 (39.1%) 47 (50.5%) 12 (54.5%) 34 (53.1%) 12 (48.0%) 18 (54.5%)   213 (46.8%) 284 (45.5%)  
5-9 6 (15.8%) 13 (30.2%) 23 (33.8%) 21 (30.4%) 31 (33.3%) 2 (9.1%) 15 (23.4%) 10 (40.0%) 8 (24.2%)   129 (28.4%) 178 (2z8.5%)  
10+ 3 (7.9%) 4 (9.3%) 9 (13.2%) 7 (10.1%) 7 (7.5%) 0 (0%) 5 (7.8%) 0 (0%) 1 (3.0%)   36 (7.9%) 51 (8.2%)  
unknown 6 (15.8%) 3 (7.0%) 11 (16.2%) 14 (20.3%) 7 (7.5%) 8 (36.4%) 8 (12.5%) 3 (12.0%) 6 (18.2%)   66 (14.5%) 94 (15.1%)  
Number of  male sexual partners in last 3 months              
0 9 (23.7%) 7 (16.3%) 12 (17.6%) 9 (13.0%) 19 (20.4%) 1 (4.5%) 6 (9.4%) 6 (24.0%) 8 (24.2%) 0.305 0.174 77 (16.9%) 111 (17.8) 0.434 
1 29 (76.3%) 34 (79.1%) 50 (73.5%) 51 (73.9%) 72 (77.4%) 19 (86.4%) 54 (84.4%) 19 (76.0%) 24 (72.7%)   352 (77.4%) 476 (76.3)  
2-4 0 (0%) 1 (2.3%) 5 (7.4%) 7 (10.1%) 1 (1.1%) 1 (4.5%) 3 (4.7%) 0 (0%) 1 (3.0%)   19 (4.2%) 29 (4.6%)  
5-9 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4.5%) 0 (0%) 0 (0%) 0 (0%)   1 (0.2%) 1 (0.2%)  
10+ 0 (0%) 1 (2.3%) 1 (1.5%) 1 (1.4%) 1 (1.1%) 0 (0%) 1 (1.6%) 0 (0%) 0 (0%)   5 (1.1%) 5 (0.8%)  
unknown 0 (0%) 0 (0%) 0 (0%) 1 (1.4%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)   1 (0.2%) 2 (0.3%)  
Median age at first intercourse (IQR) 18 (16-19) 17 (16-18) 17 (16-19) 17 (16-19) 18 (17-19) 17 (16-19) 18 (17-19) 18 (16-19) 18 (17-19) 0.061 0.623 18 (16-19) 18 (16-19) 0.801 
Practice vaginal cleansing at least 
weekly 
17 (44.7%) 17 (39.5%) 30 (44.1%) 26 (37.7%) 32 (34.4%) 10 (45.5%) 20 (31.3%) 13 (52.0%) 14 (42.4%) 0.710 0.328 179 (39.3%) 254 (40.7%) 0.295 
Ever earned money/drugs/food/bed 
for sex 
2 (5.3%) 1 (2.3%) 7 (10.3%) 11 (15.9%) 7 (7.5%) 0 (0%) 5 (7.8%) 2 (8.0%) 0 (0%) 0.140 0.339 35 (7.7%) 42 (6.7%) 0.164 
1P value for differences between VMB-HARP study groups in part 1 (negative, incident, cleared, type-swap and persistent HR-HPV). 
2P value for differences between VMB-HARP study groups in part 2 (persistent HR-HPV and incident, cleared, persistent and prevalent CIN2+). 
3P value for differences between women selected for VMB-HARP and those in the HARP study not selected for VMB-HARP. 
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Table 4.1 (cont.) 
VMB-HARP STUDY PART PART 1 1&2 PART 2      
 Negative 
(controls) 
Incident 
HR-HPV 
Cleared 
HR-HPV 
Type swap 
HR-HPV 
Persistent 
HR-HPV 
Incident 
CIN2+ 
Cleared 
CIN2+ 
Persistent 
CIN2+ 
Prevalent 
CIN2+ 
Part 1 Part 2 VMB-HARP 
(all) 
HARP 
(all) 
 
HIV-RELATED FACTORS               
Median CD4 count cells/mm3 at 
baseline 
457 
(347-595) 
439  
(318-562) 
483 
(348-604) 
403 
(281-523) 
433  
(335-555) 
438 
(355-547) 
398 
(298-580) 
377 
(245-436) 
326 
(214-514) 
0.207 0.284 425 
(318-566) 
428 
(322-581) 
0.149 
Median baseline plasma viral load 
(HIV-1 copies per millilitre log10) 
2.6 
(2.0-3.7) 
2.7 
(1.9-3.5) 
2.2 
(1.6-2.8) 
2.4 
(1.6-3.4) 
2.8 
(1.6-3.9) 
3.2 
(2.1-4.3) 
3.0 
(1.9-4.5) 
3.9 
(1.7-4.6) 
2.9 
(1.6-4.0) 
0.102 0.602 2.6 
(1.6-3.9) 
2.7 
(1.6-4.0) 
0.043* 
Antiretroviral therapy             
not on ART throughout study 10 (26.3%) 7 (16.3%) 14 (20.6%) 14 (20.3%) 26 (28.0%) 10 (45.5%) 17 (26.2%) 8 (32.0%) 6 (18.2%) 0.142 0.164 112 (24.6%) 181 (29.0%) <0.001* 
on ART at study commencement 25 (65.8%) 35 (81.4%) 54 (79.4%) 54 (78.3%) 61 (65.6%) 11 (50.0%) 38 (58.5%) 15 (60.0%) 26 (78.8%)   319 (70.0%) 406 (65.1%)  
started ART during study 3 (7.9%) 1 (2.3%) 0 (0%) 1 (1.4%) 6 (6.5%) 1 (4.5%) 10 (15.4%) 2 (8.0%) 1 (3.0%)   25 (5.5%) 37 (5.9%)  
VAGINAL INFECTIONS AT BASELINE             
Bacterial vaginosis (Nugent score 7-
10) 
14 (37.8%) 18 (41.9%) 23 (33.8%) 37 (55.2%) 41 (46.1%) 10 (45.5%) 25 (39.7%) 11 (45.8%) 13 (40.6%) 0.131 0.938 192 (43.1%) 254 (41.5%) 0.210 
Candidiasis 2 (5.4%) 4 (9.3%) 2 (2.9%) 5 (7.5%) 9 (9.9%) 2 (9.1%) 6 (9.5%) 1 (4.0%) 3 (9.4%) 0.474 0.973 34 (8.1%) 53 (8.7%) 0.193 
SEXUALLY TRANSMITTED INFECTIONS AT BASELINE             
Any HPV (genotyping) 22 (57.9%) 19 (44.2%) 68 (100%) 69 (100%) 93 (100%) 22 (100%) 60 (93.8%) 24 (96.0%) 33 (100%) <0.001* 0.058 410 (90.1%) 552 (88.7%) 0.711 
HR-HPV (genotyping) 0 (0%) 0 (0%) 68 (100%) 69 (100%) 93 (100%) 21 (95.5%) 58 (90.6%) 24 (96.0%) 30 (90.9%) <0.001* 0.011* 363 (79.8%) 491 (78.9%) 0.823 
Chlamydia trachomatis 1 (2.6%) 5 (11.6%) 1 (1.5%) 3 (4.3%) 4 (4.3%) 0 (0%) 5 (7.8%) 1 (4.0%) 4 (12.1%) 0.201 0.360 24 (5.3%) 31 (5.0%) 0.741 
Neisseria gonorrhoeae 0 (0%) 2 (4.7%) 1 (1.5%) 2 (3.0%) 1 (1.1%) 1 (4.5%) 0 (0%) 1 (4.0%) 2 (6.1%) 0.562 0.103 10 (2.2%) 13 (2.1%) 1.000 
HSV-2 35 (92.1%) 41 (95.3%) 67 (98.5%) 68 (98.6%) 88 (95.7%) 21 (95.5%) 60 (93.8%) 21 (87.5%) 31 (93.9%) 0.361 0.623 432 (95.4%) 591 (95.2%) 1.000 
Mycoplasma genitalium 4 (10.5%) 3 (7.0%) 4 (5.9%) 7 (10.1%) 6 (6.5%) 4 (18.2%) 4 (6.3%) 4 (16.0%) 2 (6.1%) 0.809 0.219 38 (8.4%) 46 (7.4%) 0.211 
Active syphilis (Treponema pallidum) 0 (0%) 0 (0%) 1 (1.5%) 0 (0%) 0 (0%) 2 (9.1%) 0 (0%) 0 (0%) 0 (0%) 0.479 0.008* 3 (0.7%) 7 (1.1%) 0.094 
Trichomonas vaginalis  3 (7.9%) 8 (18.6%) 9 (13.2%) 17 (24.6%) 12 (12.9%) 3 (13.6%) 11 (17.2%) 4 (16.0%) 4 (12.1%) 0.134 0.939 71 (15.6%) 101 (16.2%) 0.651 
1P value for differences between VMB-HARP study groups in part 1 (negative, incident, cleared, type-swap and persistent HR-HPV). 
2P value for differences between VMB-HARP study groups in part 2 (persistent HR-HPV and incident, cleared, persistent and prevalent CIN2+). 
3P value for differences between women selected for VMB-HARP and those in the HARP study not selected for VMB-HARP. 
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4.4.2 Sequencing results 
A total of 125,034,772 paired 16S rRNA sequence reads (V3-V4 region) were 
generated from the VMB-HARP samples (946 microbiome profiles, of which 71 
were experimental (PCR) replicates, were generated from 875 samples from 455 
women). After error correction (0.2% of total reads discarded), paired-end alignment 
(3.1% discarded) and removal of sequences containing ambiguous bases (0.1% 
discarded), singletons (4.8% discarded), small OTUs under 100 reads (0.3% 
discarded), chimeric sequences (1.0% discarded) and contaminants (0.5% 
discarded), 112,558,944 sequences remained. After discarding contaminant OTUs 
and those with a total read count below 100, 1983 OTUs remained. After discarding 
samples with a read count <1000 reads (resulting in loss of four samples from four 
different women, two of whom were in part 1 of VMB-HARP and two in part 2), the 
median read count was 122,490 reads, ranging from 1039 to 859,842 reads (not 
including repeat sample profiles that were discarded). In one case there were two 
samples for visit 5 for the same subject, which produced distinct VMB profiles. 
These profiles were used in the clustering of samples, but were removed from 
downstream analyses. The presence of two samples for the same subject may have 
been due to sample mislabelling and since the identity of neither sample could be 
ascertained with complete certainty, neither profile was used in the final analysis. 
Negative PCR controls (12 samples) contained a median of only 208 raw reads, 
despite a similar or higher average volume of amplicon added to the final amplicon 
pool when compared to samples. Most of these reads failed to align (82%). Using 
the criteria described in the methods section, only five OTUs were identified as PCR 
contaminants (see Appendix G), which amounted to <0.01% of total classified 
sample reads. PCR contamination was therefore considered negligible. 
Contamination originating from the extraction process was higher, with 111 
contaminant OTUs identified (see Appendix G) making up 0.5% of total classified 
sample reads. By far the most common contaminant in all negative extraction 
controls was Rhodanobacter glycinis/terrae with a relative abundance of 43-96%. 
This OTU was more than 450 times as abundant in the negative extraction controls 
when compared to the most common PCR contaminant in negative PCR controls 
(Achromobacter denitrificans/ruhlandii/xylosoxidans), indicating that contamination 
from the DNA extraction process was much higher than that occurring during PCR. 
This is supported by the observation that the Rhodanobacter OTU was more 
prevalent in vaginal samples compared to the Achromobacter OTU (median relative 
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abundance in samples of Rhodanobacter was 0.020%, while Achromobacter was 
absent from the majority of samples). Of the total classified reads in negative PCR 
and negative extraction controls 30.3% and 97.6% were identified as contaminants, 
respectively. The majority of remaining reads belonged to the top 10 most common 
OTUs in terms of total read count in the entire dataset (56.0% and 69.5% of non-
contaminant reads in the negative PCR and negative extraction controls, 
respectively). This is consistent with barcode switching, although cross-
contamination from samples cannot be ruled out. 
4.4.3 Vaginal microbiome composition in the VMB-HARP population 
The OTUs with the highest read counts in the VMB-HARP population as a whole 
were Lactobacillus iners (36.5% of classified reads), Gardnerella vaginalis OTU 0 
(9.2%), Lactobacillus acidophilus/casei/crispatus/gallinarum (7.9%), G. vaginalis 
OTU 1 (4.5%), BVAB1 (4.5%), Sneathia amnii/sanguinegens (4.0%), Atopobium 
vaginae (2.5%), Megasphaera OTU 0 (2.5%), Prevotella OTU 0 (1.8%), G. vaginalis 
OTU 2 (1.7%), Megasphaera OTU 1 (1.6%), Dialister (1.5%), Coriobacteriales 
(1.5%), Lactobacillus jensenii (1.3%), Sneathia sanguinegens (1.3%), Prevotella 
bivia (1.0%) and Streptococcus agalactiae/pyogenes (1.0%). All other OTUs made 
up less than 1% of classified reads. The distribution of these OTUs across samples 
from both visits is shown in Figure 4.3.  
The use of Swarm for clustering of reads into OTUs allowed for higher resolution 
compared with older methods based on an arbitrary global similarity threshold (such 
as USEARCH) and allowed distinction between closely related sequences. This was 
particularly true in the case of G. vaginalis, where a total of 4 OTUs were identified, 
sharing between 98.8-99.8% sequence similarity. G. vaginalis OTU 0 shares 100% 
sequence identity with the published complete genome sequences of G. vaginalis 
strains 409-05 and GV37. The former was isolated from the vagina of an 
asymptomatic woman with a Nugent score of 9 (Yeoman et al 2010), while the latter 
was isolated from the blood of a woman with toxic encephalopathy (Tankovic et al 
2017). G. vaginalis OTU 1 shares 100% sequence identity with three complete 
genomes, those of G. vaginalis strains HMP9231, ATCC14018 (=JCM10026) and 
ATCC 14019. HMP9231 was isolated from endometrium, while the other two were 
isolated from women with symptomatic BV (Cornejo et al 2018, Yeoman et al 2010). 
There are no complete genome sequences available with an identical 16S rRNA 
sequence to G. vaginalis OTUs 2 and 3, although identical 16S rRNA gene 
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Figure 4.3 Heat map showing the relative abundance of all OTUs that made up at least 1% of reads in all VMB-HARP samples. The tree 
shown represents the results of complete linkage hierarchical clustering on the Euclidean distance. The cut-off for separating sequences into 
fine scale clusters is indicated by a red line. For samples from visit 1, the top bar indicates the Nugent score.
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sequences from uncultured bacteria do exist in the NCBI database. In addition to G. 
vaginalis, multiple OTUs were also identified for other species, including A. vaginae 
(two OTUs with 98.8% sequence similarity), Bifidobacterium breve (two OTUs with 
99.5% sequence similarity) and Veillonella montpellierensis (two OTUs with 99.3% 
sequence similarity). Furthermore, the method was able to differentiate between 
closely related species or species groups. For example, the sequence for L. jensenii 
could be distinguished from the L. acidophilus/casei/crispatus/gallinarum group, 
despite sharing 97.2% of DNA in the sequenced region. Similarly, Mobiluncus 
curtisii could be differentiated from Mobiluncus mulieris (98.1% similarity). 
4.4.4 Vaginal microbiome community types in the VMB-HARP population 
Hierarchical clustering of the rarefied reads from 871 samples resulted in 37 fine 
scale clusters, which were pooled into seven biologically meaningful VMB 
community types for use in downstream clinical epidemiological analyses (see 
Figure 4.3 for sample clustering tree, Table 4.2 for the definitions of the community 
types, Table 4.3 for the reasoning behind the choice of community types, Figure 4.4 
for the composition of fine scale clusters, and Appendix H for a written description of 
each fine scale cluster). The following community type descriptions are based on 
raw read counts. Two types were dominated by lactobacilli, the largest of which was 
dominated by L. iners (type "Li"; n = 214) and the smaller contained predominately 
L. acidophilus/casei/crispatus/gallinarum (which in this niche most likely represents 
L. crispatus and as which it will be referred to from here on) or L. jensenii (type "Lcj"; 
n = 68). Most of the samples of these two types had >50% relative abundance of 
the dominant lactobacillus species and all had >70% relative abundance of all 
lactobacilli combined. Most samples of these types also contained very small 
proportions of BV-associated bacteria, most commonly G. vaginalis (median relative 
abundance 0.08%), and pathobionts (streptococci, staphylococci, 
Escherchia/Shigella, Proteus and/or Salmonella). Pathobionts (i.e. bacteria that 
have pathologic potential, but may be normally found associated with the healthy 
human body) were more common in the Li type (99.5% of samples) compared to 
the Lcj type (65% of samples) but the median relative abundance was very low in 
both types (0.02% and 0.01%, respectively). Three further VMB community types 
were characterised by the presence of substantial proportions of bacteria typically 
associated with BV, including G. vaginalis, A. vaginae, BVAB1, Megasphaera, P. 
bivia, S. amnii/sanguinegens and V. montpellierensis. These were further divided  
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Table 4.2 Vaginal microbiome type definitions used in this study. 
VMB COMMUNITY TYPE DESCRIPTION CLUSTERS N 
(visit 1) 
N 
(visit 5) 
Lactobacillus-dominated: L. crispatus 
/L. jensenii group (“Lcj”) 
90% of samples have at least 50% relative abundance of 
lactobacilli (which may be more than one species) and 
the proportionally largest OTU is L. crispatus or L. 
jensenii. 
D1, D2a, G 28 40 
Lactobacillus-dominated: L. iners 
(“Li”) 
90% of samples have at least 50% relative abundance of 
lactobacilli (which may be more than one species) and 
the proportionally largest OTU is L. iners. 
Ca, Cc 117 97 
Bifidobacterium-dominated (“BD”) 90% of samples have at least 50% relative abundance of 
Bifidobacterium spp 
A13, A15 0 2 
Lactobacilli with BV anaerobes 
(“L+A”) 
90% of samples have at least 10% relative abundance of 
lactobacilli (which may be more than one species) in 
combination with bacteria typical of BV 
A3, A4a, A4b, Cb, D2b, F2a, 
F2b 
111 97 
Bacterial vaginosis type (“BV”) Contains anaerobes typically associated with BV, but 
none dominate (as per definition above) and there is no 
significant amount of lactobacillus (as per definition 
above). 
A1a, A1b, A1c, A1e, A2, A6, 
A7, A8, A9, A10, B1a 
152 151 
BV anaerobe-dominated (“AD”) 90% of samples have at least 50% relative abundance of 
an anaerobe associated with BV (single species, but may 
be more than one OTU) 
B1b, B2, E, F1, I 29 27 
Pathobiont-characterised (“PB”) 90% of samples have at least 25% relative abundance of 
pathobionts (streptococci, staphylococci, 
Enterobacteriaceae) 
A1d, A5, A14, H1, H2, J 8 11 
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Table 4.3 Reasoning behind the pooling of fine scale clusters into the seven vaginal microbiome types. 
VMB COMMUNITY TYPE REASONING FOR POOLING OF THESE CLUSTERS 
Lactobacillus-dominated: L. crispatus /L. 
jensenii group (“Lcj”) 
A L. crispatus cluster is commonly encountered in VMB studies using next-generation sequencing (van de Wijgert et al 
2014) and the two L. crispatus-dominated fine scale clusters closely associated by hierarchical clustering. L. jensenii-
dominated clusters were rare (consisting of 4 endline samples) and were placed in the same group as L. crispatus as 
these species have been associated with a lower prevalence and increased clearance of HPV (Borgdorff et al 2014, 
Brotman et al 2014, Dols et al 2012, Reimers et al 2016). 
Lactobacillus-dominated: L. iners (“Li”) This is a common type, which has been found in the majority of VMB studies using next-generation sequencing (van de 
Wijgert et al 2014). It consisted of two fine scale clusters which closely associated by hierarchical clustering. 
Bifidobacterium-dominated (“BD”) This cluster contained only two samples which were each dominated by a different Bifidobacterium sp. 
Lactobacilli with BV anaerobes (“L+A”) It has been observed that, compared to other lactobacilli, an L. iners-dominated VMB is more likely to transition to a 
high diversity VMB (Gajer et al 2012, Mitchell et al 2009, Verstraelen et al 2009). Therefore, considering that a VMB 
consisting of L. iners in combination with BV-anaerobes may represent a transitional state, we opted to put these 
samples in a separate category. 
Bacterial vaginosis type (“BV”) This group is the most diverse of the community types in this study and, although it could have been subdivided 
further, we decided against this because this would have resulted in too small a sample size. The BV type fine scale 
clusters all closely associated by hierarchical clustering. 
BV anaerobe-dominated (“AD”) These samples were mainly dominated by G. vaginalis and associated poorly with each other by hierarchical clustering 
due to the diversity of G. vaginalis strains present in them which were differentiated by the OTU clustering tool used in 
this study. Gardnerella dominated clusters have been identified in other studies (van de Wijgert et al 2014). A small 
number of additional samples (N = 3) were dominated by A. vaginae. These were added to this group as both bacteria 
are commonly associated with bacterial vaginosis. 
Pathobiont-characterised (“PB”) Several facultatively anaerobic enteric bacteria have been associated with inflammation and opportunistic infections in 
the vaginal niche (Donders et al 2017). In this study, these bacteria co-occurred with lactobacilli and BV-associated 
bacteria and tended to be closely associated by hierarchical clustering with these species rather than each other. 
However, we have grouped them here due to their association with inflammation and infection. Furthermore, there is 
some evidence that these clusters may constitute a separate clinical entity coined “aerobic vaginitis” because, in 
contrast to bacterial vaginosis, they are associated with overt vaginal inflammation on speculum examinations 
(Donders et al 2017). 
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Figure 4.4 Summary barcharts of sample clusters obtained by hierarchical clustering. 
Samples per cluster are indicated at the bottom of each bar. For clusters containing multiple 
samples, bars represent the mean of each OTU. Each bar and the corresponding key are 
arranged in order of abundance. For simplicity, OTUs with a mean relative abundance below 
1% are shaded light grey and not represented in the key. Continued on next page. 
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Figure 4.4 Continued on next page. 
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Figure 4.4 Continued from previous page.
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into those that were dominated by a single anaerobe species, either G. vaginalis or 
A. vaginae (type "AD"; n = 56), those that also contained a sizeable proportion of 
lactobacilli (90% of samples having at least 10% relative abundance of lactobacilli; 
type "L+A", n = 208) and those in which no single species dominated (type "BV", n = 
303). A further VMB type consisted of samples that contained a substantial 
proportion of pathobionts (90% of samples have at least 25% relative abundance of 
pathobionts; type "PB", n = 19) which included Escherichia/Shigella, Streptococcus 
anginosus/milleri, S. agalactiae/pyogenes and Streptococcus 
dysgalactiae/pyogenes. The final type contained only two samples that were 
dominated by either Bifidobacterium breve or Bifidobacterium longum (type "BD"). A 
single sample was dominated by Scardovia wiggsiae (a Bifidobacteriaceae species 
reported most commonly from the oral cavity) and was not assigned to a VMB type. 
As expected, the lactobacillus percentage was highest for the Lcj and Li community 
types, intermediate for the L+A type and lowest for the BV, AD and PB types (Figure 
4.5). These differences were statistically significant (P <0.0001 in all cases after 
Holm-Bonferroni correction). Similarly, alpha diversity (Simpson index) was lowest 
for the Lcj and Li types, intermediate for the L+A, AD, and PB types and highest for 
the BV type (Figure 4.6). These differences were statistically significant (P <0.001 in 
all cases after Holm-Bonferroni correction, and additionally the diversity of the L+A 
type was significantly higher than that of the AD type (P <0.0001). 
4.4.5 Correlation of molecular data with bacterial vaginosis by Nugent score 
At baseline, women were evaluated for BV by Nugent score and a valid result was 
available for 435/445 (97.8%) women for which a VMB profile had been obtained at 
the same visit. As described in section 1.2.1, the Nugent score provides a crude 
assessment of VMB composition using microscopy and is therefore expected to 
correlate with sequencing results. The variation in VMB composition was graphed 
using nonmetric multidimensional scaling (NMDS) in three dimensions, illustrating 
that the 16S rRNA composition was associated with the Nugent score (Figure 4.7). 
As expected, the samples with a high Nugent score had a higher alpha diversity 
(Spearman's rank correlation, P <0.0001) and lower relative abundance of 
lactobacilli than those with a low Nugent score (P <0.0001; Figure 4.7). 
Furthermore, the Nugent score results were significantly different between the 
different fine scale clusters (Figure 4.3) and vaginal community types (Figure 4.8),  
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Figure 4.5 Lactobacillus relative abundance by vaginal microbiome type. The 
Bifidobacterium-dominated cluster is not shown due to the low sample size. Lcj: L. 
jensenii/L.crispatus dominated; Li: L. iners-dominated; L+A: Lactobacilli with BV anaerobes; 
BV: Bacterial vaginosis type; AD: BV anaerobe-dominated; PB: Pathobiont-characterised. 
 
Figure 4.6 Simpson index (1-D) by vaginal microbiome type. The Bifidobacterium-dominated 
cluster is not shown due to the low sample size. Lcj: L. jensenii/L.crispatus dominated; Li: L. 
iners-dominated; L+A: Lactobacilli with BV anaerobes; BV: Bacterial vaginosis type; AD: BV 
anaerobe-dominated; PB: Pathobiont-characterised. 
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with Li and Lcj having the lowest scores, intermediate for L+A, AD and PB types 
and highest for BV (Mann Whitney U test, P ≤0.0001 in all cases after Holm-
Bonferroni correction). This illustrates the value in 16S rRNA sequencing in being 
able to distinguish the different species of Lactobacillus and in providing much more 
detail on the species present in non-Lactobacillus dominated VMB types. 
 
 
Figure 4.7 NMDS plots summarising the variation in composition between samples in three 
dimensions. This distribution closely follows the Nugent score (a) and Simpson index (b). 
The distribution of lactobacilli is shown in graph c, d and e to aid interpretation.  
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Figure 4.8 Distribution of Nugent scores by vaginal microbiome type at visit 1 (baseline). 
4.4.6 Change in VMB composition over time 
The VMB of only 143 of the 414 women (35%) who had data available for both visits 
remained in the same VMB community type between visits 1 and 5. Of the 5 most 
common VMB types, women who had BV or Lcj at baseline were most likely to have 
the same VMB type at endline (50.7% and 44.4%, respectively) while those with Li, 
L+A or AD were less stable (25.5%, 26.2% and 14.8%, respectively). The VMB 
types most likely to transition to a BV-type microbiome were Li and L+A (31.8% and 
31.1%, respectively), while this was least common with Lcj and AD types (11.1% in 
both cases). The median Bray-Curtis similarity between the baseline sample and 
that taken at visit 5 was 33% for women with an Lcj type at the first visit, 44% for 
women with an Li type, and 40% for women with a L+A type. The median Bray-
Curtis similarity between visits 1 and 5 samples was lower for women who had a BV 
(22%), BD (19%), or PB type (6.7%) at visit 1. This difference is statistically 
significant (P <0.001). 
4.4.7 Unadjusted associations between VMB and HR-HPV 
In Part 1 of the study – which aimed to investigate the association between the VMB 
and incidence, persistence and clearance of HR-HPV in HIV-infected South African 
women – the control group (i.e. HR-HPV negative at both time points) had the 
highest proportion of the L. crispatus-dominated VMB at both baseline and endline 
(Figure 4.9 and Tables 4.3 and 4.4). When compared to the most common VMB 
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type (L. iners-dominated, Li), this difference was not statistically significant at 
baseline, but at endline was significantly different for the incident group (odds ratio 
(OR) = 0.1, P = 0.019) and approached significance for the persistent HR-HPV 
group (OR = 0.3, P = 0.074). The control group also had the lowest median diversity 
score at baseline (0.50) and the highest median relative abundance of lactobacilli 
(73%; Figure 4.9 and Tables 4.3 and 4.4). This difference was statistically significant 
for the type swap group only (Simpson index OR = 4.5, P = 0.021, Lactobacillus 
relative abundance OR = 0.3, P = 0.008). The control group also had the lowest 
median diversity score (0.49) at endline and a relatively high Lactobacillus relative 
abundance (64%), but at this time point the Lactobacillus relative abundance was 
slightly lower than in the incident HR-HPV group (69%; Figure 4.9 and Tables 4.3 
and 4.4). These differences were not statistically significant, but approached 
significance for the clearance group (Simpson index OR = 3.3, P = 0.052, 
Lactobacillus relative abundance OR = 0.4, P = 0.097). Both the incident and 
cleared HR-HPV groups have a lower alpha diversity and a higher Lactobacillus 
relative abundance at the visit at which HR-HPV was present. Non-metric 
multidimensional scaling in three dimensions did not result in obvious separation 
between groups (see Figure 4.10a and 4.10b). 
LEfSe analysis was performed to compare each of the VMB-HARP study groups to 
its control group. Discriminant OTUs were found only at endline and are shown in 
Figure 4.11. We also used LEfSe to compare the HR-HPV status (positive vs 
negative) for all women who had data available for both visits (including those with 
CIN2+ at any time point) and found that the median relative abundance of L. iners 
was lower at both visits in women who were HR-HPV positive at that visit. 
4.4.8 Unadjusted associations between VMB and CIN2+ in HR-HPV infection 
In Part 2 of the study – which aimed to investigate the association between the VMB 
and the presence of CIN2+ lesions among HIV-infected South African women – the 
groups had similar proportions of the L. crispatus-dominated VMB at both baseline 
and endline. However, the BV-type VMB was more highly represented in the 
incident and persistent CIN2+ groups compared to the cleared CIN2+ and control 
(persistent HR-HPV) groups at both time points (Figure 4.9 and Tables 4.5 and 4.6). 
This difference was not statistically significant when compared to the most common 
VMB type (L. iners-dominated, Li), but approached significance for the incident 
CIN2+ group at endline (Table 4.7), which also had a relatively low proportion of  
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Figure 4.9 Prevalence of VMB types by study group. V1 = visit 1 (baseline); V5 = visit 5 (endline). The number of women in each group is given below each 
set of bars. 
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Table 4.4 Results of univariable multinomial logistic regression modelling comparing each VMB-HARP group in Part 1 to the control group at baseline (visit 
1). Odds ratios with a P value <0.05 are indicated in bold and starred. 
 Negative  
HR-HPV 
Incident HR-
HPV 
 Cleared HR-
HPV 
 Type swap 
HR-HPV 
 Persistent HR-
HPV 
 
 N (%) N (%) OR (95% CI) N (%) OR (95% CI) N (%) OR (95% CI) N (%) OR (95% CI) 
Vaginal microbiome type          
Lcj 4 (10.5%) 1 (2.4%) 0.2 (0.0-2.2) 6 (8.8%) 0.9 (0.2-3.9) 2 (2.9%) 0.4 (0.1-2.8) 5 (5.4%) 0.6 (0.1-2.5) 
Li 12 (31.6%) 14 (33.3%) ref 20 (29.4%) ref 14 (20.3%) ref 26 (28.0%) ref 
BD2 0 (0%) 0 (0%) sparse data 0 (0%) sparse data 0 (0%) sparse data 0 (0%) sparse data 
L+A 10 (26.3%) 13 (31.0%) 1.1 (0.4-3.4) 16 (23.5%) 1.0 (0.3-2.8) 14 (20.3%) 1.2 (0.4-3.7) 25 (26.9%) 1.2 (0.4-3.1) 
BV 11 (28.9%) 12 (28.6%) 0.9 (0.3-2.9) 20 (29.4%) 1.1 (0.4-3.1) 29 (42.0%) 2.3 (0.8-6.4) 31 (33.3%) 1.3 (0.5-3.4) 
AD 1 (2.63%) 1 (2.4%) 0.9 (0.0-15.2) 4 (5.9%) 2.4 (0.2-24.1) 7 (10.1%) 6.0 (0.6-56.0) 4 (4.3%) 1.8 (0.2-18.3) 
PB 0 (0%) 1 (2.4%) sparse data 2 (2.9%) sparse data 3 (4.3%) sparse data 2 (2.2%) sparse data 
Total 38 42  68  69  93  
 Median (IQR) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) 
Median Simpson Index 
(IQR) 
0.50 0.67 1.7 (0.4-6.4) 0.57 1.5 (0.4-5.0) 0.72 4.5 (1.3-16.0)* 0.63 1.5 (0.5-4.9) 
(0.15-0.81) (0.17-0.83)  (0.24-0.79)  (0.48-0.85)  (0.18-0.82)  
Median lactobacillus 
relative abundance (IQR) 
0.73 0.48 0.6 (0.2-1.8) 0.55 0.6 (0.2-1.5) 0.26 0.3 (0.1-0.7)* 0.46 0.5 (0.2-1.3) 
(0.20-0.99) (0.16-0.95)  (0.05-0.97)  (0.01-0.72)  (0.04-0.98)  
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Table 4.5 Results of univariable multinomial logistic regression modelling comparing each VMB-HARP group in Part 1 to the control group at endline (visit 5). 
Odds ratios with a P value <0.05 are indicated in bold and starred. 
†P value <0.1 
 Negative  
HR-HPV 
Incident HR-
HPV 
 Cleared HR-
HPV 
 Type swap 
HR-HPV 
 Persistent HR-
HPV 
 
 N (%) N (%) OR (95% CI) N (%) OR (95% CI) N (%) OR (95% CI) N (%) OR (95% CI) 
Vaginal microbiome type          
Lcj 8 (21.1%) 2 (4.7%) 0.1 (0.0-0.7)* 7 (10.4%) 0.7 (0.2-2.7) 7 (10.1%) 0.5 (0.1-1.7) 7 (7.5%) 0.3 (0.1-1.1) † 
Li 9 (23.7%) 18 (41.9%) ref 11 (16.4%) ref 17 (24.6%) ref 25 (26.9%) ref 
BD2 0 (0%) 1 (2.3%) sparse data 0 (0%) sparse data 0 (0%) sparse data 1 (1.1%) sparse data 
L+A 6 (15.8%) 8 (18.6%) 0.7 (0.2-2.5) 13 (19.4%) 1.8 (0.5-6.6) 16 (23.2%) 1.4 (0.4-4.9) 20 (21.5%) 1.2 (0.4-3.9) 
BV 11 (28.9%) 10 (23.2%) 0.5 (0.1-1.5) 26 (38.8%) 1.9 (0.6-6.0) 24 (34.8%) 1.2 (0.4-3.0) 33 (35.5%) 1.1 (0.4-3.0) 
AD 4 (10.5%) 2 (4.7%) 0.3 (0.0-1.6) 9 (13.4%) 1.8 (0.4-8.0) 3 (4.3%) 0.4 (0.1-2.2) 3 (3.2%) 0.3 (0.1-1.4) 
PB 0 (0%) 2 (4.7%) sparse data 1 (1.5%) sparse data 2 (2.9%) sparse data 4 (4.3%) sparse data 
Total 38 43  67  69  93  
 Median (IQR) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) 
Median Simpson Index 
(IQR) 
0.49 0.53 1.2 (0.3-4.3) 0.65 3.3 (1.0-11.2)† 0.59 1.9 (0.6-6.1) 0.64 2.2 (0.7-6.9) 
(0.10-0.77) (0.05-0.74)  (0.39-0.84)  (0.21-0.80)  (0.17-0.86)  
Median lactobacillus 
relative abundance (IQR) 
0.64 0.69 1.2 (0.4-3.5) 0.22 0.4 (0.2-1.2)† 0.50 0.8 (0.3-2.1) 0.37 0.7 (0.3-1.6) 
(0.07-0.99) (0.11-0.99)  (0.02-0.95)  (0.05-0.97)  (0.03-0.98)  
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Figure 4.10 NMDS plots summarising the variation in VMB composition between samples in 
three dimensions. The VMB composition of women with no evidence of CIN2+ (VMB-HARP 
Part 1) is shown at the top for visits 1 (a) and visit 5 (b). Women with CIN2+ at any time point 
(VMB-HARP Part 2) are shown in the lower graphs for visit 1 (c) and visit 5 (d), alongside 
the women with persistent HR-HPV infection but <CIN2 at both time points for comparison. 
 
Figure 4.11 Schematic showing OTUs most likely to explain differences between classes 
listed on the left and negative controls, as identified by the linear discriminant analysis (LDA) 
score using LEfSe analysis. A positive score shown in red means increased relative 
abundance and a negative score shown in green a decreased relative abundance. HPV 
positivity at visits 1 and 5 is also shown. 
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samples of the Li type (OR 4.2, P= 0.079). At endline, but not at baseline, the L+A 
type was lowest in the control group (21.5% compared with 27.3%, 30.2% and 
28.0% in the incident, cleared and persistent CIN2+ groups, respectively; Figure 4.9 
and Tables 4.5 and 4.6). This difference was not statistically significant when 
compared to the Li type, but approached significance for the cleared CIN2+ group 
(OR 2.4, P = 0.079). 
At baseline, the incident CIN2+ group had the highest diversity score and the lowest 
Lactobacillus relative abundance, with all other groups having similar values, but 
these differences were not statistically significant. However, at endline, both the 
incident CIN2+ and the persistent CIN2+ group showed this pattern. The difference 
in diversity was statistically significant when compared to the control group at 
endline for the incident CIN2+ group (OR 7.0, P = 0.031) and approached 
significance for the persistent CIN2+ group (OR 4.0, P = 0.077). Additionally, the 
difference in Lactobacillus relative abundance approached significance for the 
incident CIN2+ group (OR 0.3, P = 0.093). The results of NMDS in three dimensions 
are shown in Figure 4.10c and 4.10d. Although no obvious separation of the groups 
is evident, at visit 5 it does appear that both the incident and prevalent CIN2+ 
groups are found mainly towards the negative side of the x-axis, which corresponds 
to the region with higher bacterial diversity and a low Lactobacillus relative 
abundance. 
We were unable to identify any OTUs that were significantly different between the 
VMB-HARP groups by LEfSe. We also used LEfSe to compare CIN2+ status 
(CIN2+ vs <CIN2) for all women who had data available for both visits, but no 
differences were identified between these groups either. 
4.4.9 Associations of VMB with HR-HPV and CIN2+ in multivariable models 
In order to correct for confounding, potential confounding variables were selected a 
priori. These variables were: sexual activity (currently having a regular partner and 
number of sexual partners in the last 3 months), ART status, log plasma viral load, 
age, co-infections (chlamydia, candiasis, trichomoniasis and M. genitalium) and 
vaginal cleansing at baseline as well as self-reported smoking, current hormonal 
contraceptive use of any type and CD4+ T-cell count at both baseline and endline. 
Pregnancy was not included as pregnant women were excluded from the study at 
baseline and only one woman was pregnant at the endline visit. Active syphilis and
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Table 4.6 Results of univariable multinomial logistic regression modelling comparing each VMB-HARP group in Part 2 to the control group at baseline (visit 
1).  
 Persistent 
HR-HPV 
Incident CIN2+  Cleared CIN2+  Persistent 
CIN2+ 
 Prevalent CIN2+ 
 N (%) N (%) OR (95% CI) N (%) OR (95% CI) N (%) OR (95% CI) N (%) 
Vaginal microbiome type         
Lcj 5 (5.4%) 1 (5.0%) 1.0 (0.1-10.9) 7 (11.1%) 2.6 (0.7-9.7) 1 (4.3%) 0.9 (0.1-8.8) 1 (3.4%) 
Li 26 (28.0%) 5 (25.0%) ref 14 (22.2%) ref 6 (26.1%) ref 6 (20.7%) 
BD2 0 (0%) 0 (0%) sparse data 0 (0%) sparse data 0 (0%) sparse data 0 (0%) 
L+A 25 (26.9%) 4 (20.0%) 0.8 (0.2-3.5) 16 (25.4%) 1.2 (0.5-2.9) 5 (21.7%) 0.9 (0.2-3.2) 8 (27.6%) 
BV 31 (33.3%) 8 (40.0%) 1.3 (0.4-4.6) 19 (30.2%) 1.1 (0.5-2.7) 10 (43.5%) 1.4 (0.4-4.4) 12 (41.4%) 
AD 4 (4.3%) 2 (10.0%) 2.6 (0.4-18.3) 7 (11.1%) 3.3 (0.8-13.0) 1 (4.3%) 1.1 (0.1-11.5) 2 (6.9%) 
PB 2 (2.2%) 0 (0%) sparse data 0 (0%) sparse data 0 (0%) sparse data 0 (0%) 
unassigned2 0 (0%) 0 (0%) sparse data 0 (0%) sparse data 0 (0%) sparse data 0 (0%) 
Total 93 20  63  23  29 
 Median (IQR) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) Median (IQR) 
Median Simpson Index 
(IQR) 
0.63 0.74 2.2 (0.5-10.6) 0.57 0.8 (0.3-2.2) 0.60 1.4 (0.3-5.9) 0.67 
(0.18-0.82) (0.40-0.88)  (0.21-0.77)  (0.26-0.88)  (0.38-0.87) 
Median lactobacillus 
relative abundance (IQR) 
0.46 0.28 0.6 (0.2-2.0) 0.50 1.0 (0.5-2.3) 0.41 0.8 (0.3-2.6) 0.29 
(0.04-0.98) (0.02-0.93)  (0.04-0.93)  (0.00-0.97)  (0.06-0.72) 
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Table 4.7 Results of univariable multinomial logistic regression modelling comparing each VMB-HARP group in Part 2 to the control group at endline (visit 5). 
Odds ratios with a P value <0.05 are indicated in bold and starred. 
†P value <0.1 
 Persistent 
HR-HPV 
Incident CIN2+  Cleared CIN2+  Persistent 
CIN2+ 
 Prevalent CIN2+ 
 N (%) N (%) OR (95% CI) N (%) OR (95% CI) N (%) OR (95% CI) N (%) 
Vaginal microbiome type         
Lcj 7 (7.5%) 1 (4.5%) 1.8 (0.1-22.7) 6 (9.5%) 2.1 (0.6-8.0) 1 (4.0%) 0.9 (0.1-9.3) 1 (25.0%) 
Li 25 (26.9%) 2 (9.1%) ref 10 (15.9%) ref 4 (16.0%) ref 0 (0%) 
BD2 1 (1.1%) 0 (0%) sparse data 0 (0%) sparse data 0 (0%) sparse data 0 (0%) 
L+A 20 (21.5%) 6 (27.3%) 3.7 (0.7-20.6) 19 (30.2%) 2.4 (0.9-6.2) † 7 (28.0%) 2.2 (0.6-8.5) 1 (25.0%) 
BV 33 (35.5%) 11 (50.0%) 4.2 (0.8-20.5) † 22 (34.9%) 1.7 (0.7-4.1) 12 (48.0%) 2.3 (0.7-7.9) 2 (50.0%) 
AD 3 (3.2%) 1 (4.5%) 4.2 (0.3-60.9) 4 (6.3%) 3.3 (0.6-17.6) 1 (4.0%) 2.1 (0.2-25.3) 0 (0%) 
PB 4 (4.3%) 1 (4.5%) sparse data 1 (1.6%) sparse data 0 (0%) sparse data 0 (0%) 
unassigned2 0 (0%) 0 (0%) sparse data 1 (1.6%) sparse data 0 (0%) sparse data 0 (0%) 
Total 93 22  63  25  4 
 Median (IQR) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) Median (IQR) OR (95% CI) Median (IQR) 
Median Simpson Index 
(IQR) 
0.64 0.81 7.0 (1.2-41.0)* 0.63 1.6 (0.6-4.4) 0.77 4.0 (0.9-19.0)† 0.77 
(0.17-0.86) (0.61-0.85)  (0.35-0.84)  (0.59-0.84)  (0.61-0.83) 
Median lactobacillus 
relative abundance (IQR) 
0.37 0.14 0.3 (0.1-1.2)† 0.37 0.7 (0.3-1.6) 0.26 0.5 (0.2-1.6) 0.37 
(0.03-0.98) (0.03-0.54)  (0.02-0.81)  (0.01-0.64)  (0.22-0.56) 
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gonorrhoea were rare (0.7% and 2.2%, respectively) in the VMB-HARP population 
while a positive HSV-2 serology result was very common (95.4%), so these 
variables were not included in multivariable models either. The stage of the 
menstrual cycle and menopause were considered but excluded as these self-
reported variables were inconsistent and therefore considered unreliable. Variables 
included in the final model for Part 1 were: age (continuous), log10 plasma viral load 
(continuous), number of sexual partners in last 3 months (categorical; none, 1 or 
more than 1) and T. vaginalis PCR results (positive/negative) at baseline and self-
reported smoking at either visit (categorical; current smoking declared at baseline or 
endline: yes/no). Variables included in the final model for Part 2 were: CD4+ T-cell 
count (continuous), condom use (categorical; over the last 3 months: had no sexual 
partner, used condoms never/sometimes or always used condoms) and current 
hormonal contraceptive use (including combined oral contraceptive pills, injectables, 
or patches) at baseline. 
After adjusting for these variables, the associations found in Part 1 of the study 
remained essentially unchanged. At endline, the control group had a higher 
proportion of the L. crispatus-dominated VMB when compared to the incident group 
(compared to L. iners-dominated VMB type: OR = 0.1, P = 0.016) and persistent 
HR-HPV group (compared to L. iners-dominated VMB type: OR = 0.3, P = 0.084). 
The control group had lower diversity scores and higher relative abundance of 
lactobacilli when compared to the type swap group at baseline (Simpson index OR 
= 3.2, P = 0.085, Lactobacillus relative abundance OR = 0.3, P = 0.027), although 
only the latter remained significant at a 0.05 significance level. The control group 
also had lower diversity and higher Lactobacillus relative abundance compared to 
the clearance group at endline, with little change in statistical significance (Simpson 
index OR = 3.2, P = 0.070, Lactobacillus relative abundance OR = 0.4, P = 0.056). 
In contrast, after adjusting for confounding, the associations found in Part 2 of the 
study changed considerably. The difference in diversity and Lactobacillus relative 
abundance between the control group and the incident CIN2+ group at endline were 
no longer significant at the 0.05 level (Simpson index OR 5.2, P = 0.070, 
Lactobacillus relative abundance OR = 0.4, P = 0.196). As in the unadjusted 
analysis, there were no significant differences in VMB type between outcome 
groups at the 0.05 significance level, although at endline the higher level of L+A 
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type and Lcj type in the cleared CIN2+ group approached statistical significance 
when compared to the controls (OR 3.4 P = 0.083 OR 2.5 P = 0.072). 
4.5 Discussion 
The fact that BV results in an increased risk of concurrent detection of HR-HPV 
infection has been well established (Gillet et al 2011, Gillet et al 2012). However, 
less is known about the temporality, bacterial species and mechanisms behind this 
association. We found that women who had HR-HPV infection at any time point in 
the study had a higher diversity VMB with a lower relative abundance of lactobacilli 
at baseline. After adjustment for confounding variables, this difference was 
significant for the type swap group such that for each unit increase in the 
Lactobacillus relative abundance, the odds of being in the control group over the 
type swap group are increased by a factor of 3.3. The reason for this difference 
being significant only for this group is unknown, although it may be related to a lack 
of statistical power. It is also possible that there are behavioural factors 
predisposing this group to multiple HR-HPV infections and concurrent changes in 
the VMB. However, even after adjustment for the number of sexual partners, a 
significant difference remained. We also found a similar difference in diversity and 
Lactobacillus relative abundance at endline for the clearance group, although this 
did not reach statistical significance. In agreement with this observation, at endline, 
the HR-HPV negative women had a higher proportion of the L. crispatus/L. jensenii-
dominated VMB than all other groups and this difference was significant for the 
incident HR-HPV group and approached significance for the persistent HR-HPV 
group. Accordingly, the results of LEfSe analysis found that the incident group was 
enriched in L. iners and the persistent group had a lower abundance of L. crispatus 
when compared to the HR-HPV negative control group. The fact that these two 
groups show the most significant difference might suggest that the change in the 
VMB precedes HR-HPV infection. This would agree with the results of two large 
cohort studies which enrolled both HIV-positive and HIV-negative women and 
concluded that BV is a risk factor for incident HR-HPV infection, even after 
adjustment for important confounders (King et al 2011, Watts et al 2005). The 
observation that BV results in local pro-inflammatory changes (Jespers et al 2017) 
and disrupts the cervicovaginal barrier (Borgdorff et al 2016b) suggests a possible 
mechanism for such an association in which loss of epithelial integrity secondary to 
inflammation provides access to the basal layer of the vaginal epithelium, allowing 
infection by HR-HPV. However, no definitive conclusions can be drawn on the 
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temporality of the association from the results of our study, particularly as there was 
also a trend in the HR-HPV clearance group for a high diversity VMB low in 
lactobacilli at endline and LEfSe analysis showed a concurrent enrichment in G. 
vaginalis OTU 0 together with a reduced abundance of L. crispatus in this group. It 
is possible that the association may occur in both directions, with disruption in the 
VMB increasing the risk of HR-HPV and vice versa. Put together, the differences 
found in this study suggest an association between HR-HPV infection and a high 
diversity VMB with a paucity of lactobacilli, in particular L. crispatus. This result is in 
agreement with cross-sectional studies that have shown similar results suggesting a 
link between diverse bacterial communities lacking in lactobacilli and HR-HPV 
infection (Borgdorff et al 2014, Dols et al 2012, Gao et al 2013, Lee et al 2013, Oh 
et al 2015). Furthermore, two small longitudinal studies found that a high diversity 
VMB was associated with a reduced clearance rate of HR-HPV infection (Brotman 
et al 2014, Di Paola et al 2017) and another longitudinal study showed that L. 
crispatus-dominated VMB reduced the risk of detection of new HPV types (Reimers 
et al 2016). 
In agreement with our results, some of these studies found a stronger reduction in 
risk of concurrent HR-HPV infection with L. crispatus compared to L. iners 
(Borgdorff et al 2014, Brotman et al 2014, Dols et al 2012, Reimers et al 2016). The 
reasons for this difference remain uncertain. However, a number of potential 
mechanisms have been suggested. One of these is that an L. iners-dominated VMB 
is more likely to transition to a VMB characterised by a mixture of BV-associated 
anaerobes when compared to a L. crispatus-dominated VMB (Gajer et al 2012, 
Mitchell et al 2009, Verstraelen et al 2009). This is consistent with our findings in 
which 31.8% of women with the Li type VMB at baseline transitioned to a BV type at 
endline, compared to only 11.1% of women who had an Lcj type VMB. This 
suggests that either L. iners is less able to prevent colonisation by BV-associated 
anaerobes, or otherwise that it is better able to tolerate the environmental conditions 
associated with BV. Furthermore, there are a number of differences in the metabolic 
capabilities of L. crispatus and L. iners. While both species produce lactic acid 
which results in a low vaginal pH and is generally considered protective, L. crispatus 
is more strongly associated with low pH than L. iners (Ravel et al 2011). 
Furthermore, L. crispatus produces predominately the D-isomer of lactic acid which 
has been associated with increased mucous viscosity and viral trapping (Nunn et al 
2015), while L. iners produces mainly the L-isomer which may reduce epithelial 
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integrity by leading to activation of matrix metalloproteinase (Witkin et al 2013). L. 
crispatus has also been reported to be capable of producing bacteriocins that are 
thought to reduce colonisation success by other species such as G. vaginalis (Ojala 
et al 2014). It should be noted that the sampling interval in this study was relatively 
long, with a median time interval of 15.9 months. Considering the dynamic nature of 
the VMB, it is therefore likely that many transitions in between these time points 
were missed. However, even over this time interval, clear differences in the 
frequency of transitions were evident, supporting the idea that the VMB may exist in 
either a relatively stable state or transitions between a small number of alternative 
equilibrium states (Gajer et al 2012). 
Since persistent infection with HR-HPV is a necessary precursor to CIN and the 
progression to cervical cancer, it is difficult to ascertain whether an observed 
association between the VMB and CIN is related to the precancerous changes, the 
persistent viral infection, or both. By utilising longitudinal data, and comparing 
women with CIN2+ to women with persistent HR-HPV infection that did not develop 
CIN2+, this study is the first to attempt to separate these effects. However, although 
we did find some differences in the VMB between women with incident CIN2+ and 
persistently HR-HPV positive controls, these differences were not robust to 
adjustment for confounding. After adjustment for confounding, there were no 
significant differences in VMB measures between the study groups. There was a 
non-significant trend towards higher levels of Lcj and L+A VMB types at endline in 
the group that cleared CIN2+, but this difference – assuming it is not a spurious 
finding – may be merely a consequence of the clearance of HR-HPV. Although 
previous studies investigating the VMB by molecular methods in relation to CIN 
have found some differences (Audirac-Chalifour et al 2016, Mitra et al 2015, Oh et 
al 2015, Piyathilake et al 2016), none of them included any longitudinal data, so 
these differences could be due to the presence of persistent HR-HPV infection 
rather than the associated development of CIN. Furthermore, no adjustment for 
potential confounding variables was made. There are also three published 
longitudinal studies that have investigated the relationship between BV and the 
development of cytological or histological precancerous cervical changes. One of 
these found that BV was a significant risk factor for incident LSIL or HSIL, but also 
did not adjust for confounding and HIV status was not reported (Engberts et al 
2007). A further smaller study in HIV-positive women also found that BV was a 
significant risk factor for histologically diagnosed CIN, but the association became 
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non-significant in multivariable analyses (Lehtovirta et al 2008). In contrast, a larger 
study in HIV-positive women concluded that there was no association between BV 
and HSIL (Denslow et al 2011). Both studies in HIV-positive women also assessed 
the risk of persistent BV (defined as BV at baseline and the following visit by 
Denslow and colleagues and as BV at 50% of visits by Lehtovirta and colleagues) 
on precancerous cervical changes and found a trend for an increase in risk, which 
was significant in one of the studies. However, none of these studies adjusted for 
HR-HPV infection status so any association with BV cannot be distinguished from 
an association with persistent viral infection.  
The overall picture of the VMB obtained in this study is one where the majority of 
women have either a VMB dominated by L. iners (community type "Li"), a VMB 
consisting of a mixture of anaerobes typically associated with BV (community type 
"BV") or lie somewhere between these two (community type "L+A"), with lower 
levels of Lactobacillus spp. – most commonly L. iners – together with BV-associated 
anaerobes. The remaining community types were dominated by one of L. crispatus, 
L. jensenii, G. vaginalis, A. vaginae or Bifidobacterium spp. or were characterised 
by the presence of pathobionts and together made up only 14.6% and 18.8% of the 
study population at baseline and endline, respectively. This is broadly consistent 
with other studies where the most commonly identified community types consist of 
one dominated by L. iners, one dominated by L. crispatus and one made up of a 
mixture of different anaerobes with low levels of lactobacilli typical of BV (van de 
Wijgert et al 2014). However, this latter community type contains a very diverse 
mixture of VMB profiles, with many samples having almost no OTUs in common and 
this high degree of heterogeneity is suboptimal in terms of allowing researchers to 
investigate which groups of bacteria are important in affecting health outcomes. As 
a result, many research groups have further subdivided this group (Brotman et al 
2014, Di Paola et al 2017, Gajer et al 2012). The majority of VMB studies have used 
some form of hierarchical clustering to define community types. Although our study 
also used this approach, we opted to use a more stringent cut-off that provided a 
good level of separation of grossly dissimilar samples. However, this resulted in 37 
fine scale clusters, of which 23 contained fewer than 10 samples, and this high 
number would have precluded meaningful downstream analyses. Clusters therefore 
had to be pooled, which was achieved by making use of knowledge of VMB 
structure gained from previous studies, as has been previously reported (Borgdorff 
et al 2017). For example, hierarchical clustering with a less stringent cut-off would 
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have combined samples containing up to 100% relative abundance of lactobacilli 
with VMB profiles containing as low as 42% relative abundance of lactobacilli in 
combination with BV-associated species. Since L. iners-dominated VMB is more 
likely to transition to a high diversity VMB, this suggests that a VMB consisting of L. 
iners in combination with BV-anaerobes may represent a transitional state, we 
opted to put these samples in a separate category. This allowed us to separate 
communities that are likely to have different impacts on health. Nevertheless, even 
at this fine scale level, hierarchical clustering grouped samples that are likely to 
have very different biological functions, for example there were a small number of 
samples containing mainly L. iners and L. jensenii that were clustered with samples 
containing higher levels of BV-associated anaerobes together with lactobacilli. This 
has occurred because these sample types were rare and therefore did not fit well 
with other profiles. However, only a relatively small number of samples were 
affected and is likely to be no more of a problem than in any other study utilising 
hierarchical clustering to delineate community types. 
As in our study, the L. iners dominated VMB type is usually common and in many 
populations represents the most frequently encountered VMB type (Frank et al 
2012, Ravel et al 2011, Zhou et al 2010). In contrast, the prevalence of a L. 
crispatus-dominated VMB is highly variable between populations and may be 
uncommon (Frank et al 2012, Hummelen et al 2010) or represent the most frequent 
VMB type present (MacIntyre et al 2015, Mitra et al 2015). In our study, an L. 
crispatus-dominated VMB was only present in 6.3% and 8.5% of women at baseline 
and endline, respectively and an L. jensenii-dominated VMB was rare, present in 
0.9% of women at endline only. This relatively low level may be due to the racial 
background of the HARP cohort, in which most women identified as black. Several 
studies have shown that, while race does not generally appear to affect the types of 
VMB profiles encountered, it does influence the frequency of each type. When 
compared to women with white or Asian background, black populations tend to have 
a lower proportion of women with L. crispatus- and L. jensenii-dominated VMB and 
a higher proportion of mixed high-diversity VMB communities, typical of BV as well 
as a higher prevalence of BV-associated bacteria in general (Borgdorff et al 2017, 
Fettweis et al 2014, Ravel et al 2011, Srinivasan et al 2012, Zhou et al 2010). For 
example, in a sample of healthy non-pregnant North American women of 
reproductive age 23/104 (22%) of black women had an L. crispatus-dominated 
microbiome, compared to 44/97 (45%) of white women and 24/96 (25%) of Asian 
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women (Ravel et al 2011). In two other studies conducted in North American 
populations, the percentage of black women with this VMB type was even lower at 
below 10% in a group of 960 African-American women (Fettweis et al 2014) and 
19/459 (4%) of samples from 16 individuals in another (Gajer et al. 2012). A more 
recent study in a population of healthy women in Amsterdam found similar results 
with 17/109 (16%) African-Surinamese women and 15/74 (20%) of Ghanaian 
women having a L. crispatus-dominated microbiome compared to 38/99 (38%) of 
Dutch women (Borgdorff et al 2017). 
A further potential contributing factor influencing the prevalence of different VMB 
types in our study is the fact that all women were HIV-positive. Several studies have 
shown that BV prevalence is higher among women with HIV infection (Chehoud et 
al 2017, Dols et al 2011). While it has also been shown that disturbances in the 
VMB are a risk factor for HIV acquisition (Gosmann et al 2017, Low et al 2011), it is 
less clear whether HIV infection itself has an effect on VMB composition. Studies 
that have used molecular methods to characterise the VMB have found variable 
results on the association between community types and individual bacterial species 
and HIV infection, probably because the sample sizes were generally small. 
However, of those that reported a significant difference or trend between HIV-
positive and HIV-negative women, most found that HIV-positivity was associated 
with lower relative abundance of lactobacilli, in particular L. crispatus and/or L. 
jensenii, higher overall bacterial diversity and increased levels of BV-associated 
bacteria, such as G. vaginalis, A. vaginae and Prevotella (Benning et al 2014, 
Dareng et al 2016, Demba et al 2005, Dols et al 2012, Gautam et al 2015, Mitchell 
et al 2013, Pépin et al 2011, Redelinghuys et al 2017, Schellenberg et al 2011). 
This is consistent with the results of our study in which a high diversity VMB 
consisting of a mixture of anaerobes was relatively common and a VMB dominated 
by L. crispatus or L. jensenii was not. In this study, the prevalence of an L. 
crispatus-domintated VMB type (6.3% and 8.5% of women at baseline and endline, 
respectively) was relatively low compared to other studies. One study using next-
generation sequencing of the V4 region of the 16S rRNA gene to characterise the 
microbiome of healthy black South African women of reproductive age reported an 
L. crispatus-dominated VMB in 23/236 (10%) of women (Gosmann et al 2017). 
Other studies conducted in South Africa using culturing techniques or qPCR 
reported a higher prevalence of L. crispatus ranging between 22-25% (Damelin et al 
2011, Jespers et al 2015, Pendharkar et al 2013). However, these differences might 
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be explained by differences in methodology, since in the latter studies presence of 
L. crispatus, rather than dominance, was measured. A further study on South 
African women showed that women with HIV infection had significantly lower levels 
of L. crispatus, compared to uninfected women (Dols et al 2012).    
While the reason for the association between HIV infection and the VMB requires 
further investigation, it is possible that HIV infection causes a shift in vaginal 
bacterial community structure. Since this study did not include HIV-negative women, 
this was not addressed and is one of the limitations of our study. If that were to be 
the case, and given that HIV infection is also associated with incidence and 
persistence of HR-HPV infection, it may confound the relationship between the VMB 
and HR-HPV infection and cervical cancer. By conducting an analysis stratified by 
HIV status, Dareng and others (Dareng et al 2016) found some evidence that HIV 
status may actually modify the association between the VMB on HR-HPV infection: 
as measured by weighted UniFrac, VMB composition differed significantly between 
HR-HPV positive and HR-HPV negative women, but only among those women that 
were HIV-negative. HIV status is effectively controlled for in our study by the 
exclusion of women without HIV. If HIV infection does weaken the association 
between the VMB and HR-HPV infection, this might explain the relatively small 
associations found in this study when compared to others with a similar or smaller 
sample size, highlighting the importance of taking HIV status into account. 
4.6 Conclusion 
In summary, this population of women at high risk of HR-HPV infection and cervical 
cancer showed a distribution of VMB types typical of women with black ethnic 
background and HIV infection. Our results support an association between HR-HPV 
infection and a high diversity VMB with a paucity of lactobacilli, especially L. 
crispatus. Conversely, we found no evidence of an association of the VMB with CIN, 
beyond that due to HR-HPV infection. However, the number of CIN2+ endpoints in 
this study was too small to draw definitive conclusions and this may have been 
compounded by the fact that all women were HIV-positive. Future studies 
investigating the relationship between the VMB and HR-HPV should aim to have a 
larger sample size, take HIV status into account and aim to characterise the VMB 
using newer, more accurate methods of species definition. Furthermore, studies on 
the relationship between the VMB and CIN should use appropriate comparison 
groups to avoid confounding due to persistent HR-HPV infection.  
140 
 
CHAPTER 5: General Discussion 
The overall aim of this study was to accurately characterise the vaginal microbiome 
(VMB) of HIV-positive South African women to determine whether there is an 
association between the bacteria that inhabit the vaginal niche and high risk human 
papillomavirus (HR-HPV) infection and the progression to cervical cancer. Although 
shotgun characterisation of total DNA in vaginal samples would have provided 
details on the metabolic potential of the bacterial population and may have provided 
less biased data on proportional abundance, it does require a much greater 
sequencing effort and is currently prohibitively expensive for large scale 
epidemiological studies such as VMB-HARP. Therefore the method of choice for 
this study was to use the 16S rRNA gene as a marker to determine the bacterial 
taxa present in each sample, which has the additional advantage that public 
databases contain far more comprehensive information on the 16S rRNA genes of 
vaginal bacteria, than on their genomes as a whole. 
5.1 Optimising 16S rRNA Microbiome Characterisation 
Despite its obvious advantages, there are a number of potential biases associated 
with 16S rRNA sequencing which should not be ignored. Accurate interpretation of 
results can only be achieved if researchers make every effort to choose protocols 
that minimise bias by carrying out sufficient validation work and by using appropriate 
controls. Of course it would not be feasible to explore every potential source of bias 
in every study and therefore a choice must be made – based on the available 
literature – as to which parts of the methods are most likely to require validation or 
optimisation. Unfortunately, even after all effort is made it is inevitable that some 
bias will remain and it is equally important to be aware of how the choice of methods 
has affected the results. At the beginning of this study, we therefore set out to 
answer the following questions relating to the methodology: 
1. Are samples stored in BoonFix® at room temperature suitable for characterising 
the microbiome by 16S rRNA amplicon sequencing? 
2. Does the use of bead-beating or enzymes in addition to lysozyme in the DNA 
extraction process significantly alter the VMB profiles obtained by 16S rRNA 
amplicon sequencing? 
3. Are the microbiome profiles obtained by 16S rRNA amplicon sequencing 
significantly contaminated by bacteria originating from the extraction kit and if so 
how can this signal be minimised? 
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4. What influence does PCR bias have on the microbiome profile obtained? 
5. How accurate is operational taxonomic unit (OTU) delineation using sequence 
read clustering methods based on a similarity threshold and how accurate are 
taxonomic assignments inferred from the most abundant DNA sequence in these 
OTUs using RDP classifier? Can newer clustering methods improve on this? 
These questions have been addressed in Chapters 2 and 3, and I discuss the 
implications and limitations of our findings for each of them below. 
5.1.1 Storage in BoonFix® at room temperature 
The question of whether samples stored in BoonFix® at room temperature are 
suitable for characterising the VMB by 16S rRNA amplicon sequencing was 
particularly relevant for the VMB-HARP study, since the samples had already been 
collected and stored in this way. Even though the Witwatersrand Reproductive 
Health and HIV Institute (WRHI) research clinic in South Africa where the samples 
were sourced is well equipped, freezer space is limited and storage in a fixative at 
room temperature was therefore an attractive option. Vaginal samples stored in 
BoonFix® have previously been used for VMB characterisation (Dols et al 2011), 
but there is no published literature comparing microbiome profiles obtained from 
these samples to profiles obtained from frozen specimens, which are more 
commonly used. We were able to show that samples stored in BoonFix® produce a 
VMB profile that is comparable to samples stored frozen at -80°C. We did this firstly 
by comparing a subset of vaginal swabs stored in BoonFix® with cervical brush 
samples collected at the same time and stored frozen in PBS-methanol, and 
secondly by comparing VMB profiles produced from frozen cervico-vaginal lavage 
samples extracted either directly or first stored for an additional period of 7 months 
in BoonFix® at room temperature. 
One possible limitation of this work is that we were unable to compare VMB profiles 
from stored samples with those obtained by immediate processing of fresh samples. 
This is important because studies using faecal samples have reported that freeze-
thawing alters community composition when compared to direct processing of fresh 
samples (Bahl et al 2012, Fouhy et al 2015). However, it is possible that the length 
of time fresh samples were kept aside prior to processing (up to 4 hours in one 
study) may have caused the differences found by allowing bacterial division to take 
place. Furthermore, most studies on faecal sample storage conclude that any effect 
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on microbiome profiles is small when compared to the differences between different 
individuals (Bahl et al 2012, Carroll et al 2012, Fouhy et al 2015, Roesch et al 2009, 
Tedjo et al 2015), making freeze-thawing unlikely to affect the results of large scale 
microbiome studies in a significant way. 
Two recent studies on faecal samples showed that storage at room temperature for 
8 weeks in a fixative (95-100% ethanol or OMNIgene Gut kit) produced results that 
are comparable to processing on the day of collection (Hale et al 2015, Song et al 
2016). As far as I am aware, there is currently no published literature on the 
suitability of samples stored for a longer period at room temperature for 16S rRNA 
amplicon studies. Our results provide proof of principle that achieving meaningful 
results using samples stored for several months is possible, which is especially 
relevant to studies conducted in poor resource settings where freezers are either 
unavailable or the electricity supply to run such equipment is unreliable. 
5.1.2 Bacterial cell lysis efficiency with bead-beating and enzymes 
In a study using a mock community, Yuan and others (2012) found that the choice 
of DNA extraction method biases 16S rRNA microbiome profiles. Their findings 
suggested that the addition of further enzymatic digestion steps to the Qiagen 
QIAamp DNA mini kit protocol could improve the accuracy of obtained profiles when 
compared to the expected result. In particular, protocols including the enzyme 
mutanolysin (with or without additional enzymes and bead-beating) produced a 
significantly better approximation of the expected community profile when compared 
to the other methods. Although these other methods used different commercial 
extraction kits and the protocols therefore differed in more ways than the addition of 
the enzymatic digestion step, this does suggest that the pretreatment with lysozyme 
could be insufficient to satisfactorily lyse all bacteria in a sample. Furthermore, 
several studies have reported increased extraction efficiency and/or increased 
proportional abundance of gram-positive bacteria – particularly the hard-to-lyse taxa 
Staphylococcus and Streptococcus – in extraction protocols that include a bead-
beating step (Abusleme et al 2014, Guo and Zhang 2013, Knudsen et al 2016, 
Salonen et al 2010, Wagner Mackenzie et al 2015, Willner et al 2012, Yuan et al 
2012). However, these extraction protocols again differed in several other ways. We 
therefore wanted to determine whether vaginal sample profiles extracted with a 
commercial DNA extraction kit (the Qiagen DNeasy Blood and Tissue kit including 
the recommended pretreatment with lysozyme), differed significantly if the protocol 
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was modified by prolonging the lysozyme digestion step, the addition of mutanolysin 
and lysostaphin to the enzymatic digestion step or the addition of a bead-beating 
step. However, we found few differences in VMB profiles between protocols and 
these were greatly outweighed by the biological variation between samples. We 
therefore concluded that the addition of further steps to the DNA extraction protocol 
is not necessary when working with vaginal samples. In agreement with our results, 
most studies comparing different extraction protocols on environmental or clinical 
samples also reported that differences between extraction methods were smaller 
than those relating to biological variation (i.e. differences between 
samples/subjects) (Kennedy et al 2014, Salonen et al 2010, Wagner Mackenzie et 
al 2015). Although this means that the underlying biological signal is not obscured 
by the choice of extraction kit, it is advisable to use the same protocol for all 
samples within a study and take into consideration the differences in extraction 
protocol when making comparisons between studies. 
5.1.3 Contamination in 16S rRNA amplicon studies 
It has been demonstrated relatively recently that bacterial contamination of 
commercial DNA extraction kits results in contaminant sequences in microbiome 
profiles (Salter et al 2014). It was therefore important to identify any such 
contaminants in our dataset by the inclusion of negative extraction controls on all 
sequencing runs. We found several contaminants originating from both Qiagen kits 
used in this study, the DNeasy Blood and Tissue kit and the QIAsymphony DSP 
Virus/Pathogen kit. The most common contaminant in both these kits was 
Rhodanobacter glycinis/terrae, followed by Pseudoalteromonas 
mariniglutinosa/prydzensis/tetraodonis and Vibrio metschnikovii. These species 
have been isolated from soil and water samples (Bowman 1998, Jellouli et al 2009, 
Romanenko et al 2003, Weon et al 2007), making them obvious candidates as 
reagent contaminants. Rhodanobacter has also been reported as part of the human 
vaginal and semen microbiome, being found at 4.6% in one sample in the vaginal 
study and at a median abundance of 2.1% in semen (Audirac-Chalifour et al 2016, 
Weng et al 2014). Both studies used Qiagen extraction kits and neither reported the 
use of negative controls. 
It has been observed that kit contamination is most significant for low biomass 
samples (Salter et al 2014), and our data supports this finding (see Appendix B). 
The vaginal niche is a rich source of bacteria and therefore usually yields plenty of 
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bacterial DNA such that contamination from reagents is trivial. Consistent with this, 
the sequencing results from the cervicovaginal lavage samples described in 
sections 2.6 and 2.7 contained only a negligible amount of contaminant sequences. 
However, vaginal swab samples are likely to yield less DNA which could explain the 
very low DNA concentration in extracts from BoonFix®-stored samples. 
Interestingly, although others have found that storage in ethanol-based media may 
additionally reduce this yield (Hale et al 2015, Vlčková et al 2012), we actually found 
that storage in BoonFix® for 7 months significantly increased DNA yield. Low DNA 
yield would have led to poor sequencing results, making it important to optimise this 
step. We were able to do this by including the vaginal swab in the extraction 
process during the proteinase K/"buffer AL" digestion step, allowing us to avoid high 
levels of contaminants in the results. In future it would be prudent for all 16S rRNA 
amplicon studies to include negative extraction and PCR controls, allowing either 
the elimination of significant contaminants by laboratory method optimisation or 
failing that their elimination from the dataset after sequencing. 
Apart from contaminants originating from the DNA extraction kit and PCR reagents, 
we identified another source of contamination in the cervical brush samples stored 
in PBS-methanol. The most abundant of these was a Methylobacterium sp, which 
was present in 6/8 samples at up to 28.3% relative abundance. This genus is 
normally associated with soil and water (Dourado et al 2015) and has been 
identified as a reagent contaminant in this study (see Appendix G) and others 
(Salter et al 2014). The likely reason for this bacterium to be such a significant 
contaminant of the PBS-methanol samples is that these aerobic bacteria are able to 
grow using methanol (Dourado et al 2015) and they probably flourished in the 
medium before addition of the vaginal samples and subsequent freezing. The fact 
that these bacteria were contaminants was obvious in our data due to their absence 
from the paired BoonFix® samples. However, their biology and in particular the 
ability to metabolise methanol alone raised a red flag. Considering these results it is 
advisable to treat any bacteria reported as part of the human microbiome but more 
usually reported in environmental samples as potential contaminants. Researchers 
should think carefully about the suitability and handling of storage media and use 
negative storage medium controls to aid in the identification of possible 
contaminants. 
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5.1.4 PCR bias in 16S rRNA amplicon studies 
Previous work indicated that the PCR step can be a significant source of bias in 16S 
rRNA studies with perhaps the greatest differences being caused by primer 
mismatches, where the primer sequence is not an exact match to the template DNA 
(Brooks et al 2015, Hong et al 2009, Schirmer et al 2015, Tremblay et al 2015). 
Primer choice may also cause bias due to different amplicon lengths (with longer 
amplicons being less efficiently amplified) and differences in amplification and 
annealing efficiency (He et al 2013, Lee et al 2012, Tremblay et al 2015). In order to 
help understand the bias caused by our primer choice, we compared the profiles 
obtained from a mock community of six vaginal species pooled either before or after 
PCR. We were able to show that there was preferential amplification of 
Lactobacillus crispatus and Prevotella bivia over Lactobacillus iners, Lactobacillus 
jensenii, Atopobium vaginae and Gardnerella vaginalis. However, since 16S rRNA 
amplicon studies determine the relative abundance of bacteria, we cannot draw any 
conclusions on how primer choice might have altered the relative abundance of taxa 
in any given vaginal sample because that is dependent on all of the other bacterial 
species present in that sample. What we have shown is that even where primers 
are an exact match to the template, PCR bias can result in proportional abundances 
that differ from those expected and this could not be entirely explained by 16S rRNA 
copy number, amplicon length or G+C content. 
Due to this bias, comparisons between studies using different primer sets should be 
made with caution, particularly since – in agreement with our results – the PCR step 
may represent the most significant source of bias in 16S rRNA amplicon studies 
(Brooks et al 2015, Hong et al 2009, Schirmer et al 2015, Tremblay et al 2015). 
5.1.5 Optimising OTU delineation and taxonomic assignments 
Classification to the species level is desirable in VMB research, especially for the 
Lactobacillus genus, where many studies have shown there to be differences in 
terms of the association of different species with health outcomes. For example, 
several studies have found an association between HIV infection and decreased 
vaginal lactobacilli in general, but the effect is strongest with L. crispatus (van de 
Wijgert et al 2014). However, identification to species level from 16S rRNA 
sequencing data alone can be problematic. This is partly due to the fact that most 
studies have used OTU clustering algorithms that rely on an identity threshold which 
bin any sequences that share at least that similarity into the same OTU. Therefore, 
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if the identity threshold is set to 97%, there is potential for sequences that share 
only 94% sequence identity to be placed in the same OTU (which would happen if 
both sequences share 97% to the centroid sequence but none of these differences 
are mutual). The similarity between two sequences from closely related species is 
often much higher than that (see Appendix E). In Chapter 3, we showed that using 
an arbitrary similarity threshold for binning sequences into OTUs can result in 
separate species being merged into a single OTU and in a single species being split 
into more than one OTU. This occurred for example with reads from L. jensenii, 
some of which were binned with L. crispatus reads, and with reads from 
Lactobacillus amylovorus which were all binned together with L. crispatus reads. 
Although we have shown that this inadequate species separation does not generally 
alter the representative sequence obtained for the major species in the dataset, it 
does mean that less abundant species are more likely to be subsumed into OTUs 
consisting of other species, making the species IDs of any one sequence within a 
particular OTU far less certain than the ID obtained for that OTU's reference 
sequence. We also showed that using newer OTU clustering methods such as 
DADA2 and Swarm considerably improves OTU delineation, thereby greatly 
improving the accuracy of species identification from 16S rRNA amplicon 
sequencing data. Although we confirmed that DADA2 can separate DNA sequences 
that differ by only a single nucleotide, we found that in some cases read error was 
insufficiently dealt with such that the L. jensenii and L. iners controls that should 
have consisted of a single OTU also contained multiple smaller erroneous OTUs. 
We therefore recommend the use of Swarm, which can accurately separate DNA 
sequences that differ by at least 2 nucleotides. 
In addition to OTU binning, the accuracy of taxonomic assignments of reads is 
critically dependent on the bioinformatics programme used to assign taxonomy. One 
such programme that is commonly used in VMB studies is RDP classifier. The 
potential for error with this tool was nicely illustrated by the results of Chapter 3 
where Bacillus subtilis in the Zymo Microbial standard was incorrectly identified as 
Bacillus mojavensis in two of the pipelines. When the representative DNA sequence 
for this bacterium is input into the assignSpecies function in DADA2 and searched 
against the Silva v. 128 database with multiple matches enabled, an exact match is 
found to a total of nine different species, including B. mojavensis as well as the 
correct species, B. subtilis. In both cases where the sequence was incorrectly 
identified by RDP classifier, the bootstrapping confidence value was comparatively 
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low (0.80 and 0.86). At this level of accuracy, RDP classifier may misidentify up to 
30.8% of species (Wang et al 2007). Despite this, the confidence level of 
assignments is often not reported in microbiome studies that have used RDP 
classifier, nor is the cut-off used to make a positive identification, with the default 
often being as low as 0.50, at which level the accuracy of taxonomical assignments 
can fall below 50%. For researchers who are not familiar with the species 
identification methods used, this leads to misplaced confidence in taxonomic 
assignments. The problem of species identification can be illustrated further by 
considering the case of the fourth most common Lactobacillus OTU in the VMB-
HARP dataset, which was an exact match to five Lactobacillus species in the Silva 
v. 128 database according to the assignSpecies function: L. crispatus, Lactobacillus 
gasseri, Lactobacillus helveticus, Lactobacillus johnsonii and Lactobacillus 
kefiranofaciens. RDP classifier identified this OTU as L. gasseri with a high 
bootstrap value of 0.99. These results could be explained by two scenarios: the first 
is that there are indeed five species of Lactobacillus encompassing one or more 
strains that all share an identical DNA sequence in the V3-V4 region and RDP 
classifier has identified only one of them. However, it is also possible that there are 
inaccuracies in the Silva database, whereby some DNA sequences are incorrectly 
labelled. This could lead to some species being listed as possible IDs by 
assignSpecies when they should not be, resulting in unnecessarily ambiguous 
species assignments. However, in consideration of the fact that DADA2's 
assignSpecies function provided a more satisfactory result in the case of B. subtilis 
and that RDP classifier was inconsistent in its ability to assign the L. jensenii control 
to species level in different pipelines, (despite the reference DNA sequence being 
the same), we recommend the use of DADA2's assignSpecies function in addition 
to or instead of the species IDs provided by RDP classifier. 
Ultimately it is up to individual research groups to decide how to report taxonomic 
assignments by finding a balance between accuracy, clarity and comparability with 
other studies. Accuracy of taxonomic assignments with DADA2 depends critically on 
the accuracy and completeness of the 16S rRNA sequence database when 
searching for exact matches to the reference sequence with assignSpecies. The 
choice of database also affects the results with RDP classifier, which may be 
particularly important when working on less well studied microbial niches that may 
be poorly represented in public databases (Newton and Roeselers 2012). By 
comparison, the differences in the taxonomies associated with each database 
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appear to have less of an effect (Werner et al 2012). For the VMB-HARP study, we 
chose to use the current version of the Silva database, which has the advantage 
that it is regularly updated and that all sequences are quality checked. Although 
Silva contains fewer sequences than the Greengenes database, this is likely to be 
less of a problem for well-studied environments such as the vaginal niche. 
Finally it must be noted that even with improved bioinformatics methods, it may not 
be possible to call species definitively, as it would require each species to have a 
unique DNA sequence in the region of the 16S rRNA gene being sequenced and 
this is often not the case (see Appendix E). For example, in the V3-V4 region, the 
DNA sequence for L. crispatus is identical to Lactobacillus gallinarum. Although the 
latter is not associated with the vaginal niche, it is evident that L. crispatus cannot 
be conclusively identified based on its DNA sequence in the V3-V4 region alone. 
Despite this, VMB studies using this region often refer to an L. crispatus OTU, 
without any mention that this ID entails a degree of uncertainty. 
5.1.6 The use of 16S rRNA sequencing to study the vaginal microbiome 
This thesis has demonstrated that methods optimisation is important to achieve 
accurate results in 16S rRNA amplicon studies and extract as much information as 
possible from the resulting data. Some remaining bias cannot be avoided, of which 
the choice of primers has perhaps the greatest impact. It is therefore important that 
researchers are aware of this potential bias and clearly state which primers have 
been used in their work by not burying this information in the methods section. 
While greater uniformity in methods within the VMB community would be desirable 
in order to maximise the comparability of studies, this is currently difficult to achieve 
as we are in an era during which genomics and bioinformatics methods are 
constantly evolving and improving. Alternatively, research groups should strive to 
optimise their own techniques and make use of improved methods when they 
become available in order to produce accurate, future-proof data. Only then can we 
hope to answer the outstanding questions in VMB research and use this information 
to improve human health. 
5.2 The Vaginal Microbiome, HR-HPV and Cervical Cancer 
5.2.1 The vaginal microbiome and its association with HR-HPV infection 
The majority of the research on the association between the VMB and HR-HPV 
infection has been carried out using data on bacterial vaginosis (BV), diagnosed by 
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Nugent or Amsel score. From these studies, there is good evidence that there is a 
positive association between vaginal dysbiosis and HR-HPV infection (Gillet et al 
2011, Gillet et al 2012). Although most studies were cross-sectional such that 
conclusions cannot be drawn on the temporality of this association, there is some 
evidence from two large multicentre cohort studies that BV (defined as a Nugent 
score of 7 or higher) is a risk factor for incident HR-HPV infection (King et al 2011, 
Watts et al 2005). One of these studies also found that BV slightly increased the risk 
for delayed clearance of HR-HPV infection (King et al 2011). Importantly, there was 
extensive control in both studies for HIV-related and other covariates and the 
associations between BV and HR-HPV remained after adjustment for these. 
However, both studies enrolled large numbers of HIV-positive and a smaller number 
of HIV-negative women at high risk of HIV infection, which could affect the 
generalisability of the results. Little is known about whether there is also an 
increased risk of incident BV after HR-HPV infection. 
We have shown that the data from 16S rRNA sequencing correlate well with the 
Nugent score used for the diagnosis of BV and this concurs with the findings of 
others (Ravel et al 2011). However, it is also evident that the Nugent score does not 
provide the level of detail that can be revealed by 16S rRNA sequencing and which 
is likely to be relevant for health outcomes. For example, it is increasingly 
recognised that different lactobacilli have different associations with health (van de 
Wijgert et al 2014) and these species are not distinguished by the Nugent score. By 
using 16S rRNA sequencing we were able to describe the VMB in the VMB-HARP 
cohort in much more detail. 
In doing so, we have found an association between HR-HPV infection and a VMB 
that is made up of a diverse population of bacteria and is low in lactobacilli. This is 
broadly in agreement with the findings of other studies (Borgdorff et al 2014, 
Brotman et al 2014, Di Paola et al 2017, Dols et al 2012, Gao et al 2013, Lee et al 
2013, Oh et al 2015, Reimers et al 2016). However, considering that previous 
studies have found convincing associations between the VMB and HR-HPV 
infection despite having a much smaller sample size (Brotman et al 2014, Di Paola 
et al 2017, Lee et al 2013), the associations found in our study were smaller than 
expected. One possible explanation for this is that the VMB-HARP study was 
restricted to HIV-positive women which is likely to have reduced the size of the HR-
HPV negative control group, since HIV positive women have a higher prevalence 
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and persistence of HR-HPV infection (King et al 2011, Watts et al 2005). 
Concurrently, the number of women with a L. crispatus-dominated microbiome was 
small. Furthermore, there is some limited evidence to suggest that HIV infection 
could modify the association between the VMB and HR-HPV infection (Dareng et al 
2016). To date there are only four molecular studies on the VMB and HR-HPV 
infection that have taken HIV status into account (Borgdorff et al 2014, Dareng et al 
2016, Dols et al 2012, Reimers et al 2016), but the sample sizes of these studies 
were too small to definitely determine whether HIV infection was an effect modifier 
or confounder. However, the aforementioned longitudinal cohort studies that 
investigated the relationship between BV and HR-HPV both concluded that while 
HIV infection was associated with changes in the VMB, it did not modify the 
determined odds ratios between BV and HR-HPV (King et al 2011, Watts et al 
2005). Future studies should aim to include a large enough sample size to include 
HIV as a potential confounder or effect modifier, or otherwise limit themselves to 
HIV-positive or HIV-negative women, a choice that will depend on the study 
objectives. 
The results of the VMB-HARP study also indicate that an L. crispatus-dominated 
microbiome carries a lower risk of concurrent detection of HR-HPV than does an L. 
iners-dominated microbiome, which is in agreement with previous studies (Borgdorff 
et al 2014, Brotman et al 2014, Dols et al 2012, Reimers et al 2016). We also 
showed that in comparison to an L. crispatus-dominated microbiome, an L. iners-
dominated microbiome or one containing a smaller proportion or L. iners together 
with BV-associated anaerobes more often transitions to a microbiome typical of BV. 
This agrees with the findings of others (Gajer et al 2012, Mitchell et al 2009, 
Verstraelen et al 2009) and may at least in part explain why L. crispatus has been 
found to have a stronger association with positive health outcomes than L. iners. 
However, the mechanisms behind these differences are still poorly understood and 
warrant further investigation. 
5.2.2 Is the vaginal microbiome associated with precancerous cervical 
changes? 
Interesting results from the field of gastrointestinal research suggest that the 
microbiota can play an important role in the development of cancer. Recent work 
has suggested that metabolites produced by members of the gastrointestinal 
microbiome can either promote cancer development or suppress 
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carcinogenesis (Louis et al 2014). Additionally, specific bacterial species have been 
implicated in certain cancers. In particular, Helicobacter pylori, a common member 
of the gastrointestinal microbiome, has been linked to the development of gastric 
ulcers and cancer. It is currently the only bacterium recognised as carcinogenic to 
humans by the IARC (2018) and is thought to cause cancer by manipulating 
signalling pathways that promote inflammation and cell proliferation and survival 
(Gagnaire et al 2017). 
Similar mechanisms could be at play in the development of cervical cancer, and 
might be one explanation as to why some women with HR-HPV develop cervical 
cancer while most do not. In line with this, several studies have suggested a 
relationship between the VMB and cervical intraepithelial neoplasia (CIN), the 
precursor to cervical cancer (Audirac-Chalifour et al 2016, Engberts et al 2007, 
Lehtovirta et al 2008, Mitra et al 2015, Oh et al 2015, Piyathilake et al 2016). 
Additional limited evidence for a role of lactobacilli in reducing the risk of cancer is 
provided by in vitro work which has found that certain Lactobacillus spp. can be 
cytotoxic to gastrointestinal cancer cell lines (Choi et al 2006, Russo et al 2007). A 
more recent report found that L. gasseri and L. crispatus homogenates inhibited the 
growth of cancerous cervical cells when compared to normal cervical cells, but also 
reported an anti-apoptotic effect on the cancer cells (Motevaseli et al 2013). A 
further study found that live Lactobacillus delbrueckii did not have an apoptotic 
effect on cervical cancer cells in vitro, but did suppress cell migration which might 
suggest it could inhibit the formation of invasive cervical cancer. The authors also 
found a concurrent upregulation of E-cadherin expression in the presence of 
lactobacilli, which has been associated with a better prognosis in cervical cancer (Li 
et al 2017). In contrast, Kim and colleagues (2015) found no effect of Lactobacillus 
casei extracts on the growth of cervical cancer cell lines. While these studies 
suggest that there is potential for lactobacilli to influence the development and 
progression of cervical cancer, the biological relevance of their results is still 
unclear. 
Research on the role of the VMB in cervical cancer is still in its infancy and very few 
conclusions can be made from the data that is currently available. In particular, most 
epidemiological studies are cross-sectional and the small number of published 
longitudinal studies made no adjustment for HR-HPV infection status, which is likely 
to have confounded the results. Our study is the first longitudinal molecular study to 
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investigate the association between the VMB and CIN and to attempt to use women 
with persistent HR-HPV infection that did not develop precancerous lesions as 
controls. However, we found no convincing association between the VMB and 
precancerous cervical changes beyond that which may be due to HR-HPV infection. 
Larger well-designed longitudinal studies are needed to investigate this question 
further. Due to the slow progression of initial HR-HPV infection to cervical cancer, 
women should ideally be followed for a period of several years. Furthermore, in 
order to distinguish between the effects of HR-HPV and CIN, the control group 
should consist of women that are also HR-HPV positive. Finally, the consideration of 
potential confounders is vital, as there are several socio-demographic and health-
related variables that may potentially affect both VMB composition and HR-HPV 
infection. For example, HIV infection is associated with an altered VMB that has 
higher bacterial diversity, increased levels of BV-associated bacteria and is lacking 
in lactobacilli, in particular L. crispatus and L. jensenii and this is consistent with our 
findings in the VMB-HARP study (Benning et al 2014, Dareng et al 2016, Demba et 
al 2005, Dols et al 2012, Gautam et al 2015, Mitchell et al 2013, Pépin et al 2011, 
Redelinghuys et al 2017, Schellenberg et al 2011). Concurrently, women infected 
with HIV have a higher prevalence of HR-HPV which is probably a consequence of 
HIV-induced immunosuppression allowing the human papillomavirus (HPV) to 
persist and this in turn is a risk factor for the development of cervical cancer (Denny 
et al 2012, Moscicki et al 2004). It is therefore important that HIV status is not 
ignored in any future studies on the VMB and its association with cervical cancer 
since it could be an important confounder. 
5.2.3 Study limitations and future directions 
One of the limitations of this study, the small sample size of the HR-HPV negative 
control group, has already been mentioned. Additionally, our study was limited to 
HIV-positive women, which was hoped to increase statistical power, but also means 
that the results may not apply to the general population. Furthermore, although the 
study followed women over a median of 15.9 months, samples were only available 
from baseline and endline. More frequent sampling would have been ideal since 
HPV detection can be variable (Liu et al 2014) and the VMB is dynamic and may 
change over relatively short periods of time (Gajer et al 2012). The average time to 
clear an HPV infection reported in the literature is variable, ranging from 4-20 
months (Denny 2009). With a relatively long sampling interval it is therefore possible 
that some HPV infections classed as persistent may have been reinfections and a 
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shorter sampling interval of 4-6 months would have been ideal. Future work on the 
association of the VMB with HR-HPV and CIN should therefore encompass large 
cohort studies following women over a sufficiently long period of time and carrying 
out sampling at multiple time points. Furthermore, the control of potential 
confounders, including HIV and other STIs and socio-demographic variables is 
required to definitively determine if any association found is real. 
A further limitation of our study and other marker gene studies is that they provide 
limited information on how the VMB community functions, since they do not provide 
information on the rest of the genome, or what the bacteria are doing. Recently, a 
comparative genomics study of L. crispatus found that the bacterium encodes a 
protein with the potential to reduce the ability of G. vaginalis to adhere to epithelial 
cells in vitro (Ojala et al 2014). A further approach to investigate community function 
is to study gene expression using transcriptomics and proteomics techniques. Only 
a few studies have used these techniques so far but they can provide interesting 
insights into how the bacteria in the VMB interact. For example, using meta-RNA-
seq, Macklaim and others (2013) showed that the expression profile of L. iners 
markedly changes in the presence of BV and Borgdorff and others (2016a) used 
proteomics to demonstrate that L. iners glycolytic enzymes are significantly enriched 
under BV conditions. These studies highlight the potential for functional genomics 
studies in investigating the metabolic states of bacteria in the vaginal milieu.  
However, future studies need also to consider the influence of the host on the 
vaginal environment and its contribution to the metabolites present. For example, 
oestrogen is thought to have a strong influence on the VMB, with major shifts in 
bacterial populations occurring at puberty and menopause (Linhares et al 2011) and 
the use of hormonal contraceptives is associated with a reduced risk of BV (Van de 
Wijgert et al 2013). An obvious further means for cross-talk between the human 
host and the VMB is the mucosal immune system of the lower female genital tract, 
which is also under the influence of oestrogen (Wira et al 2000). The high diversity 
microbiome typical of BV has been associated with increased levels of pro-
inflammatory cytokines (Gautam et al 2015, Jespers et al 2017), indicating that 
there is a reaction to the presence of BV-associated microbes from the host. 
Gaining a better understanding of the vaginal microenvironment, and in particular 
elucidating the cross-talk between the human host and the VMB, as well as which 
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factors disrupt the balance between the two, should therefore be a priority for VMB 
research in the future. 
Nonetheless, the current study provides important information on the VMB 
associated with HPV infection and carcinogenesis, thereby providing a first step 
towards the development of novel and cost-effective screening and control 
strategies for the prevention of cervical cancer. Understanding which bacterial 
communities and/or species are involved in HPV infection and carcinogenesis will 
allow a targeted approach, for example by more frequent screening of high-risk 
individuals and by aiding the development of personalised prevention strategies. 
One such prevention strategy might be the development of effective probiotic 
treatments. Recent studies have shown that there is potential for probiotics to alter 
the vaginal flora and reduce the risk of STIs, including HR-HPV infection (Palma et 
al 2018). However, there is currently a paucity of good quality randomised controlled 
trials on the use of probiotics to prevent urogenital infections and other reproductive 
disorders and recent systematic reviews have concluded that there is only weak 
evidence for their use in the prevention of urinary tract infections (Schwenger et al 
2015), vulvovaginal candidiasis (Xie et al 2017) and preterm labour (Jarde et al 
2018) such that they cannot currently be recommended for clinical use in place of 
drug treatments. Clearly, more research is needed before recommendations on the 
use of probiotics to optimise health through manipulation of the VMB can be made. 
One of the challenges in making advances in this area is that different studies differ 
in the bacterial strains or species contained in the probiotics used and many have 
been carried out using species that are not normally associated with the vagina in 
any great number. This may significantly affect the results of clinical trials, 
particularly considering that several epidemiological studies have found differences 
in health benefits between different species of naturally occurring vaginal lactobacilli 
(van de Wijgert et al 2014). Determining which bacteria are associated with a 
reduced risk of HPV infection and carcinogenesis will aid in the choice of probiotic 
strains. In conclusion, research on the VMB has great potential for improving 
women's health. However, much more research is needed before these strategies 
can be implemented on a large scale with sufficient confidence in their accuracy 
and/or efficacy. 
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Appendix A: Gel Image Sample P01 
 
Figure A.1 Gel image of sample P01 described in section 2.3.2. The ladder is 
Bioline Hyperladder IV, this corresponding sizes of relevant bands are labelled in 
base pairs. The concentration of DNA in the BF-QS extract was too low to show a 
band. The PBS-QS extract shows a single band below 600 bp in size while the 
PBS-BT extract produced a double band around 600 bp. The positive control 
contains Lactobacillus amylovorus DNA, with an expected band size of 605 bp. The 
extraction control was produced from nuclease free water that was taken through 
the DNA extraction process alongside samples. The negative control is a PCR 
control that contained nuclease free water. 
  
190 
 
Appendix B: Reagent Contamination 
 
Figure B.1 Scatterplot of PCR product DNA concentration against the percentage of sample 
made up of Rhodanobacter OTU for each of the vaginal sample extracts described in 
section 2.2 (along with additional samples sequenced on the same run but not presented as 
part of this thesis). Rhodanobacter was the major contaminant of this sequencing run and 
can be thought of as a proxy for the degree of sample contamination. The DNA 
concentration of the sample extract (prior to PCR) is indicated by colour. Negative extraction 
controls are circled. Note that the axes are on a log scale. There is a significant negative 
correlation between PCR product concentration and the percentage of Rhodanobacter OTU 
(Spearman’s rank correlation coefficient -0.85; p < 0.0001). There is also a significant 
negative correlation between DNA extract concentration and the percentage of 
Rhodanobacter OTU (Spearman’s rank correlation coefficient -0.76; p < 0.0001). The 
relationship is likely to be less strong due to the fact that the relative abundance of 
contaminants is dependent on the amount of bacterial DNA in the sample and PCR product 
concentration provides a better estimation of this than DNA extract concentration (because 
the latter is also affected by the presence of eukaryotic DNA). In order to achieve a low level 
of contamination (defined arbitrarily as <1% of Rhodanobacter), PCR product concentrations 
of 1 ng/µl or higher are optimal, which can usually be reached for DNA extracts with 
concentrations of 1 ng/µl or higher (over 25 PCR cycles and by adding 10 µl to a 25 µl 
reaction). As is evident from the graph above, it was difficult to achieve this concentration 
with some of the samples, explaining the high levels of contamination. This is in part due to 
the removal of the swab head from these samples prior to analysis which is likely to have 
reduced yield (see section 2.4 and 2.5).   
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Appendix C: OTU Picking in QIIME with USEARCH 
In order to compare OTU picking using the pick_otus.py script in Quantitative 
Insights Into Microbial Ecology (QIIME v. 1.8.0)(Caporaso et al 2010) with method 
"usearch" using USEARCH v. 5.2.236 (Edgar 2010) with method "usearch61" using 
USEARCH v. 6.1.544 (Edgar 2010), read data from the samples described in 
section 2.2 were trimmed using Cutadapt v. 1.2.1 (Martin 2011), error corrected 
using SPAdes v 3.1.0 (Bankevich et al 2012) and paired-end aligned using PEAR 
v0.9.6 (Zhang et al 2014). All samples were included in de novo OTU picking as the 
presence of samples may affect clustering. Apart from the choice of method 
described above, default settings were used. The resulting profiles of the 
monoculture positive control sample were then compared. While method "usearch" 
resulted in lower OTU number across the whole dataset compared to method 
"usearch61" (N=567 compared with N=80,756), the former resulted in several larger 
OTUs in the positive control (Figure C.1). This appears to be due to an additional 
error correction step applied when using method "usearch" that aims to correct read 
error, but appears to erraneously inflate OTUs in this control sample.  
 
Figure C.1 Positive control (monoculture of Lactobacillus amylovorus) profiles created using 
method "usearch" and method "usearch61" using the pick_otus.py workflow script in QIIME. 
Horizontal line represents total number of reads aligned with PEAR. By default, method 
"usearch" excludes low abundance OTUs in the dataset as probable error (<4 reads in total), 
explaining the loss of reads with this method. Each colour represents a different OTU within 
each profile, but does not indicate equivalence across the two profiles. The black regions 
represent OTUs that are too small to resolve. 
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Appendix D: Base Quality and Paired-End Alignment  
Including the primer region, the V3-V4 region sequenced in this study is between 
440 and 474 bases in length. This means that, with an overlap region of 10 bases 
(the default minimum overlap using paired-end aligner PEAR), the paired end reads 
must be at least a combined length of 485 bases in order to cover all bacterial 
species that may be present in the sample. Therefore, using the Illumina 2x250bp 
system, if more than 15 bases in total are trimmed due to poor quality, the paired 
ends cannot be aligned. In the case of the two Illumina MiSeq runs described in 
section 2.6, the median phred score for read 1 was above 30 (=probability of 
incorrect base call is 1 in 1000) for both runs, indicating good base quality for read 
1. For read 2, the median phred score for the first sequencing run (samples 
described in section 2.6.2) was 30 at read position 240-249 and 24 at read position 
250 (see Figure D.1). By comparison, the median phred score for the second 
sequencing run (samples described in section 2.6.5) was 17 in region 240-259 and 
2 at read position 250 (see Figure D.1). The quality score of base calls is expected 
to decline as the run progresses resulting in a gradual drop of quality towards the 
end of a read. Poor read quality is usually dealt with in the bioinformatics pipeline, 
by trimming (i.e. removing low quality bases from the end of the read) to reduce the 
risk of erroneous results from incorrectly called bases. In the original bioinformatics 
pipeline, reads were demultiplexed and trimmed for the presence of Illumina adapter 
sequences and low quality bases (quality threshold Q = 20) using Cutadapt v. 1.2.1 
(Martin 2011) and Sickle v. 1.200 (github.com/najoshi/sickle), respectively. The 
resulting reads were error corrected using SPAdes v 3.1.0 (Bankevich et al 2012) 
and paired-end alignment was performed using PANDAseq v. 2.4 (Masella et al 
2012). The obtained sequences were then binned into operational taxonomic units 
(OTUs) based on 97% sequence similarity using USEARCH v. 5.2.236 (Edgar 
2010) through Quantitative Insights Into Microbial Ecology (QIIME v. 
1.7.0)(Caporaso et al 2010). This pipeline resulted in significantly lower alignment 
success for samples on the second run (median alignment success rate 88% vs. 
45%; P < 0.0001 by repeated measures ANOVA). Interestingly, alignment success 
appeared to be sample-dependent (i.e. all extraction methods showed the same 
pattern of alignment success rate with extracts from the same sample either aligning 
comparatively well across all methods, or comparatively poorly across all methods). 
The reason for this is likely to be sample composition since there was a differential 
effect on different OTUs, causing apparent disappearance of specific OTUs across 
all samples on the second sequencing run. This affected OTUs identified as 
193 
 
Prevotella sp. (two OTUs), Veillonella sp., Atopobium sp., Dialister sp., Mycoplasma 
sp., Ureaplasma sp., BVAB2 and Mageeibacillus indolicus (BVAB3). One of the 
Prevotella sp. OTUs, was absent from the BF extract (second sequencing run), but 
represented between 11 – 13% of all other extracts (first sequencing run). No 
difference in GC content of these OTUs and other OTUs could be identified (both 
along the length of the sequence and in the central region), nor was there any 
difference in sequence length. Even though it has been reported that 2x250bp 
compares well to 2x300bp using this 16S rRNA region (Fadrosh et al 2014) and the 
loss of reads could be at least partially corrected by altering the bioinformatics 
pipeline, it was decided that future sequencing would be performed using the 
2x300bp system rather than the original 2x250bp. However, the fact that quality 
trimming can dramatically and differentially affects OTU presence in the results 
should be borne in mind, and alignment success rates should always be evaluated 
and poor success rates investigated. This is particularly important when combining 
data from different runs that may differ in quality, but also between different samples 
on the same run. This is further highlighted by this same effect being observed with 
a positive control sample on a different Illumina MiSeq sequencing run (not 
presented in this thesis) that contained only Prevotella bivia LMG6452 DNA. Whilst 
the alignment success of samples was variable (range 23-91%), for this control only 
1% of reads aligned using the pipeline above. In light of these observations, quality 
checking this type of data for reads lost during the alignment step and investigating 
any discrepancies is recommended. 
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Figure D.1 Box and Whisker plot of per base sequence quality of read 2 for the two Illumina 
MiSeq runs described in sections 2.6.3 (upper graph) and 2.6.5 (lower graph). Boxes extend 
from the lower quartiles to the upper quartiles with median values indicated by the line within 
each box. Whiskers represent the 90th and 10th percentiles. The blue line represents the 
mean score. There is a significantly lower average base quality on the second run. Graphs 
generated by FastQC (version 0.10.1).   
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Appendix E: Global Similarity of Lactobacillus 16S 
rRNA Regions  
In the vaginal environment, Lactobacillus species are often well represented and 
previous studies have shown significant differences in the health benefits afforded 
by different Lactobacillus species. The ability to differentiate between them is 
therefore crucial for 16S rRNA amplicon sequencing studies of the vaginal 
microbiome. In order to determine what effect the choice of PCR primers would 
have on the ability to differentiate between the different Lactobacillus species, we 
used the following approach: 
Acquisition of sequence data 
Sequences of the 16S rRNA gene from lactobacilli species that had been reported 
in vaginal samples (Ljungh and Wadström 2009) were obtained from GenBank. 
Sequences were available from genome assemblies of the following species: L. 
acidophilus, L. brevis, L. crispatus, L. delbrueckii, L. fermentum, L. gasseri, L. 
helveticus, L. jensenii, L. johnsonii, L. paracasei, L. plantarum, L. reuteri and L. 
rhamnosus (see Table D.1). All sequences that were part of a complete genome 
assembly were obtained including each copy of the gene within the same genome 
(also including copies that had not been annotated as 16S rRNA genes but were 
identified as such based on sequence). Identical sequences from the same genome 
assembly were then removed. Additionally, sequences were obtained from partial 
sequences of the 16S ribosomal RNA gene from the following species for which 
whole genome assemblies were not available: L. gallinarum, L. iners and L. 
vaginalis (see Table D.1). Three commonly used regions of the 16S rRNA gene 
were selected based on their previous use in vaginal microbiome studies: V1-V2, 
V3-V4 and V6. The sequences for the V1-V2 region were extracted from each of the 
sequences above using the primer sequences AGAGTTTGATCCTGGCTCAG and 
TACGGYAGGCAGCAG (Jeon et al 2015).  The sequences for the V3-V4 region 
were extracted using the primer sequences ACTCCTACGGRAGGCAGCAG and 
GGATTAGATACCCTGGTAGTC (Jeon et al 2015). The sequences for the V6 
region were extracted using the primer sequences ACTYAAAKGAATTGRCGGGG 
and GARCTGRCGRCRRCCATGCA (Smith et al 2012). 
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Table E.1 List of GenBank bacterial 16S sequences used in this study.  
Bacterial strain Genome assembly Number of 16S 
copies identified 
L. acidophilus 30SC Y 4 
L. acidophilus La-14 Y 4 
L. acidophilus NCFM Y 4 
L. brevis ATCC367 Y 5 
L. brevis KB290 Y 5 
L. crispatus ST1 Y 4 
L. delbrueckii 2038 Y 9 
L. delbrueckii ATCC BAA-365 Y 9 
L. delbrueckii ATCC11842 Y 9 
L. delbrueckii ND02 Y 9 
L. fermentum CECT5716 Y 5 
L. fermentum F-6 Y 5 
L. fermentum IFO3956 Y 5 
L. gasseri ATCC33323 Y 6 
L. helveticus CNRZ32 Y 4 
L. helveticus DPC4571 Y 4 
L. helveticus H10 Y 4 
L. helveticus H9 Y 4 
L. helveticus R0052 Y 4 
L. jensenii JV-V16 Y 2 
L. johnsonii DPC6026 Y 4 
L. johnsonii FI9785 Y 4 
L. johnsonii N6.2 Y 4 
L. johnsonii NCC533 Y 6 
L. paracasei 8700_2 Y 5 
L. paracasei N1115 Y 5 
L. plantarum 16 Y 5 
L. plantarum JDM1 Y 5 
L. plantarum p-8 Y 5 
L. plantarum ST-III Y 5 
L. plantarum WCFS1 Y 5 
L. plantarum ZJ316 Y 5 
L. reuteri DSM20016 Y 6 
L. reuteri I5007 Y 6 
L. reuteri JCM1112 Y 6 
L. reuteri SD2112 Y 6 
L. reuteri TD1 Y 6 
L. rhamnosus ATCC53103 Y 5 
L. rhamnosus ATCC8530 Y 5 
L. rhamnosus GG Y 5 
L. rhamnosus Lc705 Y 5 
L. rhamnosus LOCK900 Y 5 
L. rhamnosus LOCK908 Y 5 
L. gallinarum ATCC33199 N N/A 
L. iners CIP109878T N N/A 
L. vaginalis DoxG3 N N/A 
 
Sequence alignment and percentage identity 
For each region, lactobacillus sequences were aligned using Clustal 2.1 (Larkin et al 
2007) and, after the alignment was visually checked for accuracy, the associated 
percentage identity matrix was used to determine sequence similarity. Primer 
regions were not included in the alignment, resulting in sequences totalling between 
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335-348 bases in length for the V1-V2 region, 427 bases in length for the V3-V4 
region and 123 bases in length for the V6 region. 
Results 
Within-species sequence similarity 
For those lactobacilli for which a genome assembly was available, between 2 (L. 
jensenii) and 9 copies (L. delbrueckii) of the 16S rRNA gene were identified within 
the same genome (see Table D.1). For region V1-V2, sequence similarity within the 
same genome (i.e. between multiple copies of the 16S rRNA gene) ranged from 
98.0-100.0%, with the lowest sequence similarity found within L. reuteri strain 
DSM20016. For region V3-V4, sequence similarity within the same genome ranged 
from 98.6-100.0%, with the lowest sequence similarity found within L. plantarum 
strain 16. For region V6, sequence similarity within the same genome ranged from 
87.0-100.0%, with the lowest sequence similarity found within L. jensenii strain JV-
V16. Additionally, L. delbrueckii strain ND02 also had a within-genome similarity 
below 97% (94.3%). 
Multiple genome assemblies were available for L. acidophilus, L. brevis, L. 
delbrueckii, L. fermentum, L. helveticus, L. johnsonii, L. paracasei, L. plantarum, L. 
reuteri and L. rhamnosus. For these lactobacilli, sequence similarity within the same 
species ranged from 95.25-100.0% for region V1-V2, with the lowest sequence 
similarity found between one of the 16S rRNA gene copies in L. acidophilus strain 
30SC and all copies of the gene in strains NCFM and La-14. For region V3-V4, 
sequence similarity within the same species ranged from 98.1-100.0%, with the 
lowest sequence similarity found between one of the 16S rRNA gene copies in L. 
plantarum strain 16 and one of the gene copies in strain p-8. For region V6, 
sequence similarity between different strains of the same species ranged from 94.3-
100.0%, with the lowest sequence similarity found between one of the 16S rRNA 
gene copies in L. delbrueckii strain ATCC11842 and the strains ATCC BAA-365 and 
2038. 
Between-species sequence similarity 
The highest inter-species similarity for the V1-V2 region was between L. gallinarum 
strain ATCC33199 and L. helveticus strains H9 and DPC4571 and some copies 
from strain CNRZ32 whose sequences were identical. The highest inter-species 
similarity for the V3-V4 region was between L. gallinarum strain ATCC33199 and L. 
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crispatus strain ST1 whose sequences were identical. In the V6 region, the highest 
inter-species similarity was between L. gasseri and L. johnsonii whose sequences 
were identical, and between L. rhamnosus and L. paracasei where all strains shared 
at least one identical sequence. 
Using a cut-off of 97%, the following species could not be separated using the V1-
V2 region: L. gasseri and L. johnsonii (with up to 98.8% inter-species similarity) as 
well as L. acidophilus, L. crispatus, L. gallinarum and L. helveticus. In the latter 
group, some similarities fell below the 97% cut-off and using a more stringent cut-off 
of 98% allowed separation of all species within this group, with the exception of L. 
gallinarum and L. helveticus. 
By comparison, using a cut-off of 97%, the following species could not be fully 
separated using the V3-V4 region: L. rhamnosus and L. paracasei (with up to 99.8% 
inter-species similarity), L. reuteri and L. vaginalis (with up to 99.8% inter-species 
similarity), L. gasseri and L. johnsonii (with up to 98.8% inter-species similarity), as 
well as L. acidophilus, L. crispatus, L. delbruekii, L. gallinarum, L. helveticus and L. 
jensenii. In the latter group, some similarities fell below the 97% cut-off, particularly 
in the case of L. jensenii. Using a more stringent cut-off of 98% allows separation of 
L. delbruekii and L. jensenii from each other and from the rest of the group. 
Finally, in the V6 region, using a cut-off of 97%, the following species could not be 
fully separated: L. rhamnosus and L. paracasei (with up to 100% inter-species 
similarity), L. gasseri and L. johnsonii (with 100% inter-species similarity), as well as 
L. reuteri and L. vaginalis (with up to 98.4% inter-species similarity).  
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Appendix F: Rarefaction Depth for VMB-HARP  
In order to find the rarefaction depth that achieves a good balance between 
maximising sample retention whilst discarding unreliable sample profiles, two 
approaches were used. First, for the subset of sample DNA extracts that had been 
PCR amplified and sequenced twice, the minimum read count of each sample pair 
was compared with the Bray Curtis similarity between pairs (see Figure F.1). 
Secondly, rarefaction curves were generated to determine at what sampling depth, 
the increase in discovered OTUs levelled off (see Figures F.2 and F.3). A read cut-
off of 1000 reads was deemed sufficient to ensure adequate sample quality and 
sequencing depth while also retaining a good number of samples. 
 
Figure F.1 Scatterplot showing repeatability of all vaginal sample extracts which underwent 
PCR and subsequent sequencing twice. The lower read count of the pair after removal of 
contaminant taxa is plotted against the Bray Curtis similarity score between the sample pair 
(where 0 is no match at all and 1 is a complete match). Data points are coloured by a 
subjective visual score which was assigned depending on how well the two sample profiles 
matched on a barchart. A partial match was defined as good concurrence in terms of taxa, 
but with obvious differences in proportions. The dotted line represents a read count of 1,000. 
Graph generated in R (version 3.2.2). 
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Figure F.2 Rarefaction curve of VMB-HARP samples from visit 1. The dotted line represents 
a read count of 1,000. Graph generated using the vegan package version 2.3-2 in R (version 
3.2.2). 
 
Figure F.3 Rarefaction curve of VMB-HARP samples from visit 5. The dotted line represents 
a read count of 1,000. Graph generated using the vegan package version 2.3-2 in R (version 
3.2.2).  
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Appendix G: Sequencing Contaminants  
PCR and DNA extraction contaminants in the VMB-HARP sequencing data were 
identified as described in section 4.3.6. Table F.1 lists PCR contaminants in order of 
decreasing abundance in controls. Table F.2 lists extraction contaminants in order 
of decreasing abundance in controls. The abundance of each contaminant OTU is 
given, as a percentage of total reads identified as contaminants within the set of 
controls.  
Table G.1 OTUs identified as PCR contaminants. The abundance of each contaminant OTU 
is given, as a percentage of total reads identified as contaminants within all negative PCR 
controls. 
PCR Contaminants  
Achromobacter denitrificans/ruhlandii/xylosoxidans 55.37% 
Stenotrophomonas maltophilia 24.79% 
Delftia acidovorans/lacustris/tsuruhatensis 10.74% 
Propionibacterium acnes/avidum 5.79% 
Pseudomonas 
azotoformans/cedrina/fluorescens/gessardii/grimontii/libanensis/marginalis/ 
poae/putida/reactans/syncyanea/synxantha 3.31% 
 
Table G.2 OTUs identified as extraction contaminants. The abundance of each contaminant 
OTU is given, as a percentage of total reads identified as contaminants within all negative 
extrraction controls. OTUs that were also identified as PCR contaminants, and may originate 
from this step are starred. 
Extraction contaminants  
Rhodanobacter glycinis/terrae 88.55% 
Pseudoalteromonas mariniglutinosa/prydzensis/tetraodonis 4.90% 
Vibrio metschnikovii 1.38% 
Flavobacterium sp. 0.76% 
Pseudomonas mendocina/pseudoalcaligenes 0.38% 
Aeromonas caviae/dhakensis/hydrophila/jandaei/media/salmonicida/veronii 0.31% 
Pseudarcicella sp. 0.21% 
Rhodoluna limnophila 0.20% 
Elizabethkingia sp. 0.18% 
Saccharibacteria sp. 0.13% 
Pseudomonas 
alcaligenes/alcaliphila/asplenii/chengduensis/indoloxydans/jessenii/mendocina/ 
nitroreducens/oleovorans/pseudoalcaligenes/toyotomiensis/trautweinii 0.13% 
Flavobacterium sp. 0.12% 
Flavobacterium sp. 0.10% 
Stenotrophomonas maltophilia 0.10% 
Flavobacterium sp. 0.10% 
Chryseobacterium sp. 0.09% 
Anoxybacillus flavithermus/kaynarcensis/tunisiense 0.09% 
Stenotrophomonas maltophilia* 0.08% 
Shewanella sp. 0.08% 
Fluviicola sp. 0.07% 
Sporichthyaceae sp. 0.07% 
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Propionibacterium acnes/avidum* 0.06% 
Streptococcus sp. FF10 0.06% 
Chryseobacterium sp. 0.06% 
Streptococcus alactolyticus/equinus/gallolyticus/macedonicus/pasteuri/ 
Pasteurianus 0.05% 
Fluviicola sp. 0.05% 
Stenotrophomonas sp. 26 0.05% 
Stenotrophomonas maltophilia 0.05% 
Streptococcus sp. 0.04% 
Cytophaga sp. 0.04% 
Curvibacter sp. 0.04% 
Curvibacter lanceolatus 0.04% 
Pseudomonas sp. 0.04% 
Cytophaga sp. 0.04% 
Chryseobacterium sp. 0.04% 
Flavobacterium sp. 0.04% 
Elizabethkingia meningoseptica/miricola 0.04% 
Limnohabitans curvus/planktonicus 0.04% 
Pseudomonas azotoformans/cedrina/fluorescens/gessardii/grimontii/libanensis/ 
marginalis/poae/putida/reactans/syncyanea/synxantha* 0.04% 
Microbacteriaceae sp. 0.04% 
Chryseobacterium sp. 0.04% 
Stenotrophomonas maltophilia 0.03% 
Paludibacter sp. 0.03% 
Sporichthyaceae sp. 0.03% 
Cloacibacterium sp. 0.03% 
Streptococcus sp. 0.03% 
Elizabethkingia sp. 0.03% 
Enterococcus cecorum 0.02% 
Pseudomonas veronii 0.02% 
Polynucleobacter asymbioticus/duraquae 0.02% 
Acetobacteroides sp. 0.02% 
Saccharibacteria sp. 0.02% 
Stenotrophomonas acidaminiphila/humi/maltophilia 0.02% 
Legionella sp. 0.02% 
Flavobacterium sp. 0.02% 
Fluviicola sp. 0.02% 
Comamonadaceae sp. 0.02% 
Fluviicola sp. 0.02% 
Methylobacterium aminovorans/extorquens/organophilum/podarium/populi/ 
pseudosasae/rhodesianum/suomiense/thiocyanatum/zatmanii 0.02% 
Sphingomonas sp. 0.02% 
Acinetobacter baumannii/junii 0.02% 
Sphingobacteriales sp. 0.02% 
Undibacterium sp. 0.02% 
Methylobacterium sp. 0.02% 
Microbacteriaceae sp. 0.02% 
Rhodanobacter sp. 0.02% 
Flavobacterium sp. 0.02% 
Clostridium sensu stricto 9 0.02% 
Holophagaceae sp. 0.02% 
Brevundimonas diminuta/naejangsanensis/vancanneytii 0.02% 
Paludibacter sp. 70 0.02% 
Limnohabitans sp. 0.02% 
Sporichthyaceae sp. 0.02% 
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Flavobacterium sp. 0.02% 
Sphingobacteriales NS11-12 marine group 0.02% 
Oligoflexales 0319-6G20 0.02% 
Sphingobacteriaceae sp. 0.02% 
Corynebacterium sp. 0.01% 
Methylophilus sp. 0.01% 
Acinetobacter gyllenbergii/tjernbergiae 0.01% 
Acinetobacter sp. 0.01% 
Bacteria sp. 0.01% 
Saccharibacteria sp. 0.01% 
Peptostreptococcaceae sp. 0.01% 
Pedobacter boryungensis 0.01% 
Gracilibacteria sp. 0.01% 
Spirochaeta 2 0.01% 
Collimonas sp. 0.01% 
Candidatus Campbellbacteria sp. 0.01% 
Sediminibacterium sp. 0.01% 
Elusimicrobia Lineage IIb sp. 0.01% 
Limnohabitans sp. 0.01% 
Neisseriaceae sp. 0.01% 
Tepidimonas arfidensis 0.01% 
Neisseriaceae sp. 0.01% 
Dechloromonas sp. 0.01% 
Flavobacteriaceae sp. 0.01% 
Chryseobacterium sp. 0.01% 
Acinetobacter sp. 0.01% 
Chryseobacterium sp. 0.01% 
Sphingomonas sp. 0.01% 
Brevundimonas sp. 0.01% 
Pseudomonas sp. 0.01% 
Paludibacter sp. 0.01% 
Thermicanus sp. 0.01% 
Flectobacillus sp. 0.01% 
Candidatus Campbellbacteria sp. 0.01% 
Pseudomonas sp. 0.00% 
Clostridiaceae 1 0.00% 
Pelomonas sp. 0.00% 
Alphaproteobacteria sp. 0.00% 
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Appendix H: Fine Scale Vaginal Microbiome Cluster Description in VMB-HARP Study  
Table H.1 Fine scale vaginal microbiome cluster descriptions in VMB-HARP study. Right hand columns represent the number of samples in each cluster at 
visit 1 and visit 5. 
VMB 
type 
Cluster Description Visit 1 Visit 5 Total 
Lcj D1 These samples are dominated by Lactobacillus acidophilus/casei/crispatus/gallinarum (63-100%). 22 30 52 
D2a These samples all contain Lactobacillus acidophilus/casei/crispatus/gallinarum (44-74%) with a lower 
relative abundance of Lactobacillus iners (25-41%). 
6 6 12 
G These samples are dominated by Lactobacillus jensenii (77-98%) together with variable proportions of 
Lactobacillus acidophilus/casei/crispatus/gallinarum (0.3-15%) 
0 4 4 
Li Ca These samples are dominated by Lactobacillus iners (75-100%). 105 87 192 
Cc These samples all contain Lactobacillus iners (44-75%) with a lower relative abundance of Lactobacillus 
acidophilus/casei/crispatus/gallinarum (19-46%). 
12 10 22 
BD A13 This sample is dominated by Bifidobacterium breve cluster 0 (69%) together with Streptococcus mitis 
group (9%), Prevotella bivia cluster 0 (5%), an Escherichia/Shigella sp. (4%) and a Veillonella sp (3%). 
0 1 1 
A15 This sample is dominated by Bifidobacterium longum (85%) together with Streptococcus anginosus 
group (6%) and Streptococcus pyogenes group (which includes group B streptococcus; 7%) 
0 1 1 
L+A 
 
A3 These samples all contain Lactobacillus crispatus/gasseri/helveticus/johnsonii/kefiranofaciens (42-53%) 
in combination with Gardnerella vaginalis clusters 0 (0.02-23%) and 1 (0.07-43%) and Peptoniphilus 
asaccharolyticus/grossensis/harei (0.02-2%).  
1 4 5 
A4a These samples all contain Lactobacillus iners (27-52%). in combination with Gardnerella vaginalis 
clusters 0 (0.3-23%) and 1 (0.06-12%) and Atopobium vaginae cluster 0 (0.02-8%). No other bacterial 
taxa are consistently present in all samples above 0.01%. However, other common taxa included 
Gardnerella vaginalis cluster 2 (≤39%; present in 33% of samples at >5%), Megasphaera cluster 0 
(≤25%; present in 38% of samples at >5%), BVAB1 (≤26%; present in 31% of samples at >5%) and 
Sneathia amnii/sanguinegens (≤20%; present in 31% of samples at >5%) 
22 17 39 
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A4b These samples all contain Lactobacillus iners (14-56%). in combination with Gardnerella vaginalis cluster 
0 (7-48%). No other bacterial taxa are consistently present in all samples above 0.01%. However 
Megasphaera cluster 0 was also common (≤26%; present in 47% of samples at >5%). 
19 19 38 
Cb These samples all contain Lactobacillus iners (40-84%), often in combination with Gardnerella vaginalis 
cluster 0 (≤27%; present in 49% of samples at >5%). 
60 55 115 
D2b These samples all contain Lactobacillus acidophilus/casei/crispatus/gallinarum (40-61%) with a lower 
relative abundance of Gardnerella vaginalis (37-44%) and a small proportion of Lactobacillus 
fermentum/gasseri/reuteri/vaginalis (0.02-7%). 
4 0 4 
F2a These samples are contain Gardnerella vaginalis clusters 0 (0.4-12%), and 1 (35-55%), in addition to 
variable proportions of Lactobacillus iners (0.03-43%) and a small proportion of Dialister microaerophilus 
(0.07-1.4%) 
4 1 5 
F2b These two samples are dominated by Gardnerella vaginalis cluster 1 (38 and 44%), and Lactobacillus 
jensenii (28 and 53%). Other bacteria include Atopobium vaginae cluster 0 (1.4 and 9%) and Gardnerella 
vaginalis cluster 0 (1.5 and 5%). 
1 1 2 
BV A1a This cluster contains high diversity samples which all contain Gardnerella vaginalis cluster 0 (0.03-20%. 
No other bacterial taxa are present consistently above 0.01%. However, common taxa include Sneathia 
amnii/sanguinegens (≤37%; present in 75% of samples at >5%), Lactobacillus iners (≤32%; present in 
40% of samples at >5%), Atopobium vaginae cluster 0 (≤30%; present in 32% of samples at >5%), 
Megasphaera cluster 1 (≤33%; present in 29% of samples at >5%), Dialister cluster 0 (≤19%; present in 
28% of samples at >5%), Gardnerella vaginalis cluster 1 (≤36%; present in 25% of samples at >5%) and 
Prevotella cluster 0 (≤24%; present in 25% of samples at >5%) 
52 47 99 
A1b This cluster contains high diversity samples which all contain BVAB1 (8-42%), Gardnerella vaginalis 
cluster 0 (0.3-16%), Gardnerella vaginalis cluster 1 (0.03-4%) and Dialister microaerophilus (0.08-1.4%). 
No other bacterial taxa are present consistently above 0.01%. However, other common taxa included 
Lactobacillus iners (≤34%; present in 52% of samples at >5%), Megasphaera cluster 0 (≤21%; present in 
48% of samples at >5%), Prevotella cluster 0 (≤15%; present in 42% of samples at >5%), Megasphaera 
cluster 1 (≤16%; present in 38% of samples at >5%), Dialister cluster 0 (≤29%; present in 32% of 
samples at >5%) and Sneathia amnii/sanguinegens (≤24%; present in 32% of samples at >5%) 
27 23 50 
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A1c This cluster contains high diversity samples which all contain Megasphaera cluster 0 (8-46%), 
Gardnerella vaginalis cluster 0 (0.4-24%), Gardnerella vaginalis cluster 1 (0.7-21%), Atopobium vaginae 
cluster 0 (0.5-8%), Dialister microaerophilus (0.02-0.6%) and Veillonellaceae (0.02-0.5%). No other 
bacterial taxa are present consistently above 0.01%. However, other common taxa included Prevotella 
cluster 0 (≤32%; present in 63% of samples at >5%), Sneathia amnii/sanguinegens (≤18%; present in 
63% of samples at >5%), Lactobacillus iners (≤15%; present in 50% of samples at >5%), Sneathia 
sanguinegens (≤21%; present in 38% of samples at >5%) and BVAB2 (≤14%; present in 25% of samples 
at >5%). 
7 1 8 
A1e These samples contain Veillonella montpellierensis clusters 0 (0.07-30%) and 1 (5-39%), Lactobacillus 
iners (0.03-5%), Gardnerella vaginalis cluster 0 (0.3-9%), Gardnerella vaginalis cluster 1 (0.3-27%), 
Prevotella bivia (0.04-23%), Peptostreptococcus anaerobius (0.18-3%) and Streptococcus 
agalactiae/pyogenes (0.04-7%) 
3 3 6 
A2 The main OTU in these samples is BVAB1 (33-68%). Additionally, all samples contain Dialister cluster 0 
(0.18-8%) and Dialister microaerophilus (0.06-0.6%). No other bacterial taxa are consistently present in 
all samples above 0.01%. However, other common taxa included Megasphaera clusters 0 (≤21%; 
present in 67% of samples at >5%) and 1 (≤23%; present in 33% of samples at >5%) and Gardnerella 
vaginalis cluster 0 (≤36%; present in 47% of samples at >5%). 
14 16 30 
A6 These samples all contain Atopobium vaginae cluster 0 (27-34%) in combination with Gardnerella 
vaginalis clusters 0 (7-12%), 1 (1.6-8%) and 2 (20-42%). 
1 2 3 
A7 These samples consist mainly of Sneathia amnii/sanguinegens (26-74%) and Sneathia sanguinegens 
(0.16-22%). Additionally, there are smaller proportions of Gardnerella vaginalis cluster 1 (0.13-2%), 
Dialister cluster 0 (0.36-6%), Dialister microaerophilus (0.05-1.3%) and Senegalimassilia (0.33-5%). No 
other bacterial taxa are consistently present in all samples above 0.01%. However, other common taxa 
included Prevotella cluster 0 (≤15%; present in 50% of samples at >5%) and Megasphaera cluster 1 
(≤11%; present in 29% of samples at >5%). 
8 6 14 
A8 These samples consist mainly of Sneathia amnii/sanguinegens (5-11%) and Sneathia sanguinegens (38-
57%). Other taxa include Lactobacillus iners (0.15-11%), Gardnerella vaginalis cluster 0 (1.3-6%) and 
Megasphaera cluster 1 (1.2-12%). 
3 0 3 
A9 These samples consist of Mycoplasma hominis (38 and 60%), an Escherichia/Shigella sp. (5 and 13%), 
Gardnerella vaginalis cluster 0 (5%) and Ureaplasma parvum/urealyticum (3 and 4%). 
1 1 2 
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A10 The main OTU in these samples is Prevotella bivia cluster 0 (37-55%). No other bacterial taxa are 
consistently present in all samples above 0.01%. Other bacteria include Anaerococcus spp., Atopobium 
vaginae, Bifidobacterium spp., Dialister spp, Gardnerella vaginalis, Megasphaera, Mycoplasma hominis, 
Parvimonas sp., Peptostreptococcus anaerobius, Senegalimassilia sp., Sneathia spp. and Veillonella 
montpellierensis. 
4 1 5 
B1a These samples consist mainly of Gardnerella vaginalis clusters 0 (6-57%) and 1 (0.03-21%). No other 
bacterial taxa are consistently present in all samples above 0.01%. However, other common taxa 
included Atopobium vaginae cluster 0 (≤31%; present in 42% of samples at >5%) Gardnerella vaginalis 
cluster 1 (≤21%; present in 27% of samples at >5%), Megasphaera clusters 0 (≤22%; present in 34% of 
samples at >5%) and 1 (≤25%; present in 37% of samples at >5%), Dialister cluster 0 (≤21%; present in 
27% of samples at >5%), Sneathia amnii/sanguinegens (≤24%; present in 40% of samples at >5%), 
Lactobacillus iners (≤24%; present in 30% of samples at >5%) and BVAB1 (≤25%; present in 27% of 
samples at >5%). 
32 51 83 
AD 
 
B1b These samples consist mainly of Gardnerella vaginalis clusters 0 (35-61%) and 1 (11-47%). 6 3 9 
B2 These samples consist mainly of Gardnerella vaginalis cluster 0 (42-97%). No other bacterial taxa are 
consistently present in all samples above 0.01%. However, other common taxa included Atopobium 
vaginae cluster 0 (≤16%; present in 36% of samples at >5%), Gardnerella vaginalis cluster 1 (≤10%; 
present in 32% of samples at >5%) and Lactobacillus iners (≤26%; present in 28% of samples at >5%). 
15 10 25 
E These samples all contain Gardnerella vaginalis clusters 0 (1.7-3%), 1 (1.0-9%) and 2 (49-84%). 2 1 3 
F1 These samples are dominated by Gardnerella vaginalis clusters 0 (0.6-10%), and 1 (60-93%). 6 10 16 
I These samples are dominated by Atopobium vaginae cluster 0 (55-95%), together with variable 
proportions of Lactobacillus iners (0.01-34%). Two samples also contain Gardnerella vaginalis clusters 0 
(11 and 13%) and 1 (11 and 33%). 
0 3 3 
PB A1d These samples consist mainly of Lactobacillus iners (15-47%) and Streptococcus mitis group (19-44%). 
Additionally, there are smaller proportions of Gardnerella vaginalis cluster 0 (0.03-1.3%), Gardnerella 
vaginalis cluster 1 (0.05-0.13%), Sneathia sanguinegens (0.02-0.05%), Granulicatella elegans (0.06-
1.3%) and a Staphylococcus sp. (0.02-0.09%). 
3 0 3 
A5 This sample contained Streptococcus anginosus/milleri (59%) and Lactobacillus 
crispatus/gasseri/helveticus/johnsonii/kefiranofaciens (38%). 
0 1 1 
208 
 
A14 These samples contain an Escherichia/Shigella sp. (43-74%), Streptococcus anginosus group (7-33%), 
Enterococcus durans/faecalis/faecium (1.2-7%), Gardnerella vaginalis cluster 1 (0.1-14%) and 
Streptococcus mitis group (0.4-13%). 
1 1 2 
H1 These samples all contain Streptococcus agalactiae/pyogenes (29-54%). No other bacterial taxa are 
consistently present in all samples above 0.01%. However, other common taxa included Prevotella bivia 
(≤31%; present in 60% of samples at >5%) and Gardnerella vaginalis cluster 1 (≤34%; present in 60% of 
samples at >5%). 
1 4 5 
H2 These samples are dominated by Streptococcus agalactiae/pyogenes (53-98%), together with variable 
proportions of Lactobacillus iners (0.01-34%). 
3 4 7 
J This sample is dominated by Streptococcus dysgalactiae/pyogenes (98%). 0 1 1 
N/A A11 This sample is dominated by Scardovia wiggsiae (79%) together with Streptococcus anginosus group 
(12%). 
0 1 1 
 
